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Conventional clinical diagnosis of epithelial cancer involving excisional biopsies 
followed by histopathological examination of suspicious lesions is often associated 
with a low detection sensitivity as well as psychological trauma and risk of infection 
to patients. Recent advances in reflectance-based optical imaging such as reflectance 
confocal endomicroscopy and Optical Coherence Tomography (OCT) are developed 
to perform minimally invasive “optical biopsies” to diagnose diseases in vivo. 
Although these imaging technologies provide cellular resolution, their optical contrast 
between normal and cancerous tissue is often too modest to be of any significant 
clinical value. Furthermore, they are unable to image the molecular changes 
associated with early stage carcinogenesis which is critical for early pre-cancerous 
detection and rational therapeutic intervention. 
 
This thesis examines the use of gold nanostructures as an exogenous cancer-specific 
optical contrast agents for reflectance-based imaging to supplement the weak inherent 
contrast signal associated with disease pathology and improve the contrast between 
different tissue types involved in early-stage epithelial carcinogenesis. Here, the focus 
is on the development and application of gold nanoshells in cancer detection based on 
the expression of the Epidermal Growth Factor Receptor (EGFR) as a clinically 
relevant prognostic marker. The hypothesis is that the use of gold nanoshells could 
increase the optical contrast between normal and suspicious lesions and 
simultaneously provide useful molecular specific information for the diagnosis of 
these lesions in vivo when used with confocal reflectance microscopy and OCT.  
 xiv
The approach adopted includes developing and characterizing gold nanostructure 
probes, conducting in vitro assessment of their optical contrast, examing their optical 
properties in phantom models and evaluating their efficacy in animal models. Gold 
nanoshells that are optically tuned to the imaging source wavelength are designed 
based on theoretical prediction of their optimum dimensions prior to synthesis and 
chacterization of their optical properties. The gold nanoshells are then surface 
functionalized with anti-EGFR through covalent conjugation with the antibody and its 
ability to improve the optical contrast to discriminate cancer from normal cells and 
provide molecular mapping of EGFR on cellular surface are assessed in vitro. 
 
The optical properties of gold nanoshells in non-biological tissue phantom models are 
examined under the OCT to investigate the different factors affecting the optical 
contrast in tissue phantoms. The results of in vitro and phantom studies provide the 
impetus for further in vivo studies which demonstrates the control of optical contrast 
by gold nanoshells in a mouse xenograft tumor model. This is achieved through 
different delivery modes, concentration variations of gold nanoshells and antibody 
targeting. The antibody targeting in vivo also allows gold nanoshells to image changes 
in molecular markers expression for real-time early diagnosis. Successful 
development of contrast enhancing gold nanostructure probes allows in vivo 
diagnostic imaging with increased sensitivity and specificity, resulting in early 
detection and management of pre-cancers through the combination of phenotypic 
markers and expression profiling of molecular markers using the gold nanostructure 
probes. 
 xv
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1.1 Conventional cancer diagnosis  
The survival of cancer patients is related to different stages of malignancy detected. 
Early detection of malignant lesions is not only crucial to the clinical outcome of 
treatment, but also exerts a significant impact on reducing the recurrence rate in most 
cancers. This is true for many epithelial type cancers which originate in the epithelium 
of hollow organs in the body e.g. oral, lungs, GIT and bladder. The current clinical 
detection of most epithelial type cancers typically involve visual examination 
followed by invasive excisional needle biopsies on suspicious lesions and histological 
examination on the excised tissue as illustrated in Figure 1.1 below. 
 
 
Figure 1.1. Conventional approach to clinical detection of epithelial type cancer such 
as oral cancer using white light endoscopy for visual examination followed by needle 




The biopsy process may introduce risks associated with tissue removal, along with 
delay, expense and psychological trauma to patients [1]. Biopsy is usually performed 
only under the condition that the lesions are spotted and appear abnormal [2]. Yet, 
pre-cancerous lesions can appear innocuous or occur in hidden sites and can therefore 
easily go undetected even with white light endoscopy [3]. Also, tissue sampling may 
not adequately represent the actual pathological condition of the entire tissue because 
of tissue heterogeneity, which is especially characteristic of tumors [4]. Furthermore, 
conventional histopathological diagnosis of these biopsies is largely based on 
phenotypic assessment of differences in cellular features which may not be 
discernable in early stage lesions that appear similar to surrounding normal tissue [5]. 
 
1.2 Optical imaging in biopsy 
Amongst the various imaging tools available for use in laboratory research or clinical 
imaging of pathological conditions such as cancer, optical imaging finds its niche in 
providing subcellular resolution which is a pre-requisite for imaging at the cellular 
and molecular levels. To overcome the shortcomings associated with excisional 
biopsies, recent advances in optical imaging are geared towards performing the 
concept of optical biopsy. Amongst the wide range of optical imaging modalities 
available to clinicians today, fluorescence imaging remains the most widely used. 
Despite their known limitations in photobleaching which may result in a bias during 
quantitative signal analysis, practically all of the current optical molecular imaging 
efforts involve the use of fluorescence, due partly to its high signal-to-noise ratio and 
a large variety of dyes available for multilabeling. It has been widely investigated in 
both the laboratory and clinical settings to detect and diagnose suspicious conditions 
or lesions in various tissue and organs of the body. 
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These fluorescence techniques are based on direct visualization of changes in optical 
properties such as fluorescence in tissue. The changes in fluorescence can arise from 
fluorescent dyes selectively accumulated in lesions e.g. tumors as in the case of 
photodynamic diagnosis [6, 7] or it can also involve detection of changes in the 
intrinsic autofluorescence of tissue in the presence of tissue abnormalities [8]. These 
fluorescence are often used to detect pre-cancerous or flat lesions of epithelial 
carcinomas under a fluorescence endoscopy system which would otherwise easily go 
undetected under the naked eye as shown in Figure 1.2. Fluorescence imaging has 
recently demonstrated its potential in grading bladder cancer in situ [9]. 
 
 
Figure 1.2. A fluorescence endoscopic system used in the clinical setting (left and 
middle) to detect flat lesions such as carcinoma in situ which would otherwise be 
missed under the naked eye (right). In this case, the flat lesion shows up in red 
fluorescence under the blue excitation light. 
 
Other less widely used, but nonetheless emerging non-fluorescent based advanced 
optical imaging systems such as diffuse optical tomography, confocal reflectance 
endomicroscopy [10-12] and optical coherence tomography (OCT) [13, 14] etc. are 
increasingly gaining attention in the early detection of diseased conditions. These 
non-fluorescent imaging techniques form their image based on other types of optical 
changes such as optical absorption or scattering and offer promising clinical 
application especially in the area of cancer imaging by increasingly proving 
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themselves to offer alternative angles in examining the same biological problems or 
diseased conditions, thereby potentially yielding greater diagnostic values.  
 
In areas where fluorescence imaging remains inaccessible such as imaging tissue 
histology in situ, these non-fluorescent techniques allow tissue structures such as 
stromal morphology to be imaged in situ without the need for any staining [14, 15]. 
These optical imaging systems, in particular the reflectance-based optical imaging 
such as reflectance confocal endomicroscopy and OCT, have been developed for in 
situ imaging of superficial tissue to perform minimally invasive optical biopsies to 
diagnose diseases in vivo due to the high resolution they afford [13, 16-19]. 
 
1.3 Reflectance-based optical imaging 
Reflectance-based optical imaging technique is a class of non-fluorescent imaging 
that examines tissue and forms images based on incident light that are backscattered 
from tissue samples without the use of fluorescence. They collect the backscattered 
light from tissue to provide a detailed two-dimensional image of it with a high spatial 
resolution of 1–25 μm and penetration depth ranging from 200 μm to 2 mm without 
the need for physical sectioning [13, 20]. Unlike the fluorescence imaging which 
primarily examines molecular changes and are unable to image structures in tissue 
without the aid of multiple staining processes, these reflectance-based imaging 
techniques allow tissue structures such as stromal morphology to be imaged without 
any prior staining [14, 15]. 
 
These high-resolution optical imaging systems are emerging clinical imaging 
modalities that allow real-time, non-invasive imaging of epithelial tissue in situ at the 
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cellular resolution and have proven themselves to offer alternative angles to 
fluorescence imaging in examining the same diseased conditions. They also offer as 
alternatives to conventional histopathology by non-invasively imaging stromal 
morphology at high resolution in real-time to significantly improve our ability to 
visualize and evaluate the epithelial tissue in vivo at the microscopic level. These 
optical imaging systems are typically simple, portable and inexpensive and they 
provide resolution much higher compared to other existing clinical imaging 
modalities such as CT, MRI or PET. 
 
Both the confocal reflectance and OCT image tissue based on such backscattered light 
and are able to detect tissue structural abnormalities by picking up changes in their 
light scattering behavior through refractive index mismatches in tissue. As such, they 
are well suited for examining superficial intraepithelial lesions. Several studies 
involving these imaging systems have reported promising applications in oncology 
such as the imaging of structural changes oral mucosa associated with carcinogenesis 
under a confocal endomicroscope [21], the detection of bladder cancer in small 
animal models [14] and the detection of oral cancer in animal models where OCT has 
shown to differentiate between tissues at different stages of malignancies [15].  
 
Despite their advantages of doing away with biopsies and their ability to provide 
cellular resolution for imaging, the issues associated with phenotypic assessment of 
cellular features remains. As these optical systems rely on scattering processes in 
tissue to form images, they can be rather indiscriminate in highlighting diseased states 
[5]. Their modest optical contrast and specificity between normal and cancerous tissue 
especially those of early malignancies are often too low to be of any significant 
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clinical value [22-26]. Therefore, these imaging modalities may miss early stage 
carcinogenesis as the visual phenotypic cues for discrimination between non-
malignant, pre-cancerous dysplastic and early carcinoma lesions are small. Changes 
associated with early stage carcinogenesis can be detected through molecular changes 
in tissue and these optical imaging modalities are unable to probe and image these 
early molecular abnormalities [27] which can provide crucial information for earlier 
and more accurate diagnosis of suspicious pre-cancerous lesions due to the detection 
limitations in their optics.  
 
1.4 In vivo clinical molecular imaging 
Molecular imaging sets forth to probe the molecular abnormalities in cancer 
biomarkers associated with carcinogenesis. These molecular changes usually precede 
any phenotypic changes which are a late manifestation of these molecular changes. 
Hence, while the phenotypic features of cancer may be absent in early stage pre-
cancers, molecular changes such as genetic disturbances and receptor expression 
abnormalities are already present in these populations. They result in excess or 
reduced production of enzymatic or structural components of cells, or of factors 
regulating their production.  
 
These early molecular signatures such as receptor expression abnormalities, which 
may remain present in small tumor populations, can provide critical information for 
earlier diagnosis of suspicious epithelial lesions compared to the later phenotypic 
changes [28]. Since these cancer-associated molecular markers precede phenotypic 
manifestations of disease, molecular imaging have the potential to base disease 
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detection on early molecular abnormalities before diseases become obvious with 
traditional anatomical-based imaging techniques.  
 
While these molecular changes can be detected in vitro using immunohistochemical 
staining, they have yet to impact in vivo imaging mainly because the high-resolution 
optical imaging modalities are designed for imaging tissue structures rather than their 
intrinsic molecular events. However, with the current growing research interest in 
clinical molecular imaging, it is likely that in the near future, contrast agents targeted 
to molecular markers of disease will routinely provide molecular information that 
enables characterization of disease susceptibility long before pathologic changes 
occur at the anatomic level. 
 
Molecular imaging requires a target cancer biomarker highly relevant to the pathology 
being examined. Amongst the wide range of cancer biomarkers investigated, the 
expression of Epidermal Growth Factor Receptor (EGFR) is a clinically relevant 
cancer biomarker often associated with epithelial type cancers. EGFR is encoded by 
the gene c-erbB-1, which is a prototype membrane of the type I transmembrane 
receptor tyrosine kinase found in cellular surface. The EGFR is a 170 kDa plasma 
membrane glycoprotein containing an extracellular ligand-binding domain, a single 
transmembrane region, a cytoplasmic domain which is composed of a tyrosine kinase 
domain and a C-terminal tail. 
 
Since EGFR directs the initiation of processes such as growth, proliferation, 
apoptosis, adhesion, migration, and differentiation, it is related to the uncoupling of 
the growth program of cells from environmental signals. EGFR realize its function in 
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the initiation of cell growth processes when it is activated by the binding of the 
ligands EGF or TGFα to its external domain [29, 30]. Upon binding of a specific 
ligand to its extracellular ligand-binding domain, the EGFR receptor dimerizes or pair 
with another ErbB family member (see Figure 1.3 for the EGFR signaling pathway). 
This dimerization may be homodimerization (i.e. EGFR dimerizes with another 
EGFR) or heterodimerization (e.g. EGFR dimerizes with ErbB-2, ErbB-3, or ErbB-4) 
determined by the levels of each receptor, and the particular ligand bound to the 
receptor. This activation then results in phosphorylation of tyrosine amino acid 
residues in both receptors by the receptors’ intrinsic tyrosine kinase activity, and 
subsequent cellular proliferation, transformation and division [31].  
 
 
Figure 1.3. EGFR signaling transduction pathway in cancer cells. 
 
Various ‘adaptor’ proteins, such as Shc and Grb2, are then recruited to the 
phosphorylated tyrosines, and transduce signals via major cell signaling pathways that 
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are comprised of signaling molecules such as the nitrogen-activated protein kinase 
(MAPK), and the p70 S6α kinase, and also multiple phosphoinositide 3-kinases 
(PI3K), protein kinase C (PKC), and the p70 S6β kinase. The sequential activation of 
these and other molecules transmit signals from the receptor dimers at the cell surface 
through particular pathways to, ultimately, the transcription machinery in the nucleus. 
The final aspect of the EGFR signaling process occurs with the receptor undergoing a 
conformational change (concomitant with ligand binding) that results in the exposure 
of motifs for endocytosis and degradation. The endocytosis of the receptor is the 
mechanism for down-regulation of signaling from the activated EGFR. 
 
Overexpression, or increased abundance, of EGFR in cancers was first identified by 
investigators from LICR (Ludwig Institute for Cancer Research) who also have done 
dominant research in the EGFR area. EGFR is overexpressed in vast majority of 
epithelial cancers [32, 33]. EGFR expression in normal cells ranges from 40,000 to 
100,000 receptors per cell [34]. In many cases, the number of EGFRs expressed in 
malignant cells is greater than that expressed in normal cells; up to 2 x 106 EGFRs per 
cell were reported in the human epidermoid carcinoma cells A-431 [35]. An ELISA 
analysis of the amount of EGFR in cell lysate of a few cancer cell lines belonging to 
two types of cancer i.e. nasopharyngeal carcinoma (NPC) and bladder carcinoma that 
are conducted by the author is also compared to normal human bronchial epithelium 
cells is shown in Figure 1.4. Compared to normal cells, the cancer cell lines all show 
higher EGFR expression in cell lysate. 
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Figure 1.4. ELISA analysis of EGFR expression in cell lysate of a few cancer cell 
lines belonging to either the nasopharyngeal or bladder carcinoma family. The 
expression is compared to normal human bronchial epithelium (NHBE) cells which 
show much lesser EGFR expression. The EGFR expression for A-431 cells is shown 
as a positive control since A-431 is well known to have a high expression of EGFR. 
 
EGFR overexpression is detected at all stages of carcinogenesis ranging from the 
premalignant early hyperplastic lesions to dysplasia and invasive carcinoma [36, 37]. 
In addition, EGFR expression is also known to be progressively elevated during the 
progression from hyperplasia to dysplasia to invasive carcinoma [38, 39]. 
Furthermore, EGFR expression is also elevated in normal epithelium that is adjacent 
to tumor [38].  
 
Therefore, the ability to noninvasively image and assess the changes in EGFR 
expression in real time in vivo under high resolution reflectance-based optical imaging 
potentially holds several clinical implications for early cancer diagnosis that is based 
on molecular specific changes. It could translate into improved ability to detect early 
dysplastic changes leading to early detection of premalignant lesions and improved 
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diagnosis of cancer and reducing incidence of cancer in high-risk individuals. It could 
also potentially serve to monitor the progression of cancer. Also, with an image map 
of the expression level of relevant biomarker in early stage pre-cancerous lesions, 
rational treatment can be better prescribed, resulting in better patient management. 
 
1.5 Optical coherence tomography 
Amongst the different modalities in reflectance-based imaging, OCT is an emerging 
imaging modality that is gaining widespread attention in recent years [13]. It is a high 
resolution optical imaging system that can potentially be used to noninvasively image 
and assess molecular changes in real time in vivo with the aid of an appropriate 
contrast agent. It is based on the principle of low coherence interferometry [13, 40] 
using a low coherence NIR light source that produces cross-sectional images by 
measuring the time delays and magnitude of optical echoes of coherent light 
backscattered from tissue. OCT is analogous to acoustic ultrasonography except that 
instead of using reflected acoustic waves, it detects tissue abnormalities by picking up 
reflections of low coherence NIR light waves due to changes in backscattering of light 
arising from mismatches in refractive indices within the tissue sample [13, 41]. The 
basic OCT scheme is shown in Figure 1.5 below. 
 
The key advantage of OCT in imaging is that it allows for high resolution cross-
sectional tomographic imaging across a mucosal surface in vivo with a typical axial 
and lateral resolution of ≈ 10 and 25 μm respectively, although the resolution tends to 
decrease with depth. The OCT light source typically operates in the NIR region (800–
1500 μm) where the scattering and absorption in tissue is minimal and the light 
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penetration in tissue is maximized to sufficiently pass through the mucosa to image 
tissue from the epithelium down to the serosa with depths of 2 to 3 mm in situ. 
 
 
Figure 1.5. Typical setup of a basic time domain OCT system [27]. 
 
OCT is becoming a standard imaging modality in ophthalmology to image the retina 
and recent studies have shown promising applications for in situ oncological imaging 
specifically in bladder and gastroenterological applications to examine superficial 
epithelial-based tumors. Given its high resolution, OCT is able to perform an optical 
biopsy to image tissue microstructures in vivo with image quality comparable to 
conventional histopathology [14, 15, 40, 42, 43]. In fact, studies have shown that the 
structural features observed under the OCT correspond well to the stained 




Figure 1.6. Histology image of untreated mouse skin with a subcutaneous tumor (left 
image), a ruler with a total length of 1 mm, and a representative OCT image (different 
location) is shown on the right image. Three different tissue layers in depth are 
indicated on the histology image: (A) skin, (B) connective tissue, and (C) tumor 
periphery consisting of the capsule and the upper part of the tumor, with arrows 
pointing to the same tissue layers in the OCT image to show the comparable 
correspondence between histology and OCT [45]. 
 
The ability to obtain high resolution images has led to several promising clinical 
applications in the diagnosis of cancers in real time [40, 42, 46-50] where OCT can be 
used to identify epithelial thickening and changes in stratification and structure of the 
mucosa during carcinogenesis [15, 51] without the need for tissue removal and 
sectioning. The use of OCT to image cancer in the hamster cheek pouch for different 
types of malignancy is shown in Figure 1.7 as an example. These tissue abnormalities 
that are observable under the OCT are usually associated with later stage carcinoma 
where the gross phenotypic changes are obvious compared to the subtle changes that 




Figure 1.7. OCT image of a normal hamster cheek pouch versus H&E stained 
histological section (top). In vivo OCT image of cheek pouch with dysplasia versus 
the histological section (middle) where epithelial thickening, inflammation and 
increased cellular proliferation are evident. OCT image of hamster cheek pouch 
containing squamous cell carcinoma tumor versus histology (bottom). The labeling in 
the images are given by: e, squamous epithelium; m, mucosa; s, submucosa; t, 
fungiform malignant tissue; b, basement membrane [51]. 
 
The reason for the difficulty in picking up the changes is due to the OCT operating in 
reflectance mode. Optical contrast in reflectance is attributed to refractive index 
mismatches within the sample [40]. The image signal from tissue thus arises from 
spatial fluctuations in tissue refractive index, which are dependent on extracellular 
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matrix architecture and intracellular composition such as the density of organelles [52, 
53]. Whilst the intrinsic OCT optical contrast in diseased state may arise from 
subcellular changes that alter light scattering such as increase in nuclear size, these 
optical change are usually similar amongst different tissue. Most pathological changes 
especially those associated with early stage carcinoma are usually not accompanied 
by an inherently strong endogenous contrast signal which can be imaged [23, 25]. 
Even though there are reports that demonstrate the use of OCT to identify phenotypic 
differences between normal and dysplastic tissue, the image contrast is often too 
modest to be of any significant clinical value. 
 
Furthermore, many other valuable molecular indicators of tissue abnormalities do not 
generate obvious intrinsic optical contrast under the OCT and the coherence gating 
process underlying the formation of OCT images renders its detection of incoherent 
fluorescence processes impossible. This makes the OCT insensitive towards imaging 
molecular changes labeled with a fluorescence probe [27]. Their use for imaging of 
early molecular changes would thus require an alternative class of labelers that rely on 
elastic coherent light scattering and are compatible with the reflectance-based regime. 
 
As with other optical imaging tools, the effectiveness of OCT in clinical imaging can 
be improved with appropriate contrast enhancement. Since OCT detects changes in 
optical scattering, image contrast enhancement can be achieved by delivery of 
contrast agents with good light scattering properties into the tissue and allowing them 
to localize in and change the light scattering property of specific region of interest. 
This image contrast enhancement can also be made specific to a relevant cancer 
biomarker i.e. EGFR for performing molecular imaging by using a target-specific 
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contrast agent which can target EGFR and elicit an image contrast to enhance the 
conspicuity of subtle pathologies for early detection of premalignant lesions. 
 
1.6 Performing molecular contrast in OCT 
Reflectance-based imaging of tissue is sensitive only to variations in refractive index 
within the tissue and molecular changes associated with pathophysiology do not result 
in these variations. Therefore, the ability of reflectance-based imaging to image 
cancer biomarkers is limited. Furthermore, the methods to elicit molecular contrast 
under an OCT are constrained by its coherent detection boundary of interferometry. 
The coherence gating process underlying the formation of OCT images renders their 
detection of incoherent fluorescence processes impossible. Therefore, fluorescent 
based contrast agents that are commonly used for molecular imaging in many optical 
imaging modalities cannot be detected in any OCT detection scheme since 
fluorescence is an incoherent optical process with no optical phase relationship with 
its excitation light field. This makes OCT insensitive towards imaging molecular 
changes labeled with a fluorescent contrast agent.  
 
The use of OCT for in situ imaging of early molecular changes would therefore 
require alternative contrast agents that are compatible. Fortunately, various modified 
OCT schemes that show promise in imaging molecular changes with the aid of 
contrast agents have been reported to date and can be broadly categorized into three 
major groups. The first group of molecular contrast OCT schemes involves 
introducing contrast agents with a specific optically excitable absorption transition 
such as the pump-probe [54] and pump-suppression [55] molecular contrast OCT or a 
well-identified absorption spectrum in the target sample such as spectroscopic OCT 
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[56] and spectral triangulation MCOCT [57]. They rely on the changes in absorption 
spectrum of backscattered light to provide the contrast and are limited in their range 
of contrast agents and complex in instrumentation requirements.  
 
The second group exploits coherent, nonlinear optical methods to identify endogenous 
molecular properties [58, 59] using contrast agents that can efficiently and coherently 
convert the incoming OCT illumination light field into an emission light field that is 
amendable to interferometry detection such as second harmonic OCT [60-62] and 
coherent anti-Stokes Raman scattering (CARS)-based contrast OCT [59]. These 
techniques are limited both in sensitivity and specificity [27].  
 
The third group makes use of exogenous contrast agents that are able to alter the light 
scattering property of tissue to profile its distribution in the sample. The traditional 
way of improving the contrast in OCT images employs the use of osmotically active 
immersion liquids such as glycerol, propylene glycol, dextranes and concentrated 
glucose solution to cause a change in the tissue refractive index [63, 64]. This is 
improved with a new generation of contrast agents based on particle technologies due 
to their improved optical properties and ease of performing surface modifications. 
There are a few scattering-based particulate contrast agents reported to date such as 
the engineered oil-filled microspheres [65], air-filled microbubbles [66, 67], magnetic 
nanoparticles [68] and metallic nanostructures [26, 69-72]. These contrast agents have 
been developed to improve the OCT image by enhancing the intensity of 
backscattered light from the tissue. The improvement in optical contrast as 




Figure 1.8. (a) OCT images of a normal human esophageal tissue without (top) and 
with (bottom) topical application of propylene glycol solution [64]. (b) OCT image 
enhancement with engineered microsphere contrast agents showing images of mouse 
liver (left) without and (right) with gold-shelled oil-filled microsphere contrast agents 
[65]. (c) OCT images obtained before (top) and after (bottom) injection of 
microbubbles [67]. 
 
These exogenous contrast agents are, in themselves, are nonspecific, but can be 
tagged to the relevant molecular markers with appropriate surface functionalization to 
perform molecular imaging. The advantage of using these scattering-based contrast 
agents is that their presence in tissue can create a sizable change in OCT signal 
without any complex modification to the existing OCT implementation. 
 
Among these scattering-based contrast agents, metallic nanostructures have been the 
most widely investigated. Different types of metallic nanostructures with different 
shapes and metal composition having peak optical response over a broad range of 
wavelengths have recently been developed and investigated by several groups as 
promising contrast agents for reflectance-based imaging techniques due to their 
favorable optical properties. The peak optical response of some of these metallic 
nanostructures is shown in Figure 1.9. 
 
(a) (b) (c) 
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Figure 1.9. A list of silver and gold nanostructures having various morphologies, 
compositions, and structures, together with their typical locations of peak optical 
response in the visible regime [73]. 
 
Among these, gold nanostructures have been the most commonly used. The use of 
gold nanostructures as an OCT contrast agent with the potential to perform target-
specific molecular contrast of EGFR expression for early cancer detection is 
examined in this thesis. For these contrast agents to be effective, three main 
considerations need to be addressed. Firstly, the contrast agent must be optically tuned 
and matched to the source wavelength of the OCT to provide an optimum scattering 
response to the system. Secondly, they must be functionalized with appropriate 
surface moieties not just to target and bind to the molecular target of interest to elicit 
the molecular contrast, but also to avoid immuno recognition and clearance from 
living systems. Thirdly, they must be sufficiently small to be efficiently delivered to 
the target tissue via the bloodstream. 
 
1.7 Gold nanostructures as optical contrast agent in OCT 
The use of several types of gold nanostructures such as solid gold nanoparticles [26], 
nanoshells [69, 72], nanocages [70] and nanorods [71] to address the limitations of 
reflectance-based imaging in biological imaging has been demonstrated [74, 75]. 
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These nanostructures exhibit surface plasmon resonance (SPR) which allow them to 
resonantly scatter light when excited at their SPR frequency to create strong optical 
scattering signals for imaging [76, 77]. This optical scattering signal is much stronger 
compared to other non-metallic nanoparticles of similar size as shown in Figure 1.10.  
 
 
Figure 1.10. (A) and (B) compare scattering properties of gold particles and 
polystyrene beads of approximately the same diameter. In (A), suspensions of gold 
nanoparticles (left) and polymeric spheres (right) were illuminated by a laser pointer 
that provides light in the 630 – 680 nm region. The images were obtained using a 
regular web camera at a 90° angle relative to illumination. To acquire the images of 
both suspensions under the same conditions, the concentration of the polymeric beads 
(in particles/ml) was increased 6-fold relative to the concentration of the metal 
nanoparticles. (B) shows the wavelength dependence of visible light scattering by the 
polystyrene spheres and the gold nanoparticles. The spectra were obtained from 
suspensions with the same concentration of metal and polymeric nanospheres [26]. 
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Gold nanostructures have been routinely used as optical labelers for electron 
microscopy and more recently, their use in reflectance-based molecular imaging has 
also been investigated. These gold nanostructures differ in their shape, size, 
composition and structure to give peak optical response at different spectral 
wavelength (Figure 1.9). Amongst the different types of gold nanostructures, gold 
nanoshells have been an emerging subject of recent research as their efficiency as an 
exogenous contrast agent for optical imaging of cells [72] and tissue phantoms [78] as 
well as a therapeutic agent for cancer [79] is well documented in recent years. 
 
Gold nanoshells are a novel class of optically active metallodielectric concentric 
sphere nanostructure consisting of a spherical dielectric core, usually made of silica or 
polystyrene, surrounded by a thin gold shell of nanometer thickness [80-82]. They are 
generally easier to prepare compared to nanorods or nanocages and their synthesis is 
highly controlled. Their optical response is plasmonic in origin where the layer of 
gold allows these nanoparticles to exhibit surface plasmon resonance (SPR) in which 
the oscillating electron cloud in the gold shell interact with light to produce an optical 
response that resonantly scatters the light as illustrated in Figure 1.11 to produce a 
scattering cross section several times the particle geometric cross section in the NIR 
[83]. The scattering cross section is also much higher compared to other nanospheres 
of the same size but having different composition. Besides scattering, these particles 




Figure 1.11. A scheme of surface plasmon absorption of spherical nanoparticles 
illustrating the excitation of the dipole surface plasmon oscillation to produce surface 
plasmon resonance when the excitation frequency matches the frequency of 
oscillation. 
 
However, the main reason for the popularity of gold nanoshells in imaging lies in 
their unique core-shell nanostructure which allows a tunable optical response to match 
the excitation wavelength of many optical imaging systems. Unlike solid gold 
nanoparticles which possess a relatively invariable plasmon resonance peak at ≈ 520 
nm, the peak optical response of gold nanoshells can be systematically tuned over a 
broad range of the optical spectrum from the visible right up to the near infrared 
(NIR) wavelengths [76]. This is done simply by changing the relative dimensions of 
the core size to shell thickness as well as the dielectric properties of the core and 




Figure 1.12. A Mie scattering plot of the plasmon resonance wavelength shift as a 
function of nanoshell composition. In this figure, the core and shell of the 
nanoparticles are depicted to relative scale directly beneath their corresponding 
optical resonances. For a core of a given size, forming thinner shells pushes the 
optical resonance to longer wavelengths [86]. 
 
The optical scattering properties of such structures coupled with their optical 
tunability have spur the use of gold nanoshells as a promising optical contrast agent 
where their optical response can be tuned to interact with light of a wide range of 
wavelengths, which includes the 750 – 800 nm optical window for biomedical 
imaging where tissue absorption of light is minimal to give rise to optimal light 
penetration as shown in Figure 1.13. This optical window includes the NIR region 
where the NIR scattering in tissue is also known to be weak. Gold nanoshells can thus 
be used to improve the SNR when used in the NIR region thus making them attractive 
as contrast agent in this wavelength range. 
 
The wide range of light interaction also facilities the matching of gold nanoshells 
optical response to a range of light sources of different wavelengths used in different 
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promising clinical imaging modalities, especially those that operate in the NIR. These 
include the scatter-based darkfield imaging [72], optical coherence tomography 
(OCT) [81, 82, 87] and photoacoustic tomography (PAT) [88] for deep tissue imaging 
where the contrast between normal and pathological tissue is usually poor. 
 
 
Figure 1.13. The NIR window is ideally suited for in vivo imaging because of minimal 
light absorption by hemoglobin (<650 nm) and water (>900 nm) [89]. 
 
Besides its spectral tunability, the relative contribution of the gold nanoshells optical 
extinction between scattering and absorption at a given wavelength can also be 
controlled by varying the absolute particle size [90]. Therefore, it is possible to 
engineer gold nanoshells to either primarily scatter light for imaging, or absorb and 
convert light into thermal energy to render them useful for photothermal therapy 
(PTT) applications such as the photothermal ablation of cancer cells. Such 
photothermal therapy offers a minimally invasive procedure to remove tumors 
providing an attractive option in situations where surgery is not possible. Several 
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studies using gold nanoshells immunotargeted to cancer cells have demonstrated 
effective destruction of the cancer cells upon exposure to NIR light, with cell damage 
limited to the laser treatment spot [79, 91-93] (See Figure 1.14). 
 
 
Figure 1.14. Calcein AM staining of cells (green fluorescence indicates cellular 
viability). Left: cells after exposure to laser only (no nanoshells). Middle: cells 
incubated with nanoshells but not exposed to laser light. Right: cell incubated with 
nanoshells after laser exposure. The dark circle seen in the image on the right 
corresponds to the region of cell death caused by exposure to laser light after 
incubation with nanoshells [81]. 
 
Apart from their optical properties, gold nanoshells also possess other favorable 
physicochemical properties for biomedical applications. Their rigid metallic structure 
makes them photostable and far less susceptible to chemical or thermal denaturation 
compared to many conventional fluorescent dyes. The surface of gold nanoshells can 
be readily functionalized with targeting moieties such as antibodies or peptides of 
interest for selective targeting to specific diseased sites to probe for specific proteins 
of clinical interest with high specificity and affinity [72, 81, 92, 94]. This is because 
the same conjugation protocols widely used to bind these biomolecules to colloidal 
gold can easily be modified for nanoshells.  
 
Gold nanoshells can be designed to target to cancer biomarkers by conjugating them 
directly to antibodies using the simple non-covalent passive absorption or via linkers 
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with more robust coordinate bonds. Because of the ability of gold to form strong thiol 
and disulphide bonds, they can be attached to one end of the linkers bearing a thiol or 
disulphide group while the other end of the linker connect to the antibodies using 
amide bonds. Their coupling to appropriate biomarkers leads to the development of 
targeted contrast agents that provide useful optical signal to enable the competent 
imaging of cancer markers in tissue. Such molecular specific information may 
potentially assist clinicians by facilitating early molecular detection and diagnosis of 
pre-cancers [26, 71, 72].  
 
The potential of gold nanoshells in biological applications have recently been 
demonstrated in several studies, including their use in molecular imaging, as contrast 
agents for OCT and also in photothermal therapeutic applications [72, 91, 92, 95]. 
Gold nanoshells with core made of microparticulate polymer beads or nanoparticulate 
silica have shown promise to enhance the optical contrast in OCT. Lee et al. reported 
the first demonstration of using gold nanoshells to improve the optical contrast in 
OCT by injecting oil-filled microspheres of diameter 0.2 to 2 μm surrounded by an 
approximate 50 nm thick gold shell into mice and imaging their liver to show an 
enhanced OCT signal compared to controls [65]. Gold nanoshells using silica as the 
core have also shown promise as non specific contrast agent in OCT [69]. The unique 
optical properties of gold nanoshells encourage further studies on their role as 
optically active agents in OCT. 
 
1.8 Toxicity and clearance of gold nanostructures 
Another reason for the popularity of gold in biological applications in that gold is also 
known to be biologically inert with excellent inherent biocompatibility [96, 97] in 
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living systems which renders them appropriate for biomedical applications. The use of 
gold in human subjects poses minimal toxicity as it has been approved by FDA for its 
medicinal uses as a dietary supplement as well as applied for long term clinical 
treatment of certain disease conditions such as rheumatoid arthritis [96, 98]. Despite 
their inert nature, it would still be worthwhile to mention some of the issues 
concerning the use of gold nanoparticles. Although the reported in vitro results on the 
use of gold nanoparticles seem promising, their use in the same manner in vivo would 
warrant attention to the challenges in the way these nanoparticles could potentially 
elicit any body response and subsequently be eliminated from the body system with 
minimal side effects after their diagnostic use. 
 
Previous studies by other groups have shown that these gold nanoparticles tend to be 
taken up by the cells through endocytosis as fast as 1 h into the incubation with gold 
nanoparticles [97]. In most cases with antibody targeting, the antibody binding to cell 
surface receptor could potentially provide a receptor-mediated endocytosis route for 
the gold nanoparticles. Connor and colleagues examined a series of gold nanoparticles 
for cellular uptake and acute cytotoxicity in human leukemia cells and found that 
despite being taken up into the cells, spherical gold nanoparticles with a variety of 
surface modifiers were not inherently toxic to human cells [97]. Mukherjee et al have 
also shown that gold nanoparticles have no effect on gene expression or other global 
transcriptional pattern of human umbilical vein endothelial cells (HUVEC) [99]. 
 
Although tests on other forms of body response in terms of cellular adhesion effects, 
local biological effects or other systemic and remote effects have not been widely 
reported, previous literatures have shown that gold nanoparticles are sufficiently inert 
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to be injected to living animals without major complications. The small size of these 
particles enables them to extravasate out of the microcirculation easily and diffuse 
through the interstitial compartments of tissue efficiently. Without proper surface 
functionalization, most of the circulating nanoparticles will be trapped by 
reticuloendothelial system in liver, kidney, spleen and lungs and may remain there 
and in other tissue for a long time without interfering with metabolism of cells, 
although a small amount may be secreted to the bile or urine [100, 101].  
 
Whilst metal poisoning is often associated with renal and hepatic toxicities, 
Mukherjee et al. have determined the effect of gold nanoparticles administration on 
liver and renal function on mice and found that there were no significant differences 
between serum levels of creatinine, blood urea nitrogen, bilirubin alkaline 
phosphatase, alanine aminotransferase, and aspartate aminotransferase between gold 
nanoparticles treated and untreated control animals after 7 days of administration, thus 
concluding  minimal effect of gold nanoparticles in renal and hepatic functioning 
[102]. Despite the fact that gold nanoparticles have been injected to many patients in 
the past to treat rheumatoid arthritis or to study the function of reticuloendothelial 
system based on the past three decades of literature, there are only a few, if any, 
reports on complications of intravenous gold injection [103]. 
 
1.9 Hypothesis 
The hypothesis behind this thesis is that the unique physico-optical properties of gold 
nanostructures can be optimized to enhance the optical contrast between normal and 
suspicious lesions as well as to perform molecular-specific contrast imaging of EGFR 
expression in these lesions for early cancer detection in vivo under reflectance-based 
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OCT. The hypothesis is based on the following observations. First, gold 
nanostructures can be engineered to strongly scatter or absorb light at frequencies 
coinciding with their surface plasmon resonances for imaging or photothermal 
conversion. Second, their surface plasmon resonance can be optically tuned and 
matched to the source wavelength of the optical imaging system to provide an 
optimum optical response. Third, gold nanostructures can easily be surface 
functionalized with a wide range of surface moieties such as antibodies to target and 
localize in cancerous tissue while avoiding the surrounding normal tissue as well as to 
avoid immuno recognition. Fourth, a rational selection of appropriate targeting moiety 
allows these nanoparticulates to probe and map the molecular expression of specific 
cancer biomarkers up to the cellular level. Lastly, gold nanostructures can be made 
sufficiently small to be efficiently delivered to the target tissue via the bloodstream. 
 
1.10 Objective and organization of thesis 
The main objective of the work presented in this thesis is to develop surface 
functionalized gold nanostructures with optimized optical properties and further 
investigate on three main aspects of their applications as cancer-specific optical 
contrast agents in reflectance-based imaging: 1. Their ability to enhance the optical 
signal under this form of imaging, 2. Their effectiveness in improving the optical 
contrast for discrimination between normal and suspicious pathological conditions, 
and 3. their potential in performing molecular specific imaging of EGFR expression 
in these pathological conditions for early cancer detection in vivo. 
 
This thesis adopts a broad multidisciplinary approach towards the development of an 
appropriate optical agent and the understanding of their applications in imaging over a 
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wide range of biological models. The scope of this thesis includes a theoretical 
understanding of the optical properties of spherical gold nanoparticles and nanoshells 
that leads to a prediction of an appropriate particle dimension to achieve an optimized 
optical response based on the theoretical framework as discussed in Chapter 2. The 
preliminary study on the use of gold nanoparticles to improve optical contrast is then 
demonstrated in Chapter 3. Chapter 4 then follows with a detailed description on the 
synthesis of gold nanoshells based on the predicted dimensions provided in Chapter 2 
and Chapter 5 gives an account of the characterization studies on their surface 
functionalization in the form of pegylation to reduce their immunogenicity in vivo and 
anti-EGFR conjugation to confer specific targeting on the particles. 
 
The three main aspects of their applications as optical contrast agents as described 
earlier are also examined in three different models, namely, an in vitro cellular model, 
a phantom model and an in vivo small animal tumor model under two different types 
of reflectance-based imaging i.e. the confocal reflectance microscopy and OCT. The 
ability of gold nanostructures to elicit an optical contrast to discriminate cancer from 
normal cells under the confocal reflectance microscope in vitro is demonstrated in 
Chapter 6. Chapter 7 examines the changes in OCT signal against theoretical OCT 
models with different concentration of gold nanoshells in a tissue phantom while 
Chapter 8 describes the investigation on the control of optical contrast provided by 
gold nanoshells in a mouse xenograft tumor model. In addition to the main thrust of 
this thesis in imaging, a small scope of this thesis is also set aside to assess the 
potential photothermal therapeutic efficacy of gold nanoshells in combination with 
conventional photodynamic therapy (PDT) in vitro in Chapter 9. The last Chapter 10 
gives the conclusion and future direction of this work documented in this thesis. 
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OPTICAL PROPERTIES OF GOLD NANOSTRUCTURES 
 
Abstract 
The theoretical approach based on Mie theory to describe the optical properties of two 
types of gold nanostructures: homogenous spherical gold nanoparticles and gold 
nanoshells with a core-shell structure is discussed in this chapter. These optical 
properties include their optical scattering ability, optical tunability and optical 
extinction modes. Based on this theoretical examination, various optical parameters of 
gold nanoshells i.e. their optical extinction, scattering, absorption, backscattering 
efficiencies and cross-sections are also calculated and subsequently used to provide a 
theoretical plot of their optical spectra for different sizes and to select an optimized 
size for imaging. The backscattering cross section is selected as an appropriate metric 
for which the design of gold nanoshells is optimized against. The theoretical results 
demonstrate that gold nanostructures inherently possess stronger optical scattering 
compared to dielectric nanoparticles of same size and that their peak optical resonance 
and optical extinction mode can be tuned by their physical dimensions. The extinction 
peak shifts to longer wavelengths as the size of the gold nanoparticle is increased 
while the shell thickness to core radius ratio of gold nanoshells is decreased. The 
theoretical prediction also suggests that the gold nanoshells synthesized with a silica 
core radius of 81 nm and gold shell thickness of 23 nm would provide an optimum 
backscattering response under OCT with source wavelength of 840 nm. This work has 
been submitted for publication in Optics Communications. 
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2.1 Introduction 
Nanoparticles composing of coinage metals such as copper, silver and gold present 
unique optical properties. When excited with an electromagnetic field, these 
nanoparticles produce an intense interaction with light in the form of scattering or 
absorption attributed to the collective oscillation of electrons on the particle surface, 
termed as surface plasmon resonance. The resonant frequency is highly dependent on 
particle size, shape, material, and environment. By altering these characteristics, the 
frequency can be shifted over a wide range of wavelengths, making them attractive as 
functional materials for many applications including electronic and optical devices 
[1], chemical and biological sensors [2-5], optical energy transport [6-8], thermal 
ablation [9] and contrast agents in optical imaging which is the subject of interest in 
this thesis. 
 
The synthesis of uniform colloidal gold nanoparticles has been widely reported for 
some time. New experimental techniques have recently produced core-shell 
nanoparticles with a consistent size and shape [10-13]. A strong surface plasmon 
resonance is observed when the layered nanoparticle is composed of silica and gold, 
which can be shifted in wavelength by adjusting the relative thickness of the shell and 
core material. The concentric sphere geometry of the nanoparticles also allows for 
control of their optical properties in a highly predictive manner, making them a new 
class of materials that are capable of tailoring radiation throughout the visible and 
infrared wavelength regimes [12, 13]. 
 
The nanoparticle optical extinction is typically measured. Extinction is the sum of 
absorption and scattering. Classical electrodynamics accurately describes the 
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scattering and absorption of electromagnetic waves by particles in this nanometer-size 
regime. Scattering arises when charged particles are accelerated by a field and 
reradiate. Hence, light scattering is the secondary radiation scattered by the induced 
oscillatory motion of protons/electrons within an obstacle when illuminated by a light 
source. Absorption occurs when the particle takes energy out of the beam and 
converts it to other forms. The equations that govern macroscopic electromagnetic 
fields that give rise to scattering and absorption are known as Maxwell’s Equations. 
These laws of electromagnetic theory express the behavior of the electric and 
magnetic portions of a field, as well as the relationship between the two. Maxwell’s 
Equations for a field varying harmonically in time are 
 
0 E  
0 H  
HiE   
EiH  ,                   (2.1) 
 
where E is the electric field, H is the magnetic field, ω is the angular frequency, µ is 
the permeability, and ε is the permittivity (dielectric constant). 
 
The optical properties of a nanosphere of arbitrary radius and dielectric constant can 
be defined within Maxwell’s Equations. In that sense, Mie was the first to provide the 
solutions to the scattering and absorption by homogeneous spheres which are 
commonly referred to as Mie Theory  [14]. Excellent descriptions of Mie Scattering 
are also given by van de Hulst [15] and by Bohren and Huffman [16]. Since then 
several papers have appeared that refine and extent the theory for non-symmetrical 
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particles, sphere with inclusions[16-18] and particles with radially variable refractive 
indices, commonly called the n-layer problem [18-22], of which gold nanoshells can 
be classified under. However, for the solutions provided in these literatures, some of 
the expressions therein are not explicit.  
 
The problem which Mie solutions attempt to solve lies in finding the electromagnetic 
field at all points in the particle and medium given the particle radius and dielectric 
constant. The solutions are subject to the boundary condition that the fields must be 
continuous when crossing between the particle and the medium. All fields are 
expanded in vector spherical harmonics. The polarization of the incident field, 
boundary conditions, and orthogonality of the basis dictate the expansions. Once the 
fields are known, the optical properties of the particle can be calculated from the 
scattered field in the far field regime. 
 
The applications of the Mie functions in this thesis are directed toward the study of 
the optical properties of two types of spherical gold nanostructures: homogenous 
spherical gold nanoparticles and gold nanoshells with a core-shell structure. While 
there have been numerous papers published on the optical properties of spherical gold 
nanoparticles (both experimental and theoretical), the number of theoretical studies on 
dielectric materials coated with gold is relatively much fewer. This chapter attempts 
to fill the void by providing a detail discussion on the optical properties of these two 
types of gold nanostructures based on the theoretical approach.  
 
In this chapter, the theoretical description of their optical properties based on Mie 
theory is discussed. This theoretical description is used to compute their optical 
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response in terms of different optical parameters such as the extinction, scattering and 
backscattering efficiencies and their corresponding cross-sections. From the computed 
efficiencies, the theoretical optical spectrum for each of the parameter can be 
predicted and characterized for changes in the particle sizes. Amongst these optical 
parameters, the backscattering cross section is selected as an appropriate parameter to 
be used to design and optimize the dimensions of gold nanoshells as suitable 
reflectance-based optical probe that would provide the best optical response for 
confocal reflectance microscopy and OCT imaging. Based on the theoretical 
prediction, the backscattering cross sectional response of gold nanoshells is also 
computed for different size configurations to select an optimized size appropriate for 
OCT imaging. 
 
The Mie theoretical framework for the scattering and absorption of gold 
nanostructures described in this chapter is implemented as programs written in the 
numeric computation and visualization software, MATLAB (Math Works, 1992). 
Functions have been developed to compute their Mie coefficients as well as optical 
parameters which include the extinction, scattering and backscattering efficiencies 
and their corresponding cross-sections. The present programs are largely related to the 




2.2 Mie solution for spherical gold nanostructures 
2.2.1 Mie coefficients for homogenous gold nanoparticles 
The key parameters for Mie calculations of the scattered field are the Mie coefficients 
an and bn of the nanoparticle which are used to compute the optical efficiencies and 
cross sections of the nanoparticle. The coefficients of the scattered electrical field for 































              (2.3) 
 
where m  is the refractive index of the nanoparticle relative to the ambient medium. In 
the subsequent calculations, the ambient medium refers to water, so m takes on the 
refractive index of gold relative to water. The size parameter is given by x = kr, r is 
the radius of the sphere, k = 2π/λ is the wave number and λ the wavelength of the 
incident light source in the ambient medium. µ1 is the ratio of the magnetic 
permeability of the sphere to the magnetic permeability of the ambient medium. The 
Index n runs from 1 to ∞, but the infinite series occurring in Mie formulas can be 
truncated at a maximum, nmax given by nmax = x + 4x1/3 + 2. 
 
The functions )(zjn and )(
)1( zhn  = )()( ziyzj nn   are spherical Bessel functions and 
spherical Hankel functions of order n (n = 1, 2,…) respectively and of the given 
arguments, z = x or mx. As observed from its definition, the spherical Hankel 
functions are linear combinations of jn and yn and in the case of Mie calculations, the 
 46
first type is required. The superscript primes mean derivatives with respect to the 
argument and they follow from the spherical Bessel functions themselves, namely 
 
)()()]'([ 1 znjzzjzzj nnn   ; )()()]'([ )1()1( 1)1( znhzzhzzh nnn               (2.4) 
 
The computation of the two Mie coefficients is the most challenging in Mie 
computations due to the involvement of these spherical Bessel functions up to high 
order. The computation has so far worked well up to x = 104 using the built-in double-
precision Bessel functions in MATLAB. However, there is a maximum x value for 
stable and correct computation of Mie scattering. For a small or moderate imaginary 
refractive index m”, the maximum size parameter ranges somewhere between 104 and 
105, but for m” >> 1, the maximum size parameter is strongly diminished. 
 
For completeness, the following relationships between ordinary Bessel and spherical 





zj nn   ; )(2)( 5.0 zYzzy nn 
                (2.5) 
 
Here, Jv(z) and Yv(z) are ordinary Bessel functions of the first and second kind and are 
standard functions which can be found in MATLAB. For n = 0 and 1, the spherical 
Bessel functions are simply given by 
 
z
zzj sin)(0  ; z
z
z
zzj cossin)( 21  ; z
zzy cos)(0  ; z
z
z
zzy sincos)( 21        (2.6) 
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The recurrence formula can be used to obtain higher orders 
)(12)()( 11 zfz
nzfzf nnn
  ; )()1()()]'()[12( 11 zfnznfzfn nnn          (2.7) 
where fn denotes either of the Bessel functions jn or yn.  
 
As the gold nanoparticles is non-magnetic i.e. µ1 = 1, this means that the permittivity 
of the nanoparticle relative to the ambient medium is given by ε = m2. In this case, 
equations 2.2 and 2.3 simplify to the expressions below which can be computed from 





















                (2.9) 
 
2.2.2 Mie coefficients for core-shell gold nanoshells 
Similar equations can also be used to calculate the Mie coefficients of core-shell 
nanoparticles. The approach is the same, except the system is now slightly more 
complex. There are two radii and two refractive indices that must be included. This 
corresponds to one set for the core material and one set for the shell material. In 
addition, there are two boundary conditions imposed to account for the core, shell, 
and medium. The expressions for the Mie coefficients are more difficult to compute; 
once known, however, they can be inserted into Equation 2.18 - 2.20 to yield the 
optical efficiencies. The Mie Coefficients an and bn of inhomogeneous core-shell 
structures are used in the same way as the ones for homogeneous nanoparticles to 
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compute their optical efficiencies and cross sections. The problem for core-shell 
nanostructures is adequately described in Figure 2.1. 
 
 
Figure 2.1. A core-shell nanostructure with two compartments placed radially 
symmetric around the core showing the geometry used in Mie calculations. The core 
has radius a and relative refractive index m1 and a total nanoparticle radius b with the 
shell layer having a relative refractive index m2. 
 
In general, there are two compartments placed radially symmetric around the core. 
The core-shell structure has an inner core radius a with size parameter x = ka (k = 
2π/λ is the wave number, with λ being the wavelength of the incident light source in 
the ambient medium as before) and m1 is the refractive index of the core relative to the 
ambient medium. The outer shell has an outer radius b with relative refractive index 
m2 and size parameter y = kb. In computing the Mie coefficients, the assumption is 
that the core and the shell material of gold nanoshells are non-magnetic and as such, 
the magnetization of the particle is governed by the magnetization of the ambient 
medium and the magnetic permeability between the particle and the medium is 
unchanged i.e. µmedium = µcore = µshell. The explicit expressions used to compute the 
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where the functions nD
~  and nG


























































m   and the functions )()( zzjz nn   and )()( zzyz nn   follow the 
Riccati-Bessel function of the first and second kind respectively, while the function 







   . Also, Dn is the logarithmic derivative 


















 . The function Dn(z) 







1)(1                  (2.16) 
 
An important consideration to be made is the number of terms an and bn required for 
convergence. The convergence criterion derived for the homogenous gold 
nanoparticles as described earlier is used [16] as there is no evidence in the literature 
that this criterion is flawed for inhomogeneous core-shell structures. In effect, the 
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However, it has been indicated in many publications that even if only the criterion y + 
4.05y1/3 + 2 is used, the difference in the results is negligible [24]. 
 
2.2.3. Mie efficiencies and cross sections 
The optical efficiencies Qi for the interaction of light with a scattering particle of 
radius r are given by their optical cross sections σi normalized to the particle 
geometrical cross section, σg = πr2, where i stands for extinction (i = ext), absorption 
(i = abs), scattering (i = sca) and backscattering (i = b), thus 
2r
Q ii 
 . These 
efficiencies are dimensionless cross sections in their true meaning. For example, the 
extinction efficiency denoted by Qext may be interpreted as defined measurable 
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quantity of the ‘shadow’ of area σext that may be casted on a detector by a particle. 
This is to say a particle will reduce detector area by σext with an efficiency Qext. 
 
Equations 2.2 and 2.3 in conjunction with Equation 2.17, can be used to determine the 
extinction (Qext), scattering (Qsca), and backscattering (Qb) efficiencies and as such 
their corresponding cross sections. The scattering efficiency Qsca follows from the 
integration of the scattered power over all directions, and the extinction efficiency Qext 
follows from the Extinction Theorem [15, 25], also called Forward-Scattering 


































Q               (2.20) 
 
where x is the overall size parameter and Re denotes the real part of the resulting 
complex number (an + bn). Note that the expressions above are applicable for both the 
homogeneous gold nanoparticles and inhomogeneous gold nanoshells with core-shell 
structure. As before in the case of Mie coefficients, the index n runs from 1 to ∞, but 
the infinite series occurring in Mie formulas can be truncated after nmax terms as given 
by nmax = x + 4x1/3 + 2 as discussed earlier in Equation 2.17. 
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Energy conservation requires that absscaext QQQ  , or absscaext   . Thus the 
absorption efficiency Qabs can be approximated as Qabs ≈ Qext – Qsca. Note that the 
condition Cabs ≤ Cext must always be satisfied. 
 
2.3 Materials and methods 
2.3.1 Theoretical prediction of optical spectrum 
Based on the Mie theoretical framework discussed earlier in the previous section, a set 
of Mie functions has been developed in MATLAB that computes the Mie coefficients 
an and bn, anisotropy factor, g, efficiencies of extinction, scattering and backscattering 
and their corresponding cross-sections for homogeneous gold nanoparticles as well as 
the core-shell gold nanoshells. The theoretically predicted optical spectrum is then 
plotted by another program written in MATLAB using the optical efficiencies 
computed for each quantum increment in wavelength over a range of wavelength 
from visible to NIR. 
 
The required input parameters to these functions include the size parameters, x = ka 
and y=kb where a and b are the sphere inner and outer radius as described earlier in 
Figure 2.1. Another input is the complex refractive indices, m = m’ + im” of the core 
and shell relative to the ambient medium. In this case, the refractive index of the silica 
core is assumed to be a constant at msilica = 1.43 [13, 26] and the embedding medium 
is taken to be water with mwater = 1.33 [12, 27]. The frequency-dependent complex 
refractive index of gold is obtained from previously published experimental data [28, 
29] which have been smoothed and interpolated as shown in Figure 2.2. The last input 
is the information about the incident light source; namely the wavelength. 
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Figure 2.2. (a) Real part and (b) imaginary part of the frequency-dependent complex 
refractive index of gold as a function of wavelength. 
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2.3.2 Determination of optimum gold nanoshells dimension 
To select gold nanoshells with optical properties that provide the best signal 
enhancement in OCT, various optical parameters of gold nanoshells over a range of 
physical dimensions are calculated using the computed solutions to Mie theory as 
described earlier for an excitation wavelength of 840 nm. This is the source 
wavelength of the OCT system used in this study. The calculations are based on a 
single gold nanoshell for simplification. The bulk effects due to particle 
heterogeneities are not considered as the heterogeneity in a population of gold 
nanoshells is assumed to be low. For each optical parameter such as extinction, 
scattering, absorption and backscattering of gold nanoshells, the optical cross section 
which is the product of the optical efficiency and geometrical cross section is 
computed as a function of core radius and shell thickness over a size range which can 
be readily synthesized with current laboratory methods.  
 
The calculated optical parameters over a range of core radii and shell thicknesses are 
then converted to a color-coded core radius-to-shell thickness space-maps of optical 
cross sections used to aid in the selection of gold nanoshells with suitable optical 
response. The backscattering cross section parameter is selected as an appropriate 
metric for predicting the OCT signal and thereby using it as a criterion for selecting 
the gold nanoshells to be used in this study since the backscattering of light is the 
basis in which the OCT images are generated. Based on the backscattering cross 
section space map, the dimension of gold nanoshells that produced the largest 
backscattering cross section is selected for further experimental investigations to be 
discussed in more details in subsequent chapters. 
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2.4 Results and discussion 
2.4.1 Optical tunability of gold nanoparticles 
The extinction spectrum of a solid gold nanoparticle has been calculated using Mie 
Theory as described in section 2.2.1 and 2.2.3. This consists of calculating the 
extinction efficiency from Equation 2.18 at many different wavelengths. The 
extinction spectrum for several nanoparticle radii can be seen in Figure 2.3.  
 
 
Figure 2.3. Extinction efficiency of spherical gold nanoparticles of varying radii. The 
values indicated are the wavelengths corresponding to the peak extinction. 
 
The wavelength corresponding to maximum extinction shifts to longer wavelengths 
(red shift) as the size of the nanoparticle increases. The peak seen at 522 nm 
corresponds to the resonance condition for small gold nanoparticles, specifically, 
when   med 2Re  , where the dielectric constant of medium water 
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is 769.12  watermed m . This in turn corresponds to a gold nanoparticle size of 20 
nm. As the size increases to 50 nm and 100 nm, the extinction peak red shifts to 530 
nm and 569 nm respectively. Although this extinction peak varies with size, its 
sensitivity towards size variations remains poor within this size range commonly used 
in biological applications as the peak hardly red shifts by more than 50 nm even as the 
size of the nanoparticle increases fivefold. 
 
A large red shift of the dipole peak and a much more complex spectrum occur when 
the particle radius is increased further, as seen in Figure 2.4. A 200 nm gold 
nanoparticle displays a broadened dipole peak at 765 nm. Also evident is the 
appearance of a quadrupole peak at 561 nm. The higher-order modes in the field 
expansion become important as the nanoparticle becomes larger. This results in the 
appearance of quadrupole resonances and possibly octopole peaks for very large 
particles.  
 
Hence, the influence of higher-order multipoles is evident for large nanoparticles, 
making the spectra more complex. Although the dipole peak appearing in the NIR 
wavelength for 200 nm gold nanoparticles seems encouraging towards their use in 
NIR imaging, its intensity is much reduced compared to the dipole peak intensity of 
smaller nanoparticles. Furthermore, the synthesis of spherical gold nanoparticles of 
this size remains a challenge in practice as large gold nanoparticles are known to 




Figure 2.4. Extinction efficiency of larger spherical gold nanoparticles of varying 
radii showing the higher order multipole peaks. The values indicated are the 
wavelengths corresponding to the peak extinction. 
 
2.4.2 Optical tunability of gold nanoshells 
The optical properties of gold nanoshells with a silica core surrounded by a gold shell 
are examined in this section. Figure 2.5 shows the extinction spectrum for several 
nanoparticles with different ratios of core to shell size. The total nanoparticle diameter 
is kept constant at 100 nm. The spectrum with a peak at 569 nm is the extinction from 
a solid gold nanoparticle having a diameter of 100 nm with no silica core (Figure 2.3). 
As the shell thickness is decreased, the peaks red shift and at the same time become 
more intense. It is also noted that the extinction efficiency of gold nanoshells as given 
by the peak intensity is also higher compared to solid gold nanoparticles. Hence, 
increasing the ratio of core radius to total radius causes the peak to shift red. Thinning 
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the shell layer also produces a large increase in polarization at the sphere boundary, 
which yields the more intense extinction peaks. 
 
 
Figure 2.5. Extinction efficiency of gold nanoshells with different ratios of core to 
shell size. The core is silica and the shell is gold. The total nanoparticle diameter is 
100 nm. 
 
The same general trends are observed when the gold nanoshell size is increased. 
Figure 2.6 shows the equivalent plot for a gold nanoshell with diameter of 200 nm 
having different ratios of core to shell size. Again, as the shell thickness of the gold 
nanoshell is decreased, the dipole plasmon resonance red shifts toward longer 
wavelengths. This red shift is accompanied by an increase in the peak intensity. 
Higher-order poles begin to show up in the spectrum for larger particles. Quadrupole 




Figure 2.6. Extinction efficiency of gold nanoshells with different ratios of core to 
shell size. The core is silica and the shell is gold. The total nanoparticle diameter is 
200 nm. 
 
2.4.3 Adjustment of optical extinction mode 
In addition to its optical tunability, it is also possible to engineer gold nanoshells to 
either predominantly scatter or absorb light by tailoring the core and shell fabrication 
materials or by varying the overall size of the gold nanoshells relative to the 
wavelength of the light at their optical resonance. Light scattering would be desired 
for reflectance-based imaging applications (see Chapters 6 to 8) while light 
absorbance permits photothermal-based therapy applications (see Chapter 9). The 
adjustment of scattering and absorption efficiency is demonstrated in Figure 2.7 
which shows the predicted extinction, scattering and absorption spectra calculated 
based on Mie theory for two nanoshell configurations, one designed to scatter light 
and the other to preferentially absorb light with the peak at the same wavelength. 
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Figure 2.7. The predicted extinction efficiency, scattering efficiency and absorption 
efficiency are shown for two nanoshells with (a) an absorbing configuration (core 
radius = 23 nm; shell thickness = 3 nm) and (b) a scattering configuration (core radius 




With the core radius-to-shell thickness ratio kept constant, a smaller nanoshell (core 
radius = 23 nm; shell thickness = 3 nm) result in an absorbing configuration with the 
absorption efficiency higher than the scattering efficiency. As the overall size of the 
nanoshell double while maintaining the core-to-shell ratio constant (core radius = 46 
nm; shell thickness = 7 nm), the extinction peak remains at 826 nm, but the scattering 
efficiency becomes higher than the absorption efficiency to result in a scattering 
configuration. In general, light absorption dominates the extinction spectrum for 
particles of relatively smaller radius and light scattering becomes the dominant 
process for larger nanoparticles. 
 
2.4.4 Comparison of scattering properties 
The scattering efficiency of solid gold nanoparticles and gold nanoshells is compared 
to two other common dielectric nanoparticle of the same size but having different 
dielectric constant. The results in Figure 2.8 show that the theoretical scattering 
efficiency of 100 nm gold nanostructures is much higher across all wavelengths 
compared to the common dielectric nanoparticles of the same size. Here, the 
scattering spectrum of gold nanoparticles shows a peak at 578 nm with a scattering 
efficiency of 4.73 and the gold nanoshells show a peak at 786 nm with a scattering 
efficiency of 8.63. These peaks are attributed to the surface plasmon resonance of 





Figure 2.8. Scattering spectrum of plasmonic gold nanoparticles and gold nanoshells 
compared to dielectric silica and polystyrene nanoparticles with the same size of 100 
nm diameter. The insert shows a scale up of the scattering spectrum of both dielectric 
nanoparticles. 
 
In contrast, the scattering efficiency of these two dielectric nanoparticles without the 
plasmon resonance effect of gold is much lower with a maximum of < 0.04 (Figure 
2.8 insert). Furthermore, it is also observed that the larger dielectric constant of 
polystyrene (mpolystyrene = 1.59) [30] over that of silica (msilica = 1.43) produces a 
scattering efficiency that is approximately four times higher across all wavelengths. 
The plasmonic optical response of gold nanostructures thus allow them to resonantly 
scatter light especially at their surface plasmon resonance where the large scattering 
efficiency gives rise to a correspondingly large scattering cross section compared to 
non-plasmonic nanoparticles of the same size. Also, when compared to molecular 
species such as organic chromophores, the absorption and scattering cross sections of 
gold nanoparticles are typically 5 – 6 orders in magnitude higher. 
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2.4.5 Computation of optimum gold nanoshells dimension 
The various optical parameters of gold nanoshells in water are computed over a range 
of core radii and shell thicknesses at 840 nm excitation to select an appropriate size of 
gold nanoshells that gives the best signal enhancement in OCT applications. Figure 
2.9 shows the contour plots of the extinction, absorption, scattering and backscattering 
cross section as well as anisotropy factor, g of gold nanoshells as a function of both 
core radius and shell thickness up to an overall diameter of 280 nm. Overall, the gold 
nanoshells have extinction cross section that increases with size with the largest 
extinction cross section occurring at core radius larger than 90 nm and shell thickness 
of more than 15 nm. Both the extinction and scattering cross section appear to be 
more sensitive to changes in the shell thickness compared to the core radius.  
 
The similarity between the extinction and scattering contour plot (Figure 2.9a and b) 
implies that the predominant extinction cross section is attributed to light scattering 
rather than absorption except in cases where the core radius is larger than 90 nm and 
the shell thickness is about 7 to 8 nm (Figure 2.9c). The contour plot of the anisotropy 
factor (Figure 2.9e) shows that most of the size configurations produce gold 
nanoshells that tend to scatter light isotropically, except in cases of large core radii of 
> 90 nm coupled with gold shell of < 10 nm thickness where the gold nanoshells tend 
to be slightly more forward scattering with g ≈ 0.4. The backscattering cross section 
contour plot (Figure 2.9d) also shows a region around 80 nm radius and 20 nm shell 
thickness where a large backscattering cross section in the order of 2 x 10-9 cm2 
occurs. Gold nanoshells with this size are expected to strongly enhance the OCT 




Figure 2.9. Computed optical cross section for each of the four optical parameters: (a) 
extinction, (b) scattering, (c) absorption and (d) backscattering of gold nanoshells as 
well as (e) anisotropy factor as a function of core radius (0 nm – 100 nm) and shell 
thickness (0 nm – 40 nm) at an excitation of 840 nm, a wavelength used in OCT 
imaging application. These contour plots aid in specifying the dimensions of gold 
nanoshells with desirable optical properties to be used in subsequent study where their 
effect on imaging signal is investigated. Except for the anisotropy factor, the cross 




An understanding of how various optical parameters affect the OCT signal would 
facilitate the selection of a relevant parameter as the criterion of choice for which the 
design of gold nanoshells can be optimized against to make them appropriate as 
optical probes for OCT. In general, optical characterization of OCT has been studied 
by several groups and a few theoretical models have been established to relate these 
optical parameters of the sample being imaged to its corresponding A-scan signal 
profile [31-33]. Most of these numerical models have been developed with an aim to 
extract out the optical parameters from the average A-scan profile of the OCT image 
for diagnostic purposes or applications such as glucose sensing in diabetes [34].  
 
With these numerical models, the reverse can also be performed i.e. to predict how 
the OCT signal would change with certain optical parameters and hence design gold 
nanoshells based on these parameters. It is known from other studies that the OCT 
depth-dependent A-scan signal profile is affected by at least three optical parameters: 
the extinction coefficient, µt affects the slope of the signal [35, 36], the backscattering 
coefficient, µb affects the offset of the signal intensity [37] and the anisotropy factor, g 
affects the linearity of the A-scan signal profile with depth [38, 39].  
 
The extinction and backscattering coefficients are related to their respective cross 
sections by the following simple relationship: optical coefficient,    where   
is the volume density i.e. number of particles per unit volume and  is the optical 
cross section. Based on this relationship, the results in Figure 2.9 suggest several 
inferences linking the physical dimension of gold nanoshells to the possible changes 
in OCT signal, assuming the concentration of particles maintains a constant. Firstly, 
as the overall size of the gold nanoshells increases, the larger extinction cross section 
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would imply that the depth dependent OCT signal would attenuate faster with depth. 
Since the extinction cross section is more sensitive to changes in shell thickness, this 
implies that small increases in the shell thickness can greatly increase the OCT signal 
attenuation with depth compared to small increases in the core radius.  
 
Since the predominant optical extinction is attributed to light scattering for the size 
range of gold nanoshells shown in Figure 2.9, this means that the attenuation observed 
in the depth-dependent OCT signal is attributed mainly to the light scattering of gold 
nanoshells which makes them well-suited as optical agents for scattering-based 
imaging technique. This OCT signal can be increased by having a positive offset to 
the overall signal. Previous studies by Oldenburg et al. have suggested that a large 
backscattering coefficient is able to produce a positive offset to increase the overall 
OCT signal and hence the image brightness [37]. This is expectedly so since OCT is a 
reflectance-based imaging technique that detects backscattered light from sample.  
 
Because of its relation to the OCT signal offset, the backscattering cross section is 
used as the criterion of choice for which the design of the gold nanoshells is 
optimized again for OCT signal enhancement. With a large backscattering cross 
section at the OCT source wavelength, gold nanoshells can potentially be useful in 
enhancing OCT signal from the tissue. Based on the results in Figure 2.9d, gold 
nanoshells with a core radius and shell thickness of ≈ 80 nm and 20 nm respectively 
are predicted to produce an optimum backscattering cross section and hence 
backscattering coefficient to increase the overall OCT image brightness.  
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It is of worth to note that the optical cross section is used in the contour plot 
simulation instead of the optical efficiency. Since the optical cross section is the 
product of the optical efficiency and geometrical cross section, the cross section takes 
into account an additional factor due to the geometrical size of the gold nanoshells 
that may also affect the OCT signal. While the optical efficiency itself can provide the 
gold nanoshells with a good measure of its optical merit, it would be insufficient to 
predict the final OCT signal based solely on its optical efficiency since gold 
nanoshells with a high backscattering efficiency may still, for example, produce a 
small backscattering coefficient if their geometrical size is small [40]. 
 
2.5 Conclusion 
In this chapter, the theoretical basis for the calculation of various optical parameters 
of spherical gold nanostructures are presented. The Mie theory of scattering and 
absorption of small particles as formalized by Bohren and Huffman [16] is used. 
These optical parameters are used to predict their various optical spectrum e.g. 
extinction, scattering and absorption spectrum which is in turn used to demonstrate 
their optical properties such as optical tunability, strong scattering and versatility in 
tailoring the extinction between scattering and absorption. The optical properties of 
spherical gold nanostructures can be tuned by adjusting their physical dimensions. 
The dielectric properties of the material are also important in playing a large role in 
the intensity and placement of the plasmon resonances. 
 
The optical parameters obtained from theoretical calculation are also used to generate 
the contour plot of intensity of various parameters over a wide range of gold 
nanoshells core size and shell thickness to facilitate the selection of appropriate size 
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configurations of gold nanoshells for imaging. The design of an appropriate optical 
probe for any optical imaging modality requires a good understanding of how various 
optical parameters affect the generation of the image signal. For OCT, the 
backscattering cross section is used as a parameter of choice for which the design of 
gold nanoshells can be optimized for signal enhancement. The contour plots have 
shown that gold nanoshells with a silica core radius of 81 nm and gold shell thickness 
of 23 nm would provide an optimum backscattering response under OCT with source 
wavelength of 840 nm. The synthesis process of gold nanoshells based on this size 
configuration is described in the following chapter. 
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PRELIMINARY STUDY ON                                           
GOLD NANOPARTICLES IN VITRO 
 
Abstract 
Following the theoretical discussion in Chapter 2, the resonance light scattering 
property of gold nanoparticles under reflectance-based imaging is demonstrated in 
this chapter as a preliminary in vitro study on their potential use as molecular contrast 
probes for imaging molecular changes associated with carcinoma. Gold nanoparticles 
were synthesized and conjugated to anti-epidermal growth factor receptor (EGFR) for 
imaging. Their localization on nasopharyngeal carcinoma CNE2 cells and normal 
human lung fibroblast NHLF cells were imaged and compared under confocal 
microscopy in vitro. The localization of gold bioconjugates on EGFR increases the 
reflectance properties of CNE2 cells and the regions of increased reflectance 
correspond to regions of high EGFR expression in the cells. The optical properties of 
normal fibroblast cells are not greatly affected. These gold bioconjugates are thus able 
to map the expression of relevant biomarkers and elicit an optical contrast to 
discriminate cancer from normal cells under confocal reflectance microscopy. The 
results as described in this chapter demonstrates the potential of gold nanoparticles to 
target and probe cancer cells and illuminates them for cancer detection under 
reflectance-based imaging systems based on biomolecular changes. The work 
presented in this chapter has been published in International Journal of Nanomedicine 
2007; 2: 785-798 and Molecular and Cellular Probes 2008; 22: 14-23. 
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3.1 Introduction 
Gold nanoparticles show potential as contrast agents for reflectance-based optical 
imaging systems to address the limitation of these systems in providing contrast for 
early molecular signatures present in cells and tissue based on their optical properties 
[1-3]. The reflectance confocal endomicroscope is an example of a reflectance-based 
imaging system. It is essentially an endoscope that performs confocal microscopy in 
the reflectance mode and is able to able to achieve subcellular resolution. It has a 
typical system setup as shown in Figure 3.1 below. The use of confocal 
endomicroscopy to image cellular structures and other morphological features 
associated with carcinoma within living tissue to a depth of about 100 to 200 µm has 
been demonstrated [4].  
 
 
Figure 3.1. Typical schematic diagram of a laser confocal endomicroscope system 




However, such system operating in the visible light range can image no further than ≈ 
200 µm below the mucosal surface [4], and hence would be insufficient to image the 
entire epithelium and its underlying mucosa stromal. Furthermore, molecular 
abnormalities in cells do not present changes in cellular light scattering behavior that 
can be picked up by the microscope, hence requiring the need of a mediating agent to 
transduce these changes into optical signals. 
 
The potential of gold nanoparticles to function as contrast agents arises from their 
unique optical response to light which allow them to resonantly scatter light when 
excited at their surface plasmon resonance frequency [5]. Such property has also been 
theoretically demonstrated earlier in Chapter 2. Besides a strong scattering response 
from individual particles, the scattering cross section per particle is also known to 
increase when gold nanoparticles aggregate and their surface plasmon interact to 
produce an even larger optical signal [2]. This mode of enhanced scattering from 
coupled surface plasmon resonances of aggregated gold nanoparticles can be 
exploited to further enhance the optical scattering signal when the gold nanoparticles 
are brought close together under the influence of biochemical processes associated 
with disease pathology in cellular environment. 
 
Apart from their optical properties, gold nanoparticles also possess other favorable 
physicochemical properties for use as cancer targeting optical probes. They can be 
easily conjugated to antibodies or peptides through electrostatic charge interaction or 
coordinate bonding to probe for specific cellular biomarkers with high specificity and 
affinity [6]. When coupled with appropriate biomarkers which is known to be 
overexpressed in most epithelial cancer, these gold nanoparticles bioconjugates may 
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provide useful optical signal for molecular specific information to assist clinicians in 
diagnosis of precancers. As discussed in Chapter 1, the epidermal growth factor 
receptor (EGFR) is one such clinically relevant cell surface receptor biomarker that is 
overexpressed in vast majority of epithelial cancer but not in normal cells [7-10]. Its 
expression is known to correlate with cancer progression in the epithelial origin [11, 
12]. Gold nanoparticles are also generally biocompatible and benign in biological 
tissues and have been applied for clinical treatment of other disease conditions such as 
rheumatoid arthritis [13]. 
 
The first demonstration of gold nanoparticles in optical imaging by Sokolov et al. uses 
these solid gold nanoparticles to create an optical contrast to image precancer [2]. In 
this chapter, the preparation of antibody conjugated gold nanoparticles and their use 
as an optical probe to increase the molecular contrast of a clinically relevant 
biomarker of epithelial cancer is demonstrated in vitro under confocal reflectance 
microscopy. The focus in this case is on the imaging of changes in molecular 
expression of EGFR. The optical signal intensity of cells in the presence and absence 
of gold nanoparticles and between normal and cancer cells incubated with gold 
nanoparticles are compared. The reflectance signal from the gold nanoparticles does 
not just increase the optical contrast, but also allows a molecular mapping of the 
EGFR biomarker expression. The results shown in this chapter serve as a preliminary 
demonstration of the potential of gold nanostructures to perform molecular contrast 
imaging of cancerous signatures of tissues for early detection of epithelial carcinoma 
under reflectance-based imaging systems. 
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3.2 Materials and methods 
3.2.1 Synthesis and characterization of gold nanoparticles 
Gold nanoparticles of 20 nm in diameter were synthesized based on established 
protocols [14]. Briefly, a 200 ml solution of 0.259mM tetrachloroauric acid (HAuCl4, 
Sigma-Aldrich) was brought to 90 °C before a 3 ml solution of 34mM trisodium 
citrate (Sigma-Aldrich) was added rapidly to the HAuCl4 solution, while maintaining 
vigorous stirring throughout the process. The mixture was heated continuously at 90 
°C for the next 10 minutes under stirring before a color change from gray to ruby red 
was observed, indicating the formation of the gold nanoparticles. The particle size 
was determined by transmission electron microscopy (TEM) (Jeol JEM-1010), 
operating at 100 kV and their UV–Vis extinction spectrum was characterized using a 
UV–Vis spectrophotometer (Shimadzu UV-2401 PC). The concentration of gold 
nanoparticles in the colloid was measured against known standards from British 
Biocell International Ltd. (EMGC.15, particle concentration = 1.4  1012 particles per 
ml), using the absorption spectroscopy and was stored at 4C when not used. 
 
3.2.2 Conjugation of gold nanoparticles with anti-EGFR 
The mouse monoclonal anti-EGFR (Santa Cruz Biotechnology, Inc.) was used as the 
molecular marker of interest for imaging its expression in cells. Gold nanoparticles 
have been conjugated to various antibodies for biological applications such as staining 
studies since 1950s’ [14]. Therefore, the 20 nm gold nanoparticles were conjugated to 
anti-EGFR via established protocols for passive absorption of anti-EGFR on the 
surface of gold nanoparticles. The conjugates are simply formed by noncovalant 
interactions between the citrate capping molecules on the surface of the gold 
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nanoparticles and the antibodies (see Figure 3.2). The binding is in such a way that 
the bioactivity of the antibodies are preserved and thus the conjugates can be used for 
further biofunctional studies such as imaging cancer biomarker in this case. 
 
 
Figure 3.2. Graphical scheme of gold nanoparticles-IgG conjugation [15]. 
 
Briefly, the conjugation was performed by incubating the colloidal gold nanoparticles 
with anti-EGFR for about 10 minutes at room temperature according to the procedure 
modified from Geoghegan and Ackerman [6]. The minimal amount of anti-EGFR 
required to tag the surface of gold nanoparticles and stabilize them against salt-
induced aggregation was determined using titration with varying amounts of anti-
EGFR [14]. The optimal pH of conjugation was also determined by titration with 
various amount of potassium carbonate. The pH of the gold nanoparticles colloid was 
adjusted to the isoelectric point of the antibody to give the optimum pH for 
conjugation where the non-covalent binding of anti-EGFR form very stable complex 
with gold nanoparticles.  
 
The successful conjugation of antibodies on gold nanoparticles was ascertained by 
addition of 10% common salt solution and observing any visible color change in the 
colloidal solution. The stability of the conjugated particle against salt-induced 
 78
aggregation can be assessed by the value of OD580/OD520 in the absorption 
spectrum. The presence of salt will cause unconjugated gold nanoparticles to 
aggregate and result in a visible color change from red to purple or gray in the 
colloidal solution while conjugated gold nanoparticles will remain stable in red as 
shown in Figure 3.3. 
 
 
Figure 3.3. Gold nanoparticles with a range of different amount of anti-EGFR 
conjugated aggregate to different degree to give a range of color in the colloid upon 
salt-induced aggregation. Those that are sufficiently conjugated to give stable 
nanoparticles in the presence of salt remain red (towards the right) while those that are 
insufficiently conjugated will aggregate in the presence of salt to give a purple or grey 
colloid (towards the left). 
 
After the 10 minutes of incubation time, the anti-EGFR conjugated gold nanoparticles 
were then washed and resuspended in 1 X PBS buffer (pH 7.4) containing 5% bovine 
serum albumin (BSA) (Sigma Aldrich, Inc.) and stored at 4 °C. Spectrophotometry 
was used to confirm conjugation of anti-EGFR to gold nanoparticles. The gold 
nanoparticles were also conjugated to BSA, a non-cellular binding protein, as 
negative control probes using the same procedures as above. BSA was coated on the 
gold nanoparticles to stabilize them against aggregation in salt-containing 
physiological medium such as PBS and RPMI through steric exclusion. 
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3.2.3 Cell culture and EGFR expression analysis 
Both the poorly differentiated nasopharyngeal epithelium carcinoma CNE2 cell line 
(kindly provided by Professor K. M. Hui, National Cancer Centre Singapore) and the 
normal human lung fibroblast (NHLF) cell line (Clonetics, Cambrex Walkersville, 
MD) were used in this study. The CNE2 cells were grown in RPMI 1640 
supplemented with 10% fetal bovine serum, 2mM glutamine, sodium pyruvate, non-
essential amino acids and 100 unit/ml penicillin/streptomycin while the normal cells 
were grown in fibroblast growth medium (Cambrex Corp.). Both cell lines were 
grown to about 1 x 106 cells in petri dish and maintained at 37 °C in humidified 5% 
CO2 and 95% air atmosphere. To verify the differential expression of EGFR between 
the normal and cancer cells, fluorescence-activated cell sorting (FACS) analysis on 
both cell lines was performed using a primary mouse anti-EGFR (Santa Cruz 
Biotechnology, Inc.) staining followed by secondary staining using FITC conjugated 
chicken anti mouse IgG (Molecular Probes). The cells were ran through a flow 
cytometer and sorted based on the fluorescence intensity of the FITC staining which 
corresponded to the EGFR expression on the cells. 
 
3.2.4 Cellular imaging in vitro 
Prior to imaging, both cell lines (1 x 106 cells) were trypsinized and fixed in 2% 
paraformaldehyde before incubating them with the anti-EGFR conjugated gold 
nanoparticles for 2 h at 37 °C. The cells were also incubated with BSA conjugated 
gold nanoparticles as a negative control for the antibody binding. Following the 
incubation, the cells were rinsed thrice with PBS to wash away the excess and 
unbounded gold bioconjugates and were then placed on a microscope slide for 
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imaging. Imaging was performed using a confocal microscopy (Carl Zeiss LSM510 
Meta) in the reflectance mode with 20 X and 40 X objectives under 543 nm excitation 
with a helium neon laser. To compare the EGFR mapping on cells between labeling 
with gold nanoparticles and labeling with conventional immunofluorescence dye, the 
CNE2 cells were also incubated with anti-EGFR in the absence of gold nanoparticles 
and then further stained with secondary FITC conjugated chicken anti-mouse (CAM-
FITC) IgG for another 1 h at 37 °C and examined for anti-EGFR immunofluorescence 
staining under confocal fluorescence microscopy at 488 nm excitation with an argon 
laser. The experiments were performed in triplicates to ascertain reproducibility. 
 
3.3 Results and discussion 
3.3.1 Synthesis and characterization of the gold bioconjugates 
The TEM image of the synthesized gold nanoparticles is shown in Figure 3.4. The 
TEM image shows that the particles are uniformly spherical and monodisperse with 
an average diameter of 20 ± 1.8 nm.  
 
 
Figure 3.4. TEM image of the synthesized gold nanoparticles with inset showing the 
red gold nanoparticles colloid. 
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The extinction spectrum of the gold nanoparticles in Figure 3.5 shows a sharp peak at 
520 nm which corresponds to the surface plasmon resonance typical of gold 
nanoparticles of that size [14, 16] and matches the excitation wavelength of the 
confocal reflectance system at 543 nm well to allow good optical response when the 
gold nanoparticles are excited for imaging. The measured spectrum also agrees well 
with the theoretical spectrum as shown in Figure 2.3. Since the light scattering of 
biological tissue in this wavelength range is small compared to the light scattering 
afforded by gold nanoparticles [17], the presence of gold nanoparticles in tissue may 
be distinguishable from its scattering intensity. From the intensity of the extinction 
spectrum, the particle concentration was determined to be approximately 1.23 x 1012 
particles per ml when measured against standards. 
 
 
Figure 3.5. Measured extinction spectrum of the 20nm gold nanoparticles synthesized 




The gold nanoparticles were conjugated to monoclonal anti-EGFR via passive 
absorption of the antibodies onto its surface. Both the antibody titration and pH 
titration suggested that about 0.4 mg of anti-EGFR was needed to conjugate and 
stabilize 1 ml of gold nanoparticles colloid (1.23 x 1012 particles) at an optimum pH 
of 8 to give the optimal stability of gold nanoparticles against salt-induced 
aggregation. Spectrophotometry was used to confirm the successful conjugation of 
anti-EGFR to gold nanoparticles. The extinction spectrum of the gold nanoparticles 
both before and after conjugation with anti-EGFR was measured and is shown in 
Figure 3.6. The UV-Visible extinction spectrum shows a characteristic red-shift (≈ 6 
nm) of the peak of the surface plasmon resonance which is typical of protein binding 
on the surface of the gold nanoparticles. The 6 nm red-shift in the peak surface 
plasmon resonance of the gold nanoparticles after conjugation with the antibody is 
associated with alterations in the local refractive index and hence dielectric constant 
around the surface of the gold nanoparticles due to the presence of a layer of 
antibodies around its surface. The change in dielectric constant affects the light 
scattering properties of gold nanoparticles according to the Mie theory [18]. This red-
shift is typical of protein binding on the surface of the gold nanoparticles and serves 
as an indication of the successful conjugation of the anti-EGFR on surface of the gold 
nanoparticles. An additional verification of anti-EGFR binding to the surface of the 
nanoparticles is their stability in 10% common salt solution where the gold 
bioconjugates did not aggregate to result in a color change after the addition of salt 
solution. The reduction in the intensity of the peak after conjugation could be due to 




Figure 3.6. Changes in extinction spectrum of gold nanoparticles after conjugation 
with anti-EGFR to demonstrate the binding of anti-EGFR on gold nanoparticles. 
Spectrum after conjugation is shown in dashed line. 
 
3.3.2 FACS analysis of EGFR expression 
The expression of EGFR in the two cell lines used was analyzed by FACS. The result 
of the FACS analysis as shown in Figure 3.7, shows two distinct fluorescence 
populations of CNE2 cells not observed in NHLF cells. The lower fluorescence 
population corresponds to the reference fluorescence of cells from secondary FITC 
conjugated IgG staining only, in the absence of primary anti-EGFR, while the higher 
fluorescence population corresponds to fluorescence of cells population after both the 
primary and secondary staining of EGFR on the cells. The higher fluorescence 
population in CNE2 cells shows strong EGFR staining on the cells and hence 
indicates a high level of EGFR expression on the CNE2 cells. On the other hand, such 
higher fluorescence population is not observable in NHLF cells, indicating minimal 
EGFR staining due to the nominal expression level of EGFR in NHLF cells. This 
 84
result verifies an overexpression of EGFR in the cancerous CNE2 cells compared to 
the nominal expression level in normal NHLF cells. 
 
 
Figure 3.7. FACS analysis of EGFR expression in (a) CNE2 cells and (b) NHLF cells. 
 
3.3.3 Increase in optical contrast of cancer cells 
The ability of gold nanoparticles to increase the optical scattering of cells when 
attached to their surface was investigated by labeling the cells with these particles and 
observing them under confocal reflectance microscopy. Figure 3.8 shows the confocal 
reflectance images of CNE2 cells before and after labeling with anti-EGFR 
conjugated gold nanoparticles, as well as CNE2 cells labeled with the control BSA 
conjugated gold nanoparticles which are not known to exhibit high binding affinity to 
the cells. A significant increase in the reflectance signal was observed in the cells 
labeled with the antibody conjugated gold nanoparticles compared to the other two 
negative controls where the reflectance signal seems to be non-specific and at random 
and could barely be resolved from the dark background. The increase in reflectance 
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signal can be attributed to the localization of gold nanoparticles on the cell membrane 
as it was not observed in the unlabeled cells. 
 
 
Figure 3.8. Confocal reflectance images of CNE2 cells (a) before labeling; (b) after 
labeling with the control BSA conjugated gold nanoparticles; and (c) after labeling 
with anti-EGFR conjugated gold nanoparticles. Images are cross-sectional slices of 
cells taken at the mid-focal plane at 20 x magnification. False-color reflectance 
images obtained at excitation 543 nm. Scale bar in all images is 20 µm. 
 
The results have shown that the anti-EGFR were able to target and bind to the 
extracellular domain of EGFR on the cellular membrane even after conjugation to the 
gold nanoparticles. This means that the anti-EGFR still retains its antigen-binding 
sites and activity after conjugation. The localization of the anti-EGFR gold 
nanoparticles forms highly reflective beacons due to the strong resonant light 
scattering response of gold nanoparticles on the cell surface to the excitation light. 
This resonant scattering condition is further enhanced when the gold nanoparticles 
cluster close together on the cell membrane as they attach to their receptor and their 
surface plasmon interacts with each other. This result in bright reflectance rings being 
formed around the cytoplasmic membrane as their optical reflectance properties were 
increased significantly under confocal reflectance microscopy.  
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In contrast, the strong reflectance signal from the bright scattering rings was not 
observed in the control labeling with a non-binding BSA conjugated gold 
nanoparticles as BSA was unable to target and bind to the cells and were therefore 
removed during the washing steps. These results clearly demonstrate that the anti-
EGFR gold nanoparticles can serve as a potential optical contrast agent to increase the 
detection visibility of cells under reflectance-based imaging systems. 
 
In addition to increasing the optical scattering on cells, the anti-EGFR conjugated 
gold nanoparticles also exhibited specific targeting and binding to cancer cells 
overexpressing EGFR compared to normal cells. The labeling of anti-EGFR gold 
nanoparticles on both CNE2 and NHLF cells under confocal reflectance microscopy 
is shown in Figure 3.9 together with their corresponding autofluorescence image. The 
autofluorescence images of the two cell lines show similar autofluorescence level.  
 
However, as EGFR is differentially expressed in the two cell lines used in this study, 
this differential expression of EGFR can be exploited to regulate the amount of gold 
nanoparticles attached to the cells and thus eliciting an optical contrast to 
‘‘illuminate’’ the cancer over normal cells and discriminating them based on such 
differential expression rather than consequential phenotypic changes. The 
overexpression of transmembrane EGFR in CNE2 cells caused more anti-EGFR gold 
nanoparticles to be selectively bounded to the cytoplasmic membrane of the CNE2 
cell compared to the nominal EGFR expression in normal NHLF cells. This results in 
significantly higher reflectance intensity, sufficient to elicit an optical contrast 
between them for discriminating the cancerous against from normal cells. 
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Figure 3.9. Autofluorescence image of (a) NHLF and (b) CNE2 cells. Their 
corresponding confocal reflectance images after labeling the (c) NHLF and (d) CNE2 
cells with anti-EGFR gold nanoparticles is shown below the autofluorescence image. 
Images are cross-sectional slices of cells taken at the mid-focal plane at 20x 
magnification. False-color fluorescence images obtained at excitation 488nm and 
reflectance images obtained at excitation 543 nm. Scale bar in all images is 20 µm. 
 
In practice, the EGFR expression is detected at all stages of carcinogenesis, from 
normal-early hyperplasia, dysplasia to invasive carcinoma [19] and it is elevated 
during the progression from hyperplasia to dysplasia and increases during progression 
from dysplasia to invasive carcinoma [7], thus giving a spectrum of expression levels 
with disease progression. As the reflectance signal depends on the level of EGFR 
expression, its intensity may provide indications of the progression of diseases at the 
molecular level. However, heterogeneous labeling with the anti-EGFR gold 
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nanoparticles on CNE2 cells was also observed (Figures 3.8c and 3.9d). This 
heterogeneity of protein expression in cell lines is common and has been described 
previously in the case of EGFR [20]. 
 
3.3.4 Molecular mapping of EGFR expression 
Besides increasing the optical contrast to discriminate cancer from normal cells, the 
strong optical response of gold nanoparticles can also be exploited to transduce 
molecular signals into observable optical signals to generate molecular contrast to 
image the expression of EGFR in cancer cells. The potential of anti-EGFR conjugated 
gold nanoparticles as a probe to perform molecular imaging was investigated by first 
identifying the regions of high level of EGFR expression and subsequently mapping 
the reflectance signal from the gold nanoparticles to these regions. The confocal 
immunofluorescence image of a representative CNE2 cell stained with anti-EGFR is 
shown in Figure 3.10b together with a corresponding confocal reflectance image of 
CNE2 cell labeled with anti-EGFR conjugated gold nanoparticles as shown in Figure 
3.10d. The intrinsic autofluorescence and reflectance images of unlabeled cells are 
also shown as negative control in Figure 3.10a and c respectively. 
 
In the immunofluorescence labeling shown in Figure 3.10b, a ring of higher 
fluorescence intensity was observed around the cytoplasmic membrane of the CNE2 
cell and not within the cell. As the image was a confocal image showing the cross-
sectional slice of cells taken at the mid-focal plane, this ring of strong fluorescence 
intensity shows that the anti-EGFR labeling is specific and predominantly localize on 
the cell membrane where a high level of their transmembrane EGFR expression is 
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found instead of within the cell. The uniform anti-EGFR staining also implies a 
relatively homogenous distribution of the anti-EGFR antibody on the cell surface. 
 
 
Figure 3.10. The (a) autofluorescence and (c) reflectance image of a representative 
unlabeled CNE2 cell is shown as control to the (b) anti-EGFR immunofluorescence 
labeling and (d) labeling with anti-EGFR conjugated gold nanoparticles on another 
representative CNE2 cell to demonstrate EGFR mapping. Images are cross-sectional 
slices of cells taken at the mid-focal plane at 40 x magnification. False-color 
fluorescence images obtained at excitation 488 nm and reflectance images obtained at 
excitation 543 nm. Scale bar in all images is 20 µm. 
 
A comparison of this labeling pattern with the confocal reflectance image in Figure 
3.10d shows that the strong reflectance signal that forms a bright scattering ring 
around the cytoplasmic membrane is consistent with the regions of high fluorescence 
intensity on the cell membrane. As discussed previously, this bright scattering ring is 
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associated with the localization of anti-EGFR gold nanoparticles on the cell 
membrane as it was not observed in the unlabeled cells. Since the gold labeling 
pattern corresponded well to the typical fluorescent labeling pattern of high EGFR 
expression, this strong reflectance signal was thus able to provide a map of EGFR 
expression under confocal reflectance microscopy. This reflectance-based optical 
approach to in vitro molecular imaging thus shows that the anti-EGFR-conjugated 
gold nanoparticles can serve as an effective molecular probe to target specific cancer 
biomarkers in cancer cells.  
 
However, the high reflectance observed was not be found exclusively on the 
membrane as other cellular components could also produce such reflective signals. 
Apart from this ring of bright scattering, a region of higher reflectance signal within 
the cell was also observed as seen from the intrinsic reflectance image of the 
unlabeled cell in Figure 3.10c. As this region was present in the cell without the gold 
nanoparticles staining (Figure 3.10c), it could not be due to the presence of gold 
nanoparticles in the cytoplasm.  
 
It is widely known that cells have their own region of intrinsic reflectance as the cell 
nucleus and other various organelles in the cells are also known to be generally 
reflective due to the changes in their refractive index from the cytoplasm. This was 
observed in Figure 3.10c where the region of visible reflectance at the top right of the 
cell could possibly be due to the reflectance from the nucleus and not from the cell 
membrane since this region occupied a sizeable portion of the cell and was not 
continuous around the cell perimeter. The reflectance from the membrane, on the 
other hand, appeared weak as it was not evident especially at the bottom left of the 
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cell. Similarly, the region of higher reflectance signal inside the cell in Figure 3.10d 
may also be attributed to the cell nucleus. Therefore, the signal-to-noise ratio achieved 
using such reflective probe to image biomarker expression is generally lower than that 
achieved with fluorescent probes.  
 
Despite such reflectance noise from other cellular components, the results have still 
shown the ability of gold nanoparticles probe to discriminate between cancer and 
normal cells based on the reflectance images and that the reflectance signal from the 
gold nanoparticles probes should provide sufficiently high contrast against intrinsic 
reflectance signals in cells and tissue to map the biomarker expression under certain 
imaging modalities where the use of fluorescence regime is not possible e.g. in OCT. 
 
3.4 Conclusion 
As cancer-associated molecular markers precede phenotypic manifestations of 
disease, there is a growing research interest in clinical molecular diagnostics for early 
cancer detection. Combining advances in biomedical optics and nanotechnology 
offers the opportunity to significantly impact future strategies towards the detection of 
cancer. This preliminary study demonstrates the potential of antibody conjugated gold 
nanoparticles to target and provide an optical contrast to discriminate cancer from 
normal cells based on their differential expression of EGFR as well as their potential 
to map the EGFR expression for molecular imaging under reflectance-based imaging.  
 
The results of this preliminary in vitro study can be extended to noninvasive in vivo 
imaging using other reflectance-based high resolution optical imaging systems such as 
OCT or fiber based reflectance confocal endomicroscopy imaging systems, where the 
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use of gold nanostructures as optical contrast agents can widen the functionality of 
these imaging systems to include molecular imaging of cancerous signatures of the 
tissue, in addition to their ability to perform anatomical imaging.  
 
This combination of detailed anatomical resolution coupled with molecular 
information from suspicious epithelial lesions can greatly enhance the sensitivity and 
specificity of optical imaging in vivo to provide more information about the diseased 
site for early cancer detection. The current results encourage further work in 
developing and assessing other types of gold nanostructures as potential in vivo 
contrast agents with a red-shifted surface plasmon resonance appropriate for use with 
the NIR illumination wavelength of OCT. One such promising gold nanostructure is 
the gold nanoshells and its synthesis is described in the following Chapter 4. 
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SYNTHESIS OF GOLD NANOSHELLS 
 
Abstract 
The promising results from the gold nanoparticles provide impetus for further studies 
on the use of gold nanoshells for NIR imaging. This chapter provides a description of 
the synthesis of gold nanoshells which involves the preparation of precursor seed 
particles consisting of nanoparticulate gold loaded on a dielectric core as scaffolds on 
which the layer of contiguous gold shell is grown. The conventional route in 
preparing these seed particles involves a two-step process of synthesizing colloidal 
gold nanoparticles followed by attaching them to amine functionalized dielectric core. 
In this chapter, the use of a single step direct deposition-precipitation (DP) process to 
replace the two-step process is described. The various factors such as pH (4-11), 
temperature (65-86 °C) and time (3-60 minutes) of reaction, as well as the effect of 
amine functionalization of silica on the deposition of gold onto amorphous silica 
spheres were investigated. Amine functionalization of the silica surface is able to alter 
its isoelectric point to facilitate the deposition of gold hydroxide nanoparticles 
(Au(OH)3). By varying the pH and time of reaction, it is also possible to control the 
size of Au(OH)3 nanoparticles and density of seeding. The progressive growth of the 
Au(OH)3 seeds to eventually form a complete layer of gold shell was monitored by 
TEM and the bathochromic shift of the UV-Vis extinction was correlated with the 
evolution of shell growth. The work presented in this chapter has been published in 
Gold Bulletin 2008; 41: 23-36 and Langmuir 2008; 24: 5109-5112. 
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4.1 Introduction 
The common synthesis route of gold nanoshells involves the synthesis of the 
dielectric core material e.g. silica or polystyrene spheres and the attachment of small 
nanoparticulate gold such as colloidal gold nanoparticles, usually formed from a 
separate process, onto their surface to form the precursor seed particle for subsequent 
growth of the polycrystalline gold shell in a controlled manner (Figure 4.1a) [1-4]. 
However, it has proved challenging to attain high dispersions of gold nanoparticles 
over silica surfaces [2, 5] and has led Halas et al. to devise a procedure where an 
amine-terminated coupling agent was grafted to the core surface to functionalize the 
surface with terminal amine groups that facilitate the capture and attachment of 
colloidal gold [6] (Figure 4.1a). As there is usually a weak interaction between the 
core material and gold, the grafting of an amine terminated coupling agent to the core 
grants it a nucleophilic surface for coordinate bonding with the gold nanoparticles.  
 
This approach has proved suitable for several core materials (e.g., silica, polystyrene, 
ferrous oxide) [1, 4, 7], although the process is costly and tedious. In this common 
synthesis route, the colloidal gold particles function as nucleation sites for the 
additional gold to be added on to eventually form a shell. These small colloidal gold 
are typically formed from the reduction of gold salt by strong reducing agents [8, 9] 
and may require several days of aging [3], up to 2 weeks for their size to stabilize 
before they are seeded onto the surface functionalized silica core. Whilst this common 
two-step process of seeding i.e. formation of small colloidal gold followed by 




Figure 4.1. The approach for synthesis of gold nanoshells using the (a) common two-
step process of seeding gold nanoparticulate on silica and (b) the single step DP 
process of gold seeding on silica prior to subsequent shell growth. 
 
Different surface seeding strategies were also reported by other groups to prepare the 
precursor seed particles. Examples of these strategies include the use of electrostatic 
attraction to attach preformed anionic colloidal particles onto a polycationic 
polyethyleneimine functionalized polystyrene microspheres, as demonstrated by Ji et. 
al [10]. Besides using preformed colloidal particles, the electroless plating approach is 
another strategy where the metal ions or complex cations were absorbed onto the 
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silica surface by the negatively charged Si-OH groups on the surface through 
electrostatic attraction and were subsequently reduced in situ to form the seed 
particles [11, 12]. Another possible approach employed the use of the solvent-assisted 
route where the polystyrene core was immersed in a mixed solvent of ethanol and 
acetone containing the gold salt, causing the surface layer of the polystyrene colloid to 
swell by the mixed solvent and permeated by the gold ions. The gold ions were 
subsequently reduced such that the swollen layer of the polystyrene colloids was 
uniformly loaded with gold nanoparticles [12]. Apart from seeding using colloidal 
gold or silver, Lim et al. seeded tin (Sn) particles on the surface of silica, which in this 
case, the Sn particles formed on the silica surface acted as a linker site between the 
silica core and the gold shell as well as an efficient catalytic surface for the reduction 
of gold ions on the silica surface [13]. 
 
The deposition-precipitation (DP) process of loading small gold particles on a metal 
oxide support base developed by Haruta’s group is an attractive alternative that can 
directly crystallize gold on silica [14]. It has been widely investigated in the catalytic 
field to form supported nanoparticulate gold catalysts for low temperature oxidation 
of carbon monoxide [15-19]. The DP method, in essence, entails placing the support 
in contact with an aqueous solution of gold (III) chloride (HAuCl4), the pH of which 
has been raised by the addition of a base, so that upon heating, oxidic precursor 
particles are formed on the support. The size and density of the nanoparticulate gold 
on the substrate is easily controlled by key parameters, including the concentration of 
HAuCl4 and its mass ratio to the support, type of support base, reaction temperature 
and time, and the pH of reaction [18].  
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This DP method is the easiest to handle and is used now for producing commercial 
gold catalysts in a highly controlled manner. However, stringent control of these 
variables is required to avoid diversiform gold crystals as the isoelectric point (IEP) of 
silica is close to pH 2 [20, 21], above which the surface is negatively charged and 
unsuitable for the fine deposition of anionic gold species (e.g. [Au(OH)xCl4-x]¯). 
Alternatively, basic conditions may be used, but cationic complexes such as 
[Au(en)2]3+ are difficult to prepare [22]. 
 
In the synthesis of gold nanoshells described in this chapter, the DP method is 
demonstrated as a simple and direct alternative route to loading nanoparticulate gold 
onto the silica core that serve as nucleation sites in a single-step process to form the 
precursor seed particle without the need for prior synthesis of colloidal gold (Scheme 
1b). Compared to the widely-used two-step technique of synthesizing small colloidal 
gold particles from reducing HAuCl4 by alkaline tetrakis(hydroxymethyl) 
phosphonium chloride (THPC) followed by attaching them to the surface 
functionalized silica core [1-4], this method results in a single-step process to form the 
precursor seed particles. This precursor seed particle was then used for further growth 
of a layer of gold shell to form the gold nanoshells. The various factors such as the 
pH, temperature and time of reaction, as well as the presence of surface 
functionalization on the deposition of gold were investigated and optimized. The 
gradual growth of the homogenous gold shell on the precursor seed particle prepared 
from this DP method is also demonstrated. The effects of other reactants on the 
growth of the shell will also be briefly discussed. 
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4.2 Materials and methods 
4.2.1 Reagents for synthesis 
The reagents used for the synthesis of silica nanoparticles include tetraethyl 
orthosilicate (TEOS, 99%, Merck), ammonia (NH3, 27%, Merck), ammonia 
hydroxide (NH4OH, 14.2 M, ISPL), absolute ethanol (C2H5OH, 99.9%, Merck) and 
milliQ water. 3-aminopropyltriethoxysilane (APTES, Sigma-Aldrich) dissolved in 1 
part water and 3 parts absolute ethanol to form a 12 mM APTES stock solution was 
used as an amine terminated silanizing agent to functionalize the surface of the silica 
nanoparticles with an amine terminal group. Hydrogen tetrachloroaurate (III), also 
known as gold (III) chloride (HAuCl4.3H2O, 99.99%, Alfa Aesar) was prepared in 
6.35 mM and 25 mM aqueous solution for the DP process of seeding gold hydroxide 
(Au(OH)3) nanoparticles and for growing of the gold shell respectively. A solution of 
0.1M sodium hydroxide (NaOH, Merck) was used to adjust the pH during the DP 
process of seeding. Potassium carbonate (K2CO3, 99%, Sigma-Aldrich) was used to 
raise the pH of HAuCl4 for its hydrolysis to form gold hydroxide solution for growing 
the gold shell. Both the sodium borohydride (NaBH4, 98%, Sigma-Aldrich) and 
sodium citrate dihydrate (HOC(COONa)(CH2COO Na)2.2H2O, 99%, Aldrich) were 
used in the reduction process of the gold hydroxide solution to grow the gold shell. 
 
4.2.2 Synthesis of silica core and surface functionalization 
The dielectric monodisperse silica nanoparticles were synthesized using the common 
Stöber procedure [23], which involved the hydrolysis and condensation of TEOS in a 
sol-gel process. The volume of individual reagents in the reaction mixture used for 
producing the different sizes of silica nanoparticles were summarized in Table 4.1. 
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The mixtures were allowed to stir vigorously overnight for the reaction to complete. 
The white turbid suspension was subsequently centrifuged and washed in ethanol and 
distilled water for at least 5 times at 10,000 rpm for 30 minutes each before 
resuspending them in 80% by mass of absolute ethanol prior to surface 
functionalization. Using this protocol, spherical and monodispersed silica 
nanoparticles from a size range of 50 nm to 440 nm in diameter were synthesized.  
 
Table 4.1. Reaction volumes of various reactants used to synthesize the silica 
nanoparticles core of different diameter sizes. 
Size (nm) Ethanol (ml) H2O (ml) NH3 (ml) NH4OH (ml) TEOS (ml) 
78.9 ± 10.5 138.0 10.8 - 2.4 6.6 
120.6 ± 8.4 92.0 3.1 - 4.45 6.0 
210.9 ± 8.0 138.0 4.65 0.675 6.0 9.0 
248.8 ± 16.7 138.0 4.65 3.75 6.0 9.0 
298.9 ± 11.2 138.0 4.65 6.0 6.0 9.0 
377.0 ± 14.7 138.0 10.8 15.0 6.0 9.0 
439.7 ± 14.7 138.0 10.8 30.0 6.0 9.0 
 
The silica nanoparticles were then surface functionalized with a terminal amine group 
by grafting them with 12 mM APTES in volume ratio of 3:7 under constant heating 
and vigorous stirring at 80 °C for 1 h to make the surface amenable for deposition of 
small gold particles. Under this condition, the APTES used was in molar excess to 
achieve a complete surface functionalization. The amine grafted silica particles were 
then cooled to room temperature and washed with at least 7 cycles of centrifugation 
and redispersion in absolute ethanol and distilled water at 8,000 rpm for 30 minutes 
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each to remove residual reactants before resuspending them in 1 ml of water for every 
0.3 g of silica used for surface functionalization. 
 
4.2.3 DP process of seeding gold hydroxide nanoparticles 
The amine grafted silica nanoparticles were then seeded with Au(OH)3 nanoparticles 
on its surface using the DP process. Briefly, 4.5 ml of 0.1M NaOH was added to 20 
ml of 6.35 mM solution of HAuCl4 and allowed to stir for about 15 minutes before the 
solution became mild yellowish. The addition of NaOH raised the pH of the HAuCl4 
and allowed hydrolysis of HAuCl4 to take place to form gold hydroxide solution at pH 
8 as shown in the reaction schematic in Figure 4.2. 
 
 
Figure 4.2. Hydrolysis of HAuCl4 by addition of NaOH to form gold hydroxide 
HAuCl(OH)3 (or Au(OH)3) solution for subsequent seeding onto the silica 
nanoparticles. 
 
The amine grafted silica particles in 1 ml was then added to this gold hydroxide 
solution and the solution was heated at 70 °C for 30 minutes under vigorous stirring 
where the color of the mixture turned from milky white to orange-brown as shown in 
Figure 4.3 as an indication of successful loading of Au(OH)3 nanoparticles on the 
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amine grafted silica. The product was then centrifuged and washed with distilled 
water for at least 5 times at 800 rpm for 1 h each and the final brown pellet was 
ultrasonically redispersed in distilled water to give a final volume of 40 ml of 
precursor seed solution. 
 
 
Figure 4.3. Gradual color change during the DP process indicates the loading of 
Au(OH)3 nanoparticles on the amine grafted silica. It was later found from the TEM 
images that the darker the solution, the higher the density of seeding. 
 
Based on mass calculation, the concentration of the 300 nm diameter precursor seed 
particles in the seed solution was of the order of 2.3 x 1011 particles per ml. In this 
study, the pH, temperature and heating time of reaction were varied to investigate the 
effects of these factors on the size and seeding density of the Au(OH)3 nanoparticle 
seeds. The pH was varied by changing the volume of 0.1M NaOH added to the 
HAuCl4. The Au(OH)3 nanoparticles were deposited on a range of different sizes of 
silica cores as shown in Table 4.1. The direct seeding of Au(OH)3 nanoparticles on 
silica surface without the terminal amine group was also investigated. In this case, the 
synthesized silica nanoparticles were added directly to the gold hydroxide solution 
and the mixture heated to proceed with the DP process. 
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4.2.4 Growth of gold shell 
The Au(OH)3 nanoparticles deposited on the surface of the silica acted as nucleation 
sites and were allowed to grow in size by further addition of more gold reduced from 
HAuC14 onto these small gold hydroxide nanoparticles until they eventually coalesce 
together to form a continuous complete layer of gold shell around the silica core. In 
growing the shell, the pH of HAuCl4 was adjusted to around 10.1 by addition of 60 
mg of K2CO3 to 1.5 ml of 25 mM HAuCl4 diluted in 100 ml of water and allowing the 
solution to stir in the dark overnight at room temperature for the HAuCl4 to hydrolyze 
and age to give a colorless gold hydroxide solution. This solution is subsequently 
referred to as K-gold. The 40 ml of precursor seed particles were ultrasonically 
redispersed and 0.5 ml of the seed solution was added to different volumes of K-gold 
before a freshly prepared 6.6 mM NaBH4 was added at 1 ml for every 10 ml of K-gold 
to reduce the complex gold hydroxide anions in the K-gold onto the Au(OH)3 seeds. 
This reduction resulted in an almost immediate color change: red, purple, blue or 
green depending on the shell thickness and degree of completeness.  
 
The ratio of seed solution to K-gold solution controls the amount of gold available for 
deposition on the silica surface, hence the growth of the shell depended on the amount 
of K-gold used. Different volume ratios of K-gold to precursor seed particles from 5:1 
to 300:1 were varied to demonstrate the progressive growth of the shell. In this 
reduction step, 1 ml of 10 mM sodium citrate dihydrate per 20 ml of K-gold was also 
added to slow the reaction and stabilize the gold nanoshells by acting as a capping 
agent. Using this approach of synthesis, the core size and shell thickness of the gold 
nanoshells could be varied by changing the size of the silica core nanoparticles and 
the amount of HAuCl4 for reduction respectively. The gold nanoshells were prepared 
 105
to a final concentration of 5 x 109 particles per ml as determined using absorption 
spectroscopy and were stored at 4 C when not in use. 
 
4.2.5 Characterization of gold nanoshells 
The synthesized silica, precursor seed particles and gold nanoshells at different stages 
of shell growth was imaged using the transmission electron microscopy (TEM) (Jeol 
JEM-2100F) in brightfield mode using an objective aperture of 20 µm operating at 
200 kV. The particle size was also characterized by TEM. Samples were prepared by 
placing a drop of solution on a carbon coated copper grid and allowing the grid to dry 
on filter paper. The average size and size distribution of the silica nanoparticles were 
determined from the TEM images using the ImageJ software (National Institutes of 
Health, USA). The optical extinction spectrum of gold nanoshells at different stages 
of shell growth was measured in water using a UV-Vis spectrophotometer (Shimadzu 
UV-2401 PC) in the wavelength range from 400 nm to 900 nm with the sample 
placed in a cell with a pathlength of 10 mm. 
 
To compare the experimentally measured spectrum with theoretically predicted 
spectrum, a program for the calculation of theoretical optical spectrum of core-shell 
structures based on Mie theory was written in MATLAB (see Chapter 2). This 
program is similar to that used to compute the optical cross section space maps as 
described earlier in Chapter 2. The calculations require the following as input: the 
refractive indices of the silica core (assumed to be constant at η = 1.43) and the water 
medium (η = 1.33), the frequency-dependent dielectric constant of gold [24], the size 
of the core, and the thickness of the shell. The theoretical extinction spectrum was 
predicted using the data for the silica core radius obtained by TEM measurements and 
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the thickness of the gold shells was calculated by subtracting the silica core radius 
from the total particle radius also obtained by TEM. These spectra were then adjusted 
to the measured extinction spectra by a fitting procedure. 
 
4.3 Results 
4.3.1 Effect of amine terminated surface functionalization 
The influence of surface functionalization of the silica cores with a terminal amine 
group on the deposition of Au(OH)3 nanoparticles during the DP process of seeding 
was investigated. Both amine grafted and ungrafted silica cores were subjected to the 
same seeding conditions in DP and the results are shown in Figure 4.4 for a 30 
minutes heating with 6.35 mM HAuCl4 adjusted to pH 8 with 4.5 ml of 0.1 M NaOH.  
 
The presence of the terminal amine group on the surface of amine functionalized 
silica results in Au(OH)3 nanoparticles that were smaller and uniform in size and 
shape, although large gold clusters were occasionally observed (Figure 4.4c). The 
formation of these large clusters is discussed in more detail as the effect of heating 
duration is examined. The Au(OH)3 seeds formed were homogenously distributed on 
the silica surface with high seeding density i.e. small inter-particle distances and high 
coverage on the silica core. The seed particles were typically about 4 nm in size. 
 
In contrast, the Au(OH)3 seeds on the bare surface of the ungrafted silica cores were 
generally larger and less uniform in size and shape. The seed particles in this case 
range from 4 to 15 nm. The distribution of these seed particles was also less 
homogenous with regions of different seeding density observable, although in general, 
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the seeding density and hence surface coverage is lower on the ungrafted silica 
compared to the amine grafted silica cores. This result clearly shows the influence of 
the amine terminated surface functionalization on the DP process of seeding Au(OH)3 
nanoparticles in terms of the seed size, uniformity and surface coverage. 
 
 
Figure 4.4. The DP process of seeding gold hydroxide nanoparticles on (a) ungrafted 
naked silica cores with (b) a higher magnification image of a single precursor seed 
particle. This seeding result is compared to (c) silica cores grafted with terminal 
amine groups and (d) its corresponding higher magnification image of a single 
precursor seed particle showing the details of the gold hydroxide nanoparticles. 
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4.3.2 Effect of pH 
The pH in which the DP process occurs was varied by adding different amounts of 0.1 
M NaOH to the 6.35 mM HAuCl4 to investigate how the pH and hence the degree of 
hydrolysis of HAuCl4 affects the loading of Au(OH)3 nanoparticles on the amine 
grafted silica. Four different amounts of NaOH was used: 1.6 ml, 3.3 ml, 4.5 ml and 6 
ml, and these results in approximate pH of 4, 6, 8 and 11 respectively after 15 minutes 
of stirring the hydrolyzed HAuCl4 solution prior to adding the amine grafted silica. 
The DP process of loading Au(OH)3 nanoparticles under these four pHs with 30 
minutes heating is shown in Figure 4.5. 
 
At low pH of around 4, the solution was pale yellow after the DP reaction and the 
TEM image revealed that the density of the seed was low and was not very 
homogenously distributed with regions showing higher density of Au(OH)3 
nanoparticles compared to others (Figure 4.5a). The seed particles were generally 
small, typically < 5 nm, although the variation in size distribution is large with seed 
particles as big as 10 nm. 
 
As the pH increases to 6, the solution turned orange. One dominant observation under 
the TEM was the presence of two populations of seed particles with different sizes 
formed on the amine grafted silica core (Figure 4.5b). The smaller seed particles with 
sizes of < 2 nm were seeded with high density on the surface. These small particles 
were as fine as 1 nm and they achieved an almost complete coverage on the surface. 
The large seed particles with mean size of about 7 nm were scattered amongst the 




Figure 4.5. The DP process of seeding gold hydroxide nanoparticles at (a) pH of 4, (b) 
pH of 6, (c) pH of 8 and (d) pH of 11 on the surface of amine functionalized silica 
cores to illustrate the influence of pH on the seeding efficiency using the DP method. 
 
These two populations were not observed when the pH was raised further to pH 8 
where similar observations were made as that shown in Figure 4.4d. At this pH, the 
solution after the DP reaction was dark orange and the density of Au(OH)3 
nanoparticle seeds on the silica core remains high and homogenously distributed with 
a narrow size distribution centered at around 4 nm (Figure 4.5c).  
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Further increase in the pH to 11 reduced the density of the Au(OH)3 nanoparticle 
seeds although the particles remained rather homogeneously distributed on the silica 
core (Figure 4.5d). The lower density of seeds results in a pale yellow solution similar 
to that observed at pH 4, but in this case, the density of the seeding is slightly higher 
than pH 4. The Au(OH)3 seed particles had a large variation in size distribution, 
ranging from 4 nm to as big as 20 nm. These results thus suggest a general pH 
dependence of the size and seeding density of the Au(OH)3 seeds on the silica core 
and that to achieve a high density of Au(OH)3 loading for subsequent effective shell 
growth, a rather narrow optimal working range of pH at around 8 needs to be effected. 
 
4.3.3 Effect of temperature and duration of reaction 
The DP reaction for the formation and deposition of Au(OH)3 nanoparticles on the 
amine functionalized silica cores was observed to occur only at temperature over 65  
°C. The mixture containing the hydrolyzed HAuCl4 solution at pH 8 and amine 
grafted silica remained milky white at < 65 °C, but started to turn pale yellow at 
around 65 °C before eventually turning dark orange as heating continued. It was 
found that the temperature of reaction had little influence on the size and seeding 
density of the seeds. The DP reaction heated at 68 °C and 86 °C for the same duration 
of less than 20 minutes showed no observable differences in the size of the Au(OH)3 
seeds or their density of seeding (results not shown).  
 
However, the duration of heating at temperature > 67 °C affected the size of the 
deposited Au(OH)3 nanoparticle seeds. This influence of heating duration was 
investigated by heating the mixture (with pH 8) at 70 °C for 3, 30, and 60 minutes and 
the results were shown in Figure 4.6. Generally, the mean Au(OH)3 nanoparticles 
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seed size increased with the duration of heating from 2 nm for a 3 minutes reaction 
time to 4 nm for a 30 minutes reaction time and 7 nm for a 60 minutes reaction time.  
 
 
Figure 4.6. Comparison of DP process of seeding small gold nanoparticles on amine 
functionalized silica cores for different heating duration of 3, 30 and 60 minutes at 
temperature > 67 °C. Images on the top row were taken with the same magnification 
of 150,000X while images on the bottom row were taken with the same magnification 
of 20,000X. 
 
Beyond an hour of heating, the size of the Au(OH)3 seeds was observed to remain 
unchanged at 7 nm. However, the more prominent observation with prolonged heating 
was the higher tendency for formation of large gold clusters, typically larger than 20 
nm as the heating proceeded beyond 30 minutes (Figure 4.6c). The formation of these 
large gold clusters would subsequently affect the growth of gold shell on the 
precursor seed particles as these gold clusters could also serve as catalytic sites that 
compete with the Au(OH)3 nanoparticles seeds for the reduction of additional gold 
during the shell growth process. 
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4.3.4 Growth of gold shell 
The versatility of using the DP process to seed Au(OH)3 nanoparticles on a range of 
silica core sizes functionalized with a terminal amine group: 50, 130, 220, 300 and 
440 nm in diameter is demonstrated. The precursor seed particles formed from 
different sizes of silica core at pH 8 with reaction duration of 30 min are shown in 
Figure 4.7. For the range of silica sizes investigated, the size and size distribution of 
the Au(OH)3 nanoparticle seeds remained uniformly centered at 4 nm and the 
Au(OH)3 nanoparticles were also homogenously distributed on the surface. 
 
 
Figure 4.7. Precursor seed particles formed from a range of five different silica cores 
sizes: 50, 130, 220, 300, and 440 nm, as shown from (a) to (e) respectively, using the 
DP process of seeding small gold hydroxide nanoparticles on silica cores at pH 8 and 




The precursor Au(OH)3 seeded silica formed from seeding at pH 8 under a seeding 
temperature of 70 °C for 30 min (Figure 4.8a) were then used for the further growth 
of a layer of gold shell around the silica by reducing more hydrolyzed HAuCl4 i.e. 
gold hydroxide solution from the aged K-gold on them. Different K-gold-to-seed 
ratios from 5:1 to 300: 1 were used to progressively grow the Au(OH)3 seed 
nanoparticles until they coalesce together with their increase in size and eventually 
form a complete layer of gold shell. The typical growth of the seed particles on a 
silica core size of 300 nm diameter is illustrated in Figure 4.8 as an example. The 
results for increasing K-gold-to-seed ratios of 5:1, 20:1, 40:1, 70:1, 100:1, 160:1, 
200:1 and 300:1 for growing a shell around the 300 nm core are shown in Figure 4.8b 
to i respectively. 
 
The results show a progressive growth in the seed size at lower ratios up to around 
70:1, beyond which they started to coalesce together at 100:1. At a ratio of 200:1, the 
amount of gold ions was barely sufficient to form a complete layer of gold shell 
around the silica core with a thickness of about 10 nm. Based on calculation of the 
core size and concentration of the precursor seed particles as well as the dimension 
and density of the gold shell, a ratio of 190:1 was required to form a 10 nm thick 
uniform shell around the 300 nm diameter silica. The experimental amount is thus 
consistent with that obtained from mass calculation of the same dimension. Beyond 
this ratio of 200:1, the shell thickened to about 30 nm at a ratio of 300:1. Thicker gold 
shell can be grown at even higher K-gold-to-seed ratios using this same technique and 




Figure 4.8. Growth of the gold hydroxide nanoparticle seeds by reducing the aged 
gold hydroxide (K-gold) solution on the (a) precursor seed particles to progressively 
form a complete layer of gold shell i.e. Au(0) with increasing K-gold-to-seed ratios of 
(b) 5:1, (c) 20:1, (d) 40:1, (e) 70:1, (f) 100:1, (g) 160:1, (h) 200:1 and (i) 300:1 for a 
silica core size of 300 nm in diameter. All images in figures taken with the same 
magnification with the scale bar shown in (a). 
 
As the Au(OH)3 nanoparticle seeds were in the order of 4 nm and they need to grow 
and coalesce together before forming a complete shell covering, this technique of 
shell growth imposed a minimum shell thickness of around 10 nm (Figure 4.8g). As 
the shell grows to different thickness, the color of the resulting colloid also exhibit a 
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gradual change to give a spectrum of color corresponding to different stages of 
growth and thickness of the gold shell as shown in Figure 4.9 below.  
 
 
Figure 4.9. Colloidal solution of gold nanoshells showing a spectrum of color 
corresponding to different stages of shell growth and thickness of gold shell. 
Generally, as the shell grows on the silica core, the color changes gradually as shown 
in the direction from left to right. 
 
The changes in UV-Vis extinction spectra of the gold nanoshells at different stages of 
seed growth for the 300 nm diameter core corresponding to the same K-gold-to-seed 
ratios as in Figure 4.8 were measured and shown in Figure 4.10. The theoretically 
predicted extinction spectrum based on Mie theory for a single gold nanoshell with a 
silica core of 300 nm and shell thickness of 28 nm is also shown for comparison.  
 
Since the Au(OH)3 nanoparticles do not exhibit any surface plasmon resonance, the 
extinction spectrum of the initial precursor seed particles loaded with Au(OH)3 
nanoparticles shows a typical optical response of a Mie particle scatterer with the 
absence of any extinction peak. As the Au(OH)3 seeds were initially reduced by 
NaBH4 to gold, i.e. Au0 nanoparticles and began to grow slightly in size at low K-gold 
ratios, the formation of an extinction peak of 560 nm, typical of the surface plasmon 
resonance of large gold nanoparticles, was observed to indicate the formation and 
initial growth of the gold seeds. 
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Figure 4.10. Measured UV-Vis extinction spectrum of the gold nanoshells at different 
stages of seed growth on the (a) precursor seed particles arising from a range of 
different K-gold-to-seed ratio of (b) 5:1, (c) 20:1, (d) 40:1, (e) 70:1, (f) 100:1, (g) 
160:1, (h) 200:1 and (i) 300:1 for a silica core size of 300 nm. The theoretically 
predicted spectrum (j), shown in dashed line based on the Mie theory for a 300 nm 
diameter silica core with a 28 nm gold shell is also shown together for comparison. 
 
The UV-Vis spectra at higher K-gold:silica ratios show a gradual red shift in the 
plasmon resonance peak towards higher wavelength from 630 nm at 20:1 to about 900 
nm at 160:1, indicating the growth of the seed and increasing plasmon interactions 
between the neighboring seed particles as they grow closer together. Apart from peak 
shifts, the extinction spectra also increase in intensity with the growth of the gold seed 
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particles due to the increasing surface plasmon response and optical cross sections 
from the larger gold particles. The seeds continue to grow further in size until a 
complete shell was obtained (Figure 4.10g). In this case, the peak plasmon resonance 
for this configuration was determined to be around 800 nm. Further thickening of the 
gold shell caused a blue shift back in the wavelength of the peak optical response as 
observed in Figure 4.10i.  
 
When compared to theoretically predicted spectrum based on Mie theory for the same 
dimensions, the measured extinction spectrum of the gold nanoshells having a 300 nm 
diameter core and 28 nm shell generally agreed well with the theoretical spectrum 
with small differences that can be attributed to the heterogeneity within the population 
of gold nanoshells formed. Such heterogeneity is inevitable due to the size variations 
in the silica core as well as the small differences in the thickness of the shell formed. 
The agreement of the experimentally measure spectrum with the theoretically 
calculated spectrum using Mie theory implies that the constituent scattering, 
absorption and backscattering spectrum as well as anisotropy of the gold nanoshells 
can also be predicted with good accuracy from Mie theory. These constituent spectra 
are useful in examining the optical response of gold nanoshells for bioimaging or 
therapeutic applications based on the absorption or backscattering metric. 
 
4.4 Discussion 
4.4.1 Deposition-precipitation of Au(OH)3 on oxide support  
The process of deposition-precipitation of Au(OH)3 on oxide support starting from a 
gold precursor in the form of an aqueous solution of HAuCl4 has been widely used in 
 118
the catalytic field involving seeding such gold particles on metal oxide substrate to 
form nanoparticulate gold catalyst [15-19]. It is clear from recent work on the 
characterization of gold on alumina that addition of base to HAuCl4 hydrolyzes the 
chloroauric anion i.e. [AuCl4]¯ in solution to form a few major species of negatively 
charged gold complex anions of the general form [Au(OH)xCl4-x]¯ with the 
composition depending on the extent of hydrolysis [25] as given below.  
 
AuCl4¯ + (OH)¯ <=> AuCl3(OH)¯ + Cl¯ 
AuCl3(OH)¯ + (OH)¯ <=> AuCl2(OH)2¯ + Cl¯ 
AuCl2(OH)2¯ + (OH)¯ <=> AuCl(OH)3¯ + Cl¯ 
AuCl(OH)3¯ + (OH)¯ <=> Au(OH)4¯ + Cl¯ 
 
The extent of hydrolysis in turn depends on the pH which gives an indication of the 
amount of OH¯ available for hydrolysis. To promote the exchange of chloride in 
[AuCl4]¯ with OH¯ during hydrolysis, the aqueous solutions should be warmed to a 
temperature in the range of 60 – 80 °C [17].  
 
Out of these six species, only Au(OH)3 precipitates [25]. As a result, the gold 
available in solution is only partially deposited on the support as the remaining 
species remain dissolved in the solution. It is the control of hydrolysis to tune the 
speciation of [Au(OH)xCl4-x]¯ that subsequently influence the amount of 
nanoparticulate Au(OH)3 seeds formed on the substrate as well as their size and 
density on the silica. Therefore, this method has to be strictly controlled in terms of 
the pH value, the resulting dimension and seeding density of the Au(OH)3 
nanoparticles being dependent on it.  
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For typical HAuCl4 concentration of the millimolar range used in most DP process, 
careful control of the pH in the range of 6 to 10, and temperature in the range of 60 to 
80 °C enable selective crystallization and deposition of Au(OH)3 nanoparticles only 
on the surfaces of metal oxide support without precipitation and crystallization in the 
liquid phase. It was found that the Au(OH)3 nanoparticles loaded onto the silica 
nanoparticles using this controlled hydrolysis and DP method were stable towards 
magnetic stirring and ultrasonication. 
 
4.4.2 Nature of support substrate surface 
The nature of the support substrate surface also exerts a tandem effect on the extent of 
hydrolysis of HAuCl4 on the deposition of the Au(OH)3, as demonstrated in the 
results (see section 4.3.1). The unfortunate drawback of DP method is that it is not 
effective in the presence of metal oxides supports whose isoelectric point (IEP) is 
below 5 [17].  
 
Although the direct deposition of Au(OH)3 on bare silica surface (IEP ≈ 2) without 
any surface functionalization is possible with the reaction schematic as shown in 
Figure 4.11, the deposition has shown to be poor as demonstrated by the seeding 
results on bare silica nanoparticles in Figure 4.4b. The reason for this is that above 
this pH i.e. pH > 2, its surface is negatively charged which hinders the attraction of 




Figure 4.11. Reaction schematic of depositing Au(OH)3 on bare silica surface without 
any surface functionalization [18]. 
 
As demonstrated in section 4.3.1, the problem associated with the low IEP of silica 
nanoparticles is addressed by functionalizing their surface with a terminal amine 
group prior to seeding the Au(OH)3 nanoparticles. The reaction schematics for the 
grafting of APTES onto the silica nanoparticles are shown in Figure 4.12 below.  
 
 
Figure 4.12. Equations of (a) hydrolysis reaction from alkoxysilanes, and (b) of 
condensation reactions with another silane or (c) with the hydroxylized silica [26]. 
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Use of APTES is a typical example of obtaining cationic amine groups on nanosize 
particles [27]. Direct silanation of silica nanoparticles using a silane-coupling agent 
such as APTES is attractive for the control of surface properties. The amine groups on 
the silica surface effectively modify the IEP of silica nanoparticle since the grafting of 
APTES on the silica nanoparticles caused a drastic change in the IEP of silica 
particles from 2 to 9. At a pH of 8, the surface of amine grafted silica becomes 
positively charged, making the surface favorable for attraction of [Au(OH)xCl4-x]¯ and 
subsequent deposition of Au(OH)3 as shown in Figure 4.13.  
 
 
Figure 4.13. The surface functionalization of silica nanoparticles with a terminal 
amine group using APTES confers the surface a positive charge that favors the 
electrostatic attraction of the gold complex anion species for deposition. 
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Therefore, surface functionalization of silica nanoparticles with APTES results in 
favorable electrostatics and this favorable electrostatics coupled with dominant 
formation of [Au(OH)3Cl]¯ from the hydrolysis of HAuCl4 at around pH 8 [28] (to be 
discussed in more detail below) results in much high density of smaller Au(OH)3 
nanoparticles deposited on the silica. Furthermore, it is also known that the 
introduction of a support with polar surface groups i.e. silica with surface-
functionalized -NH2 groups leads to the acceleration of the hydrolysis reaction near 
the functionalized surface [29]. The formed nanoparticles of hydrated metal oxides 
are immediately adsorbed onto the surface of the silica. 
 
4.4.3 Influence of pH on seeding density 
Besides the influence of surface functionalization, the effect of other factors such as 
pH and time of reaction on the seeding process is also demonstrated. Perhaps one of 
the key factors controlling the seeding density of Au(OH)3 nanoparticles on the silica 
core is pH. In this case, two conditions in the DP process that are sensitive to the pH 
come into play: the hydrolysis of HAuCl4 to give [Au(OH)3Cl]¯ as the dominant 
species that would precipitate [25] and a surface with appropriate IEP to facilitate the 
adsorption of [Au(OH)xCl4-x]¯. These two conditions must both be satisfied to achieve 
good seeding on the silica. It has been found from previous studies that preparation at 
a mildly basic pH range of 7 to 9 is preferable for most oxide support [30] because at 
this pH, the value of x in [Au(OH)xCl4-x]¯ is close to 3 where precipitation is the most 
efficient as mentioned earlier. This pH range is also compatible with the IEP of most 
metal oxide [17] for electrostatic attraction and deposition as discussed previously. 
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As mentioned earlier, the amine grafted silica substrate surface has an IEP ≈ 9. At pH 
below this IEP, the surface is positively charged and is capable of adsorbing more of 
the negatively charged gold species as illustrated in Figure 4.14. However, at a much 
lower pH of 3 to 4, there is little hydrolysis of the Au–Cl bond to form Au(OH)3, and 
many studies have shown that the soluble AuCl3.H2O is the major species with traces 
of other [Au(OH)xCl4-x]¯species at this pH [18, 28]. Therefore, there is a low 
precipitation of Au(OH)3 species and its density of seeding remains poor and 
inhomogeneous despite the favorable electrostatic adsorption from the substrate. 
 
 
Figure 4.14. The deposition of [AuCl(OH)3]- requires an attractive charge on the 
surface of the grafted silica nanoparticles which can be obtained at pH less than its 
IEP of 9. This attractive charge serves to attract the gold complex anion after its 
hydrolysis, which at pH of 9 gives the dominant species of [AuCl(OH)3]-. At pH 
higher than IEP, the surface gives a repulsive charge which reduces the efficiency of 
deposition. 
 
As the pH increases to 6 while maintaining below the isoelectric point, the extent of 
hydrolysis increases due to increasing replacement of more Au–Cl with Au–OH in the 
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complex [Au(OH)xCl4-x]¯ anion. More of the precipitating [Au(OH)3Cl]¯ species are 
formed and the density of the Au(OH)3 nanoparticles increases correspondingly until 
a high seeding density is achieved at pH 8. At this pH, the hydrolysis forms 
[Au(OH)3Cl]¯ as the dominant species and their electrostatic attraction to the 
positively charged amine grafted surface (IEP ≈ 9) facilitated their deposition.  
 
Further increase in pH to 11 beyond the IEP of the amine grafted surface causes 
adsorption of the negatively charged [Au(OH)xCl4-x]¯complex to reduce rapidly due to 
repulsive negative charge from the surface [15] (Figure 4.14). Furthermore, since 
Au(OH)3 is amphoteric, its solubility increases due to the formation of [Au(OH)4]¯ at 
higher pH, thus making the soluble [Au(OH)4]¯ the most dominant species at high pH 
[18] instead of the precipitating [Au(OH)3Cl]¯. This reduces the efficiency of 
precipitation and results in a lower density of Au(OH)3 nanoparticles on the silica as 
the amount of Au(OH)3 species available for deposition is decreased. Therefore, there 
is a narrow optimal working range of pH where the [Au(OH)xCl4-x]¯ can be attracted 
to the surface and with sufficient hydrolysis to form the precipitate for deposition. 
 
4.4.4 Effect of temperature 
The DP reaction for the formation of Au(OH)3 nanoparticles on the amine grafted 
silica cores seem to take place at temperature above 65 °C. The role of temperature 
probably accounts for the rate of precipitation and deposition of the Au(OH)3 
nanoparticles which can take place as rapid as 3 min (see Figure 4.6a). Apart from 
affecting the rate of reaction, the size and seeding density of the Au(OH)3 
nanoparticles are not affected much by temperature if the duration of reaction is not a 
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limiting factor. Hence there were little or no observable differences in the seeding 
with temperature variation beyond 65 °C at longer heating time of 30 min.  
 
The more dominant factor rather, is the duration of reaction at temperature > 65 °C 
where the size of Au(OH)3 increases with the duration of heating and gold clusters 
larger than 20 nm were formed with prolonged heating time of beyond 30 min. The 
growth of the Au(OH)3 nanoparticles and formation of large gold clusters can be 
accounted for by briefly considering the surface energetics of the nanoparticles. As 
the precipitation and deposition of Au(OH)3 nanoparticles on amine grafted silica 
progresses with heating duration, the terminal amine groups on the silica available for 
attachment to Au(OH)3 nanoparticles starts to saturate and crystal growth of the 
existing deposited Au(OH)3 nanoparticles become a more dominant process compared 
to further deposition of new Au(OH)3 nanoparticles on APTES.  
 
This growth arises from the continuous precipitation of Au(OH)3 in solution and 
aggregation of these new precipitates with existing deposited Au(OH)3 particles. This 
yields increasingly larger Au(OH)3 nanoparticles until their surface charge, which 
progressively becomes more negative due to the presence of chloride [15] as more 
Au(OH)3 aggregates, render them energetically unfavorable for further growth. In this 
case, prolonged heating causes the [Au(OH)3Cl]¯ in the solution to precipitate and 
aggregate with each other instead to form larger gold clusters of Au(OH)3 in the 
solution. Such nanoparticles formed in solution compete with the deposited Au(OH)3 
as reduction sites for K-gold, thus reducing the efficiency of shell growth. 
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4.4.5 Growth of gold shell 
The Au(OH)3 nanoparticles are seeded on silica to function as nucleation sites where 
they will be reduced to Au0 nanoparticles while the K-gold is also simultaneously 
reduced to deposit more Au0 on them in the process of growing the gold shell. In the 
growth of the gold shell, the pH of K-gold solution is important to nanoshell 
formation on the precursor seed particles as it controls the speciation of [Au(OH)xCl4-
x]¯ which in turn affect its reduction on the Au(OH)3 nanoparticles. In this case, the 
gold to be reduced on the seeds was prepared by adjusting the pH of HAuCl4 solution 
through the addition of K2CO3 to around 10.1, where hydrolysis of most of the Au–Cl 
bond occurs after an overnight aging in the dark to form the soluble gold hydroxide 
complex [Au(OH)4]¯ as the dominant species [18] as shown in Figure 4.15 below. 
 
 
Figure 4.15. Predicted number of Raman active stretches for both Au-Cl and Au-OH 
over a range of different pH by Murphy et. al. which indicates the predominant 
[Au(OH)xCl4-x]¯ species formed at different pH. The pH of HAuCl4 solution can be 
adjusted by addition of a base such as NaOH (see section 4.4.1 and 4.4.3) or K2CO3 to 
different complex gold anionic species of the form [Au(OH)xCl4-x]¯. Whilst the pH is 
raised to 8 by NaOH to form the dominant specie AuCl(OH)3¯ for DP process of 
seeding, the pH is raised to 10.1 by K2CO3 to form the dominant specie Au(OH)4¯ for 
the growth of gold shell [28]. 
 
Amongst the six species of [Au(OH)xCl4-x]¯ discussed earlier, [Au(OH)4]¯ seems to 
have the lower tendency to be reduced in solution to form colloidal gold even with a 
strong reducing agent as evident from its slow and gradual color change when 
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reduced. This is in contrast to the reduction of other [Au(OH)xCl4-x]¯ species formed 
at lower pH where that the addition of NaBH4 causes an instantaneous color change to 
form colloidal gold. This observation may possibly be attributed to a weaker 
reduction potential of [Au(OH)4]¯ compared to other species although the 
electrochemistry of different species of [Au(OH)xCl4-x]¯ is not well characterized. 
 
During the reduction of K-gold, the Au(OH)3 nanoparticles also serve as catalytic 
sites to facilitate preferential reduction of [Au(OH)4]¯ on the seed particles for shell 
growth. It was found that adjustment to other pH < 10 by adding smaller amount of 
K2CO3 results in the formation of other dominant species that have greater tendency 
to be reduced in solution to form colloidal gold thus diminishing their preferential 
reduction on the seed particles and effectiveness in growing the gold shell.  
 
In reducing the K-gold solution of [Au(OH)4]¯ onto the precursor seed particles, the 
freshly prepared NaBH4 was used as the reducing agent. It was noted that increasing 
the amount of NaBH4 used for reduction also resulted in a corresponding increase in 
the tendency of gold nanoshells to aggregate. Furthermore, the formation of a brown 
scattering solution was also observed  when a large amount of NaBH4 was added. The 
formation of such brown scattering solution has also been reported by others [1] and 
on closer examination under the TEM, this observation is due to the presence of large 
bulk gold particles (data not shown). However, if the amount of NaBH4 used is too 
little, the solution will contain unreacted K-gold in solution. The amount described 
represents a good compromise based on the molar ratio of reagents used for the redox 
reaction. In addition to NaBH4, sodium citrate dihydrate was also added during the 
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reduction for shell growth. The use of sodium citrate to slow the reaction and stabilize 
the gold nanoshells during the reduction process has been reported by others [12, 29]. 
 
4.5 Conclusion 
The use of a DP process of seeding nanoparticulate gold onto amine functionalized 
silica core particles to form the precursor seed particles has shown to be a feasible 
alternative route for the growth of a gold shell in the synthesis of gold nanoshells. 
Compared to the widely-used two-step strategy of synthesizing small colloidal gold 
nanoparticles from reduction of HAuCl4 by THPC followed by their attachment onto 
the silica core, the DP method of seeding is time and cost effective since it condenses 
the process into a single-step that requires just 10 minutes of heating reaction to form 
the precursor seed particles without the need for prior synthesis of colloidal gold. The 
DP process requires amine functionalization on the silica surface to alter the 
isoelectric point of silica from 2 to 9 to facilitate the deposition of Au(OH)3 
nanoparticles and hence improving the uniformity and density of seeding. The seeding 
density and size of the Au(OH)3 nanoparticle seeds can also be controlled by varying 
the pH of HAuCl4 solution, as well as the time of reaction. The DP technique has been 
used to seed Au(OH)3 nanoparticles on different sizes of silica cores to form the 
precursor seed particles which are then used to form the gold nanoshells of different 
sizes for subsequent in vitro and in vivo studies described in the remaining chapters. 
However, before these gold nanoshells can be used effectively in biological studies, 
their surface has to be functionalized appropriately in terms of pegylation and 
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The effective use of gold nanoshells in biological studies would require appropriate 
surface functionalization in terms of pegylation and antibody conjugation. While 
antibody conjugation confers specific targeting capability, pegylation of gold 
nanoshells provides an effective means to reduce their reticulo-endothelial system 
(RES) clearance in body. In this chapter, a parametric investigation on the pegylation 
factors that affect the macrophage uptake of gold nanoshells is described, with the aim 
to optimize their pegylation and minimize their macrophage uptake. Gold nanoshells 
were synthesized and pegylated using methoxy-poly(ethylene glycol)-thiol and an in 
vitro macrophage assay was employed to examine the effect of surface density of 
PEG, chain length of the PEG and size of the gold nanoshells on their macrophage 
uptake. The results have shown that a saturated surface density would minimize 
macrophage uptake which could be obtained by experimental titration based on the 
Ellman’s reagent. The surface density of PEG is influenced by the chain length of 
PEG and size of gold nanoshells. PEG with molecular weight of around 2000 Da and 
a size range larger than 186 nm would be appropriate for facilitating a high surface 
density. The in vitro macrophage system described in this chapter thus provides a 
good model to accurately predict the RES response to different pegylation parameters. 
This work has been published in Journal of Drug Targeting 2009; 17(3): 181–193. 
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5.1 Introduction 
The effective delivery of gold nanoshells to the intended site of interest is crucial for 
any imaging or therapeutic applications. Most of the available data to date on the in 
vivo delivery of gold nanoshells for biomedical applications are based on intratumoral 
administration into the site of interest. With the exception of superficial tumors, the 
direct injection of gold nanoshells into deep seeded tumor sites may not be clinically 
feasible. Several in vivo studies involving systemic intravenous administration of gold 
nanoshells are emerging [1-3] and because of their ability to reach deep seeded 
tumors, such means of delivery are desirable for widespread clinical application. 
 
Intravenous administration of gold nanoshells allows these nanoparticles to target and 
accumulate in the tumor sites either through passive targeting based on the enhanced 
permeation and retention (EPR) mechanism or active targeting with the aid of a 
targeting moiety. Unfortunately, an efficient intravenous delivery of nanoparticles to 
the tumor site is not straightforward and is often hampered by complications arising 
from their rapid elimination from the systemic blood circulation. This elimination is 
due to the presence of the reticulo-endothelial system (RES), also known as the 
mononuclear phagocytic system (MPS) in the body [4].  
 
The RES comprises macrophages and monocytes found in the liver (Kupffer cells), 
spleen and bone marrow. Despite the biocompatibility of gold and their inert 
biological activities in the body, these gold nanoshells may still be recognized by the 
RES through the opsonin proteins that adsorb on their surface [5]. The most common 
opsonins are complement proteins such as C3, C4, C5 and immunoglobulins found in 
the blood serum components that assist macrophages in recognizing foreign particles. 
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As the opsonins adsorb on the surface of nanoparticles, the macrophages attach 
themselves to the opsonins bound to the nanoparticles and phagocytosis takes place. 
For nanoparticles which cannot be degraded, they are accumulated in one of the RES 
organs, usually the liver or the spleen [6-8]. 
 
Various strategies have been developed to reduce the uptake and elimination of 
foreign nanoparticles from the bloodstream by the RES in order to prolong their 
systemic blood circulation time. This is to ensure more of these particles are delivered 
to the target site of interest. A commonly employed strategy to reduce opsonization 
and mask these nanoparticles from macrophage recognition is to block their 
electrostatic or hydrophobic interactions with opsonins using a polymer coating. 
Amongst the various polymers used for this purpose, poly(ethylene glycol) (PEG) is 
currently the most popular and the most effective in prolonging circulation time [4, 9]. 
 
The layer of PEG on the nanoparticles confers them a hydrophilic surface that serves 
to mask the gold nanoshells from RES recognition. It is widely known that 
hydrophilic particles stay longer in the bloodstream than hydrophobic particles. The 
surface of gold nanoshells is known to be hydrophobic in nature which makes them 
susceptible to a whole host of hydrophobic interactions with the milieu of proteins 
found in the biological environment. This is especially true for the common opsonin 
proteins that tend to be adsorbed on the surface of hydrophobic particles through 
hydrophobic interactions [5] which assist the macrophages in recognizing and 
attaching themselves to the opsonin-bound foreign particles for phagocytosis. 
 
 135
The ethylene glycol functional group in the PEG is known to interact well with water 
molecules and so when the PEG chain molecules are self-assembled close together on 
the surface of the gold nanoshells, the spaces between these PEG chains can attract 
water molecules and facilitate their “trapping” to create a hydrophilic layer of water 
cloud around the gold nanoshells. Besides the PEG polymers that sterically block the 
electrostatic or hydrophobic interactions of gold nanoshells with opsonins by 
themselves, this hydrophilic layer also serves as a barrier to prevent the adsorption of 
opsonins that mediate macrophage recognition and subsequent phagocytosis and thus 
masking the gold nanoshells from the RES. The flexibility of the PEG chains 
continuously squeezes out the water molecules, preventing proteins from diffusing 
into the barrier and contacting the bare surface of the gold nanoshell [10]. 
 
Besides masking the foreign nanoparticles from the RES, PEG can also confer the 
nanoparticles a hydrophilic surface to improve their stability in aqueous media. As 
with other types of nanoparticles, the small size of gold nanoshells renders them a 
high surface energy which makes these particles susceptible to aggregation. The van 
der Waals forces of attraction are known to exert its effect over a relatively long 
range, extending over a distance of a few nanometers [9]. Despite having a negatively 
charged surface arising from the cloud of loose electrons, gold nanoshells are subject 
to Brownian motion in the aqueous colloid due to its colloidal nature and can easily 
be brought together within the range of the van der Waals forces that destabilizes the 
colloidal suspension. This is especially true in a highly ionic environment where 
charge screening occurs, resulting in flocculation of the gold nanoshells. Such an 
absence of effective charge stabilization on their surface compromises their stability 
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in solution especially in biological environment with a high ionic content that reduces 
the charge screening on these nanoshell particles. 
 
Aggregation of gold nanoshells can severely hamper the gold nanoshells from 
performing their intended imaging or therapeutic functions in biomedical applications. 
Their surface plasmon resonance will be altered in terms of shifted resonance 
wavelength and reduced resonance intensity upon aggregation which renders the gold 
nanoshells less efficient in eliciting optical contrast in imaging applications. The 
aggregated size of gold nanoshells may also compromise their ability to transverse 
through blood vessels and reach their target site for therapeutic applications. 
 
The layer of PEG on the surface of gold nanoshells can help to stabilize the gold 
nanoshells in an aqueous environment by providing a steric barrier between 
interacting gold nanoshells particles i.e. steric stabilization. This steric repulsion can 
act to attenuate the attractive van der Waals forces. However, such repulsion among 
the gold nanoshells may also cause stress within the PEG layer, increasing the risk of 
PEG desorption from the gold nanoshell surface [9]. Therefore the mPEG-thiol used 
to bind to the gold nanoshells surface require a strong covalent Au-S thiol bond to 
provide a strong anchoring that minimizes the desorption of PEG. Steric stabilization 
has also been used to explain the reduction in the uptake of stabilized particles by 
macrophages in other colloidal suspension systems [9]. Besides steric stabilization, 
the presence of PEG layer on the gold nanoshells can also confer the nanoshells a 
hydrophilic surface to improve their interaction with the aqueous media hence 
improving their stability. 
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Therefore, the pegylation i.e. the binding of PEG chains onto the surface of gold 
nanoshells for any biological applications is crucial for at least two reasons: 1. To 
improve their aqueous stability in biological environment, hence improving their 
imaging and therapeutic efficacy, and 2. To mask them from being recognized and 
eliminated by the RES from the systemic blood circulation before reaching their 
targeted site of interest and performing their intended function. There have been 
extensive parametric studies to investigate and optimize the pegylation of other types 
of nanoparticles such as liposomes [11-13] and polystyrene [14-16] nanoparticles and 
all have demonstrated the efficacy of PEG in reducing phagocytosis. Although the 
pegylation of gold nanoshells has also been reported in several in vivo application 
studies [1-3], the process has not been optimized for minimizing macrophage uptake. 
A previous study by James et al. has shown that even with pegylation on gold 
nanoshells, the amount of gold nanoshells that are trapped in the RES organs is about 
5 times that found in the target tumors [17]. 
 
This chapter describes a detailed analysis on the various parameters that would affect 
the macrophage uptake of gold nanoshells with the aim to optimize their pegylation 
conditions and minimize their macrophage uptake. In the study described in this 
chapter, an in vitro macrophage model system is employed to perform a parametric 
investigation on the various factors that would affect the macrophage uptake of gold 
nanoshells with the objective of using these in vitro results to optimize the gold 
nanoshells pegylation conditions for further in vivo studies. The macrophage model 
system represents an effective way to test the uptake of the nanoparticles since the 
cells behave in similar manner in terms of recognition and uptake as they would in 
vivo and have been used extensively by other previously reported studies [18-20]. 
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Gold nanoshells were synthesized and pegylated and examined for the following three 
parameters on the macrophage uptake: the surface density of PEG, chain length of the 
PEG used and the size of the gold nanoshells. The effect of these parameters on the 
RES uptake will be extrapolated and briefly discussed in light of the in vitro 
macrophage model. Such a study would provide valuable insights to improve the 
current state of biodistribution in tumors. 
 
5.2 Materials and Methods 
5.2.1 Synthesis and pegylation of gold nanoshells 
Gold nanoshells were synthesized in a four-step process as described earlier in 
Chapter 4. The process of shell growth on the gold hydroxide seeded silica was 
imaged by transmission electron microscopy (TEM) (Jeol JEM-1010) operating at 
100 kV. The particle size was also characterized by TEM. The gold nanoshells were 
prepared to a final concentration of approximately 2 x 1013 particles/ml as determined 
by correlating its extinction spectroscopy data to the theoretical extinction cross 
section data of the gold nanoshell based on Mie theory as described in Chapter 2. The 
synthesized gold nanoshells were stored at 4C when not in use. 
 
The gold nanoshells were pegylated using the heterobifunctional methoxy-
poly(ethylene glycol)-thiol (mPEG-thiol) of various molecular weights (MW): 750, 
2000, 5000, 10000 and 20000 Da (≥ 92%, Celares GmbH). Here, the thiol end was 
attached to the gold surface of the nanoshells while the other end was capped with a 
methoxy terminal group. The reaction schematic for the synthesis and pegylation of 
gold nanoshells is shown in Figure 5.1 below. The mPEG-thiol was dissolved in water 
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to give a range of concentration from 0.05 to 20 µmol/ml before adding it to the gold 
nanoshells colloid. The mPEG-thiol was attached to the gold nanoshells in water by 
incubating 1 ml of the gold nanoshells colloid (2 x 1013 particles/ml) with 1 ml of the 
mPEG-thiol solution under sonication for 5 minutes at room temperature. The 
pegylated gold nanoshells were then rinsed 5 times with Milli-Q water to remove 
excess mPEG-thiol from the pegylated gold nanoshells, before redispersing them in 
phosphate buffer solution (1X PBS, pH 7.4) and stored in 4 °C until further use. 
 
 
Figure 5.1. Reaction schematic of the synthesis and pegylation of gold nanoshells 
with core of 81 nm radius and gold shell thickness of 23 nm used in this study. The 
synthesis of the gold nanoshells is described in more detail in Chapter 4. 
 
The successful pegylation of gold nanoshells was determined using X-ray 
photoelectron spectroscopy (XPS) by examining the changes in the sulphur (2p) 
spectra. The sulphur (2p) spectra would indicate the presence of thiol group on the 
surface of the gold nanoshells. The saturation amount of mPEG-thiol on the gold 
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nanoshells surface was also determined by quantitation of unbound thiol group from 
mPEG-thiol using Ellman’s reagent. The Ellman’s reagent (5, 5'-dithiobis-(2-
nitrobenzoic acid) or DTNB) (Sigma-Aldrich) was used to detect the presence of 
unbound thiol group from the excess mPEG-thiol when the gold nanoshells surface 
was saturated [21]. It was added to the supernatant obtained after the first centrifuge 
that removes the excess mPEG-thiol immediately after pegylation. The presence of 
excess mPEG-thiol will cause a visible color change in the reagent which can be 
quantified at absorbance of 430 nm (TECAN Sunrise Absorbance Reader). The 
reaction of Ellman’s reagent with a thiol and the color change in the reagent is shown 
in Figure 5.2 below. 
 
 
Figure 5.2. Reaction of DTNB (Ellman’s reagent) with a thiol to release 2-nitro-5-
mercaptobenzoic acid (TNB), which ionizes to the TNB-
 
anion in water at neutral and 
alkaline pH. This TNB-
 
ion has a strong yellow color. The image on the right shows 
the color change in Ellman’s reagent on detection of different concentration of 
mPEG-thiol. 
 
5.2.2 Imaging of macrophage uptake 
The mouse leukaemic monocyte macrophage cell line RAW 264.7 was used in the in 
vitro uptake studies of gold nanoshells. The RAW 246.7 cells were grown in RPMI 
1640 supplemented with 10% fetal bovine serum, 2 mM glutamine, sodium pyruvate, 
non-essential amino acids and 100 units/ml penicillin/streptomycin and maintained at 
37 °C in humidified 5% CO2 and 95% air atmosphere. Prior to the uptake studies, the 
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macrophages were harvested and seeded in the wells of a 6-well plate (Iwaki) at 5 x 
105 macrophages in each well suspended in 2 ml of the culture medium. The plates 
were incubated overnight for cells to settle and adhere to the floor of the wells. The 
medium in the wells with macrophages was aspirated and replaced with a mixture of 
100 µl of gold nanoshells (2 x 1013 particles/ml) in 1.9 ml of culture medium. The 
macrophages were incubated with the pegylated gold nanoshells for 1 h at 37 °C. The 
macrophage loaded with gold nanoshells were then rinsed thrice with 1X PBS to wash 
away the excess non-ingested gold nanoshells and fixed in 4% paraformaldehyde.  
 
The uptake of gold nanoshells by the macrophages was imaged with both the 
brightfield and laser scanning confocal microscope (Carl Zeiss LSM510 Meta) under 
the fluorescence and reflectance mode. The autofluorescence of the macrophages and 
the reflectance of the gold nanoshells were imaging using an Olympus 63x oil 
immersion objective at 488 nm excitation with an argon laser and 633 nm excitation 
with a helium-neon laser respectively and superimposed together. The confocal 
images were taken at various optical sections of the cells and reconstructed to form a 
z-stack showing the transverse side profile of the cells. The brightfield microscopy 
was done using the Olympus CK40 microscope with a 20x objective. 
 
5.2.3 Phagocytosis assay 
A phagocytosis assay was developed to assess the amount of gold nanoshells uptake 
by the macrophages based on the UV-Vis absorption intensity of ingested gold 
nanoshells extracted from the macrophages. After incubating the macrophages with 
gold nanoshells, the existing medium in the wells was discarded and each well was 
gently rinsed five times with 1X PBS to remove the excess gold nanoshells that were 
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not ingested while keeping the macrophages intact in the wells. The macrophages 
were then lysed using the mammalian protein extraction reagent (M-Per®, Pierce) to 
release the ingested gold nanoshells out of the cells. The suspension of extracted gold 
nanoshells in each well was transferred to a centrifuge tube to be centrifuged and 
rinsed for at least three times with Milli-Q water to remove the cellular components 
which might otherwise interfere with the UV-Vis absorption measurement of the 
extracted gold nanoshells. After the last rinse, the extracted gold nanoshells were 
resuspended in 500 µl of Milli-Q water and assessed for their UV-Vis absorption 
(UV-2401 PC UV-Vis spectrophotometer, Shimadzu Corp) from 400 to 900 nm.  
 
The amount of gold nanoshells phagocytosed by the macrophages seeded in the wells 
was expressed as a percentage of the original amount of gold nanoshells added to each 
well based on their absorption intensity. The calculation is as such: the UV-Vis 
spectra of the originally added gold nanoshells and the extracted phagocytosed gold 
nanoshells were obtained. The peak absorption value (Ao) and its associated peak 
wavelength, λo of the original gold nanoshells added was noted and the absorption 
value of the phagocytosed gold nanoshells (Ap) at λo was then measured. The 
percentage of gold nanoshells phagocytosed per 100 µl of gold nanoshells colloid (2 x 






)%. In the phagocytosis assay, each condition investigated was done in 
triplicates to reduce random experimental errors. 
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5.3 Results and discussion 
5.3.1 Synthesis and characterization of gold nanoshells 
Gold nanoshells with a range of silica core diameters were synthesized to investigate 
the effect of gold nanoshells sizes on the macrophage uptake. The sizes include 79, 
100, 140, 162, 181 and 196 nm. In the shell growth process, the gold hydroxide to 
seed solution volume ratio controls the amount of gold ions available for reduction 
and deposition on the silica surface. To control the gold nanoshells sizes, the volume 
ratio has been adjusted to maintain a constant shell thickness of 23 nm for all the 
silica core sizes, thus giving an overall size of 125, 146, 186, 208, 227 and 242 nm 
respectively based on the core sizes described above. The TEM image in Figure 5.3 
shows the typical progressive growth of the gold shell around a 162 nm silica core to 
give a final gold nanoshell size of 208 nm.  
 
 
Figure 5.3. TEM images of nanoshell growth on a 162 nm silica nanoparticle core 
showing the initial gold hydroxide nanoparticles deposited on the silica and gradual 
growth and coalescence of these nanoparticles on the silica surface until a complete 
growth of 23 nm thick gold shell is obtained. 
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The gold nanoshells synthesized were spherical and generally monodispersed. The 
surfaces of the particles were also relatively smooth with an average surface 
roughness of 10 to 15 nm i.e. <10% of the particle radius from visual inspection. The 
gold nanoshells were then pegylated and the presence of mPEG-thiol on the gold 
nanoshells was assessed by XPS as shown in Figure 5.4. The XPS spectrum of the 
pegylated gold nanoshells shows a peak at binding energy of ≈ 163 eV which 
correspond to the binding energy for sulphur (2p). This peak indicates the presence of 
thiol group on the surface of gold nanoshells arising from the successful pegylation 
since such a peak is absent from the XPS spectrum of the naked gold nanoshells. 
 
 
Figure 5.4. XPS of naked gold nanoshells (left) and pegylated gold nanoshells (right) 
to detect the presence of sulphur (2p) at binding energy of 163 eV. The peak observed 
indicates the successful thiol bonding on the surface of gold due to pegylation. 
 
5.3.2 Reduction in macrophage uptake with pegylation 
The effect of pegylation in reducing the macrophage uptake of gold nanoshells was 
demonstrated by imaging the accumulation of gold nanoshells in macrophages under 
the confocal microscope after 1 h of incubation. In this case, the 227 nm gold 
nanoshells are arbitrary selected for the imaging amongst the sizes synthesized. The 
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confocal images in Figure 5.5a show the green autofluorescence of the macrophages 
with the reflectance of the gold nanoshells superimposed in yellow.  
 
 
Figure 5.5. (a) Confocal images showing the accumulation of both naked and 
pegylated 227 nm gold nanoshells ingested in the macrophages. The macrophages are 
pseudo-colored green based on their autofluorescence and the reflectance from the 
gold nanoshells is pseudo-colored yellow. Images are taken at 63X magnification with 
an oil immersion lens. False-color autofluorescence and reflectance images are 
obtained at excitation of 488 nm and 633 nm respectively. Scale bar in both images is 
20 μm. (b) The same confocal image with a z-stack reconstructed at the sides of the 
main image based on a series of optical sections to show the transverse side profile of 
the cells. The transverse section of the cells shows that the naked gold nanoshells are 
located inside the cells after being ingested by the macrophages. 
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A large amount of naked gold nanoshells is observed to co-localize together with the 
cells compare to the pegylated gold nanoshells where a much smaller amount is 
observed with the cells. The naked gold nanoshells appear aggregated possibly due to 
the high ionic content in the cell culture medium that reduces the charge stabilization 
in the nanoshells. The instability and aggregation of gold nanoshells may account for 
their increased macrophage uptake. Furthermore, the accumulation of the naked gold 
nanoshells appears to be randomized with no apparent pattern of distribution in the 
cells and the amount observed in each cell is also not homogeneously distributed. 
 
To further ascertain that the gold nanoshells were ingested in the cells rather than 
being bound non-specifically on the cells surface, a z-stack showing the transverse 
side profile of the cells was reconstructed based on a series of optical sections to show 
the exact localization of gold nanoshells in the macrophages. The transverse cross 
section of the cells in Figure 5.5b shows that the naked gold nanoshells are located 
inside the cells after being ingested by the macrophages. Most of the gold nanoshells 
are found near the base of the cells with only a small amount being ingested further up 
into the cells. These gold nanoshells may have been freshly ingested given the short 
incubation time of 1 h. 
 
5.3.3 Effect of surface density of PEG on macrophage uptake 
Although the reduction in macrophage uptake due to pegylation is well known, the 
correlation between macrophage uptake and the extent of pegylation has not been 
systematically studied. Therefore, the surface density of PEG on the gold nanoshells 
was varied and the respective amount of gold nanoshells ingested was measured. This 
relationship would provide insight to the optimum amount of PEG needed to 
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functionalize the gold nanoshells to minimize macrophage uptake. In this case, the 
different surface density of PEG on gold nanoshells was implemented by incubating 
the nanoshells (227 nm, 2 x 1013 particles) with different amount of mPEG-thiol (MW 
= 2000 Da) from 0.05 to 20 µmol to control the amount of mPEG-thiol available to 
bind to the gold nanoshells surface. The results in Figure 5.6 shows the percentage of 
gold nanoshells phagocytosed for different amount of mPEG-thiol added to gold 
nanoshells. As the amount of mPEG-thiol increases from 0 to 2.5 µmol, the 
percentage of gold nanoshells phagocytosed decreases from 78.9% to 8.9%. 
 
Figure 5.6. The percentage of gold nanoshells phagocytosed for different 
concentration of mPEG-thiol (MW = 2000 Da) added to pegylated the 227 nm gold 
nanoshells (2 x 1013 particles/ml) to give a range of surface density of PEG. 
 
The corresponding brightfield images showing the macrophage uptake for each of the 
mPEG-thiol concentration is shown in Figure 5.7. Due to the plasmonic color of the 
colloidal gold nanoshells, the presence of ingested gold nanoshells in the 
macrophages gives the cells a greenish stain under the brightfield microscope to 
provide an indication on its loading in the cells. With the percentage of gold 
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nanoshells phagocytosed decreases from 78.9% to 8.9%, the brightfield images also 
show a reduction in the green staining by gold nanoshells in the macrophages. The 
density of PEG chains assembled on the gold nanoshells surface controls the amount 
of water molecules that could be “trapped” to form the hydrophilic layer. Based on 
the amount of mPEG-thiol used in the study, an attempt is made to estimate the 
number of PEG molecules bound on the gold nanoshells surface with the assumption 
that all mPEG-thiol added to the gold nanoshells are bound to the particles surface. 
 
 
Figure 5.7. The brightfield images showing the gold nanoshells pegylated with the 
different amount of mPEG-thiol being taken up by the macrophages after 1 h of 
incubation. Due to the plasmonic color of the gold nanoshells, the presence of 
ingested gold nanoshells in the macrophages gives the cells a greenish stain under the 
brightfield microscope that provides an indication on its loading in the cells. 
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With an approximate 2 x 1013 gold nanoshells available for pegylation, the addition of 
0.05 µmol mPEG-thiol (MW 2000 Da) would give about 1500 molecules per gold 
nanoshell particle (diameter of 227 nm) with each mPEG-thiol molecule having a 
calculated footprint of about 108 nm2 on the particle surface (0.0093 PEG/nm2). With 
such a sparse amount of mPEG-thiol chains, the water interaction level is low and 
much of the hydrophobic surface on the gold nanoshells remains available for 
hydrophobic binding to proteins. Furthermore, the vast footprint provides little steric 
hindrance to opsonins such as immunoglobulins with a typical size of about 15 nm. 
This encourages macrophage recognition and uptake. 
 
As the amount of mPEG-thiol on the surface increases to 0.5 µmol, each gold 
nanoshell particle would be pegylated with about 15 000 molecules of mPEG-thiol 
with each molecule having a calculated footprint of only about 10.8 nm2 (0.093 
PEG/nm2). This increased closeness of the PEG chains allows greater interaction with 
water molecules and thus the amount of hydrophobic surface available for 
hydrophobic interactions with macrophage recognition proteins reduces and the 
corresponding macrophage uptake reduces by more than 8 fold. Hence the correlation 
obtained from the experiments was expected. 
 
5.3.4 Saturation of PEG on gold nanoshells surface 
As the amount of mPEG-thiol added to the gold nanoshells increases beyond 2.5 
µmol, there is no further reduction in the macrophage uptake which maintain at 
around 10% as shown in Figure 5.6. The corresponding brightfield images also show 
similar staining intensity with no observable change in gold nanoshells loading in the 
macrophages. This indicates that saturation of mPEG-thiol binding on the gold 
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nanoshells surface may have occurred at around 2.5 µmol and the excess mPEG-thiol 
were removed from the pegylated gold nanoshells during the rinsing steps. 
 
This saturation amount in the binding of mPEG-thiol on the gold nanoshells was 
further verified by measuring the amount of excess mPEG-thiol that were left 
unbound using the Ellman’s reagent test which detects the presence of unbound thiol 
group from the mPEG-thiol in the reaction mixture. In such a test, the amount of 
excess mPEG-thiol is determined by measuring the absorbance of Ellman’s reagent at 
430 nm. The extrapolated results as shown in Figure 5.8 suggest that excess mPEG-
thiol in the supernatant appears only after adding more than 2.5 µmol of mPEG-thiol 
and thus confirm that a minimum of 2.5 µmol of mPEG-thiol is sufficient to saturate 
the PEG binding on the gold nanoshells surface to achieve an optimum surface 
density of PEG. 
 
Figure 5.8. Quantitation of unbound thiol group from the excess mPEG-thiol in the 
supernatant using Ellman’s reagent after the addition of different amount of mPEG-
thiol to the 227 nm gold nanoshells. The extrapolated results further confirm that 
excess mPEG-thiol in the supernatant appears only after adding more than 2.5 µmol 
of mPEG-thiol to the 2 x 1013 gold nanoshells when the surface of the gold nanoshells 
is saturated with PEG binding. 
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Intuitively, for the PEG barrier to be the most effective, it has to saturate and cover 
the entire surface of a particle. A full PEG coverage denies small opsonins the 
opportunity to approach the nanoshells surface to minimize macrophage recognition. 
Because of the small size of mPEG-thiol molecule (published literature has shown 
that a 1000 Da PEG gives 1.8 nm hydrodynamic diameter [22]), the experimental 
results show that more mPEG-thiol molecules can be packed further onto the surface 
of the gold nanoshell particle until a saturation point in the PEG binding is reached at 
2.5 µmol. This would correspond to about 75 000 molecules of mPEG-thiol on each 
gold nanoshell particle with each molecule having a footprint of just 2.2 nm2 (0.46 
PEG/nm2). At this point, the footprint available per 2000 Da mPEG-thiol molecule is 
smaller than the cross sectional area based on the hydrodynamic diameter of a single 
1000 Da mPEG-thiol molecule itself [22]. Thus the mPEG-thiol molecules are so 
tightly packed that no further binding of mPEG-thiol molecules can occur. 
 
With a surface saturated with PEG, any further addition of mPEG-thiol will only form 
excesses in the supernatant as detected by the Ellman’s reagent. The saturated surface 
characteristic also causes no further reduction in the macrophage uptake beyond the 
saturation amount of mPEG-thiol added since the hydrophilic surface layer is already 
optimized by the maximum number of mPEG-thiol molecules loaded. Such a 
parametric investigation to titrate out the saturation amount of PEG would be 
beneficial to determine the minimum amount of PEG that is sufficient to saturate the 
PEG binding on the gold nanoshells surface and achieve an optimum surface density 
of PEG chains without causing additional wastage of reagents since increasing the 
PEG concentration would not result in any further decrease in phagocytosis.  
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It would be of worth to note that the amount of mPEG-thiol as determined in the study 
i.e. 2.5 µmol is only appropriate for 227 nm gold nanoshells at 2 x 1013 particles/ml. 
But the present study provides an approximate indication to the saturation amount per 
particle in a generic manner since the PEG molecular footprint of 2.2 nm2 (0.46 
PEG/nm2) for surface saturation may well be applied for nanoparticles of other sizes 
and concentration and the same technique can be applied to gold nanoshells of other 
sizes and concentration to determine their respective optimum PEG amount. 
 
5.3.5 Effect of PEG chain length on macrophage uptake 
Besides the surface density of PEG, the chain length of the PEG molecule also plays a 
role in mediating the macrophage uptake of gold nanoshells. The effect of different 
chain length of PEG on the macrophage uptake of the gold nanoshells was 
investigated by pegylating the 186 nm gold nanoshells with mPEG-thiol of five 
different molecular weights: MW = 750, 2000, 5000, 10 000 and 20 000 Da, all 
having the same concentration of 2.5 µmol/ml as determined earlier. Since the 
physical chain length is a parameter that is difficult to measure experimentally, a 
parametric investigation on the PEG chain length is examined on the basis of their 
molecular weight. As the mPEG-thiol is a linear chain polymer, its molecular weight 
is closely correlated to its chain length. For each molecular weight, their respective 
percentage of phagocytosis is obtained as shown in Figure 5.9. 
 
Figure 5.9 shows that a relatively larger amount of phagocytosis takes place for gold 
nanoshells pegylated with both the shortest and longest chain used in our study. In 
this case, the percentage of phagocytosis for gold nanoshells pegylated with 750 Da 
mPEG-thiol is 10.2% while the gold nanoshells pegylated with the longest 20 000 Da 
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mPEG-thiol shows a phagocytosis percentage of 48.2%. In between these two 
molecular weights, the percentage of gold nanoshells uptake in the mid-range of PEG 
molecular weights is very much lower, averaging at around 1%. In fact, the 
percentage of phagocytosis is lowest at 0.6% for gold nanoshells pegylated with 2000 
Da mPEG-thiol. Within this mid-range, there are also small increases in the 
macrophage uptake as the mPEG-thiol molecular weight is increased from 2000 Da to 
5000 Da (0.9%) and 10 000 Da (2.1%). Our results thus suggest that there is an 
optimum range of molecular weight of PEG that can be used to pegylated the gold 
nanoshells to minimize their macrophage recognition and uptake. 
 
 
Figure 5.9. The percentage of gold nanoshells phagocytosed for 186 nm gold 
nanoshells (2 x 1013 particles/ml) pegylated with different chain length of mPEG-thiol 
as given by their molecular weight to show the effect of different chain length of 
mPEG-thiol on the macrophage uptake of gold nanoshells. All the pegylation are done 
using the same concentration of 2.5 µmol/ml for each molecular weight of mPEG-
thiol added to the gold nanoshells. 
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The results above demonstrate the influence of the chain length in agreement with that 
reported by others [23]. PEG is known to exist in a wide range of molecular weights, 
but is also widely known that only a narrow range is appropriate for biological 
applications. The results in Figure 5.9 confirm this for gold nanoshells where gold 
nanoshells pegylated with either the smallest (750 Da) or the largest (20 000 Da) 
mPEG-thiol show higher percentages of phagocytosis than those pegylated with 
mPEG-thiol of molecular weights in between. 
 
A minimum molecular weight of PEG is often required for pegylation to avoid 
macrophage recognition because PEG chains that are too short lose their flexibility. 
This flexibility of PEG chains is important because it facilitates transient and rapid 
changes in the structural formation of the PEG layer [12] around the gold nanoshells 
in the biological fluid environment to make it difficult for proteins or macrophages to 
tether to it. In another study by Bergström et al. [24], protein adsorption was found to 
be dramatically increased on polystyrene particles coated with poly(ethylene oxide) of 
1000 Da and below, with PEG of 250 Da virtually offering no protein rejection ability 
at all. The short chain 750 Da mPEG-thiol used in this study could have such 
compromised flexibility that results in their higher macrophage uptake. 
 
On the other hand, PEGs with too much flexibility that are often associated with long 
chain lengths may also not be effective in minimizing phagocytosis. Given their very 
high flexibility, these PEG chains that are too long have a high tendency to fold into 
coils or bend into a mushroom-like configuration on the surface of the gold nanoshell 
[18] as shown in Figure 5.10. Such foldings or mushroom configurations often lead to 
lower surface density of PEG since the folding of long chains occupies more space 
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and forms a steric barrier to the attachment of other neighboring PEGs on the gold 
nanoshells surface.  
 
 
Figure 5.10. Schematic diagrams of brush and mushroom configurations of PEG 
chains on upper hemisphere of a nanoparticle. In (a), the low surface coverage of PEG 
chains is the result of a “mushroom” configuration where most of the chains are 
located closer to the particles surface. In (b), the “brush” configuration leads to a high 
surface coverage where most of the chains are extended away from the surface [4]. 
 
In a study on stealth niosomes which are a type of non-ionic surfactant vesicular drug 
carriers, often considered as the novel forms of liposomes, Shi et al. found that the 
grafting surface density was 0.53, 0.45 and 0.17 PEG/nm2 for niosomes pegylated 
with 2000, 5000 and 10 000 Da PEG respectively [25] and so attributed the low 
density of high molecular weights PEG to the fact that the long hydrophilic chains 
were more likely to fold into coils in solution compared to shorter chains. This 
suggest a link between the PEG molecular weight and the PEG surface density and 
that the uptake is ultimately affected more by surface density than on PEG molecular 
weight.  
 
The dependence of macrophage uptake on the surface density of PEG has been 
discussed earlier. An optimum range of molecular weight of PEG between the two 
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ends would allow them to tether to the gold nanoshell surface in a predominantly 
brush-like configuration with minimal folding. This brush configuration allows a 
higher density of PEG to be bound to the surface of gold nanoshells and hence 
provides a more robust barrier than a folded or mushroom configuration. The results 
in this study have shown that the moderate chain length between 2000 Da to 5000 Da 
gives the lowest macrophage uptake. This range of molecular weight represents a 
good compromise between flexibility of PEG and surface density of PEG to reduce 
opsonization and minimize macrophage recognition and uptake. Other similar studies 
that investigate the effect of molecular weights of stabilizing polymer chains in 
reducing the macrophage uptake of other colloidal drug delivery systems have also 
shown similar results, advocating the most effective molecular weight of PEG in the 
range of 1500 to 3500 Da [26-28]. 
 
5.3.6 Effect of gold nanoshell sizes on macrophage uptake 
The size of the nanoparticles is known to influences their clearance rate and final 
biodistribution in the body [23]. The above parametric studies are done using gold 
nanoshells of 186 nm (silica core diameter of 140 nm with gold shell of 23 nm). Since 
the particle size is also known to be a major factor affecting the fate of pegylated 
particles when administered into the body, a similar macrophage study on a range of 
gold nanoshells sizes would provide valuable insights on the sensitivity of the 
macrophages to their sizes. Gold nanoshells were synthesized with six different sizes:  
125, 146, 186, 208, 227 and 242 nm that are appropriate for intravenous delivery and 
pegylated with mPEG-thiol of 2000 Da. The results of their macrophage uptake are 




Figure 5.11. The percentage of gold nanoshells phagocytosed for different sizes of 
gold nanoshells (2 x 1013 particles/ml) pegylated with mPEG-thiol (MW = 2000 Da) 
at a concentration of 2.5 µmol/ml. The six different sizes are used to investigate the 
sensitivity of macrophages to gold nanoshells sizes and are appropriate for 
applications involving intravenous administration. 
 
The results in Figure 5.11 show that the smallest size 125 nm gold nanoshells used in 
this study is the most susceptible to phagocytosis by macrophages with 8.1% of the 
gold nanoshells ingested. The macrophage uptake is reduced as the diameter of the 
gold nanoshells increases from 125 to 146 nm (1.7% of gold nanoshells 
phagocytosed) before the percentage of phagocytosis reaches the lowest at 0.54% 
when the gold nanoshells are 186 nm. As the diameter of the gold nanoshells 
increases beyond 186 nm, the amount of gold nanoshells ingested by the macrophages 
begins to increase again although the change is small and barely noticeable.  
 
From Figure 5.11, a small positive correlation between the size of gold nanoshells and 
phagocytosis is observed when the gold nanoshells are larger than 186 nm. In this 
case, the macrophage uptake is increased gradually from 0.9% (208 nm) to 1.4% (227 
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nm) and remains rather constant at around 1.2% when the gold nanoshells size 
reaches 242 nm. From these results, gold nanoshells with a size of 186 nm seem to be 
the least sensitive to macrophage uptake, but increasing their size by another 60 nm 
beyond this size will not significantly increase their phagocytosis. These results on the 
sizes of gold nanoshells, together with that on the parametric investigation of the PEG 
chain length is summarized in Table 5.1 below which shows the results in terms of 
macrophage uptake versus size and PEG coating simultaneously. 
 
Table 5.1. Summary table of the in vitro macrophage uptake results for two of the 
parameters investigated in this study: the chain length of the PEG used and the size of 
the gold nanoshells. 
Sizes of gold 
nanoshells pegylated 
with 2000 Da PEG 
(nm) 
Macrophage 
uptake (%) with 
S.D. 
PEG chain length on 





125 8.08 ± 2.39 750 10.21 ± 0.54 
146 1.74 ± 0.49 2000 0.59 ± 0.02 
186 0.54 ± 0.05 5000 0.93 ± 0.15 
208 0.90 ± 0.16 10 000 2.07 ± 0.28 
227 1.37 ± 0.08 20 000 48.22 ± 3.43 
242 1.22 ± 0.28  
 
Most in vivo studies on other types of polymeric nanoparticles uptake by macrophages 
have reported that smaller nanoparticles are removed more slowly from blood 
circulation than larger nanoparticles [4]. The ability of smaller nanoparticles to better 
escape recognition by macrophages is, however, not observed in this study. Instead, 
the smallest gold nanoshells used i.e. 125 nm causes the highest macrophage uptake. 
Furthermore, the percentage of phagocytosis actually increases as the diameters 
decreases from 186 nm to 146 nm and 125 nm. Unlike the case of polymeric 
nanoparticles that are often more stable in aqueous medium even in the absence of 
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any functional stabilizing agent on their surface, the surface of gold nanoparticles is 
highly susceptible to aggregation and is thus very much dependent on the presence of 
stabilizing agents such as PEG. Unfortunately, the surface density of PEG is also 
dependent on the particle surface curvatures. A study by Li et al. on poloxamer coated 
polystyrene nanoparticles of diameters 69 nm, 130 nm, 212 nm and 272 nm has 
shown that surface density of poloxamer adsorbed decreases with decreasing particle 
size i.e. higher particle surface curvature [29]. This could explain the observation that 
the smaller gold nanoshells show a higher macrophage uptake. 
 
Since gold nanoshells possess the same spherical nature as polystyrene, similar 
inference can be made on gold nanoshells. As the smaller nanoshells possess a higher 
surface curvature than larger ones, this suggests that smaller nanoshells may prove 
less efficient for PEG chains to bind and form covalent bonds with the gold surface 
compared to the flatter surface of larger gold nanoshells with a smaller curvature. 
Consequently, smaller gold nanoshells will have lower surface density of PEG chains 
on their surfaces than their larger counterparts. The effect of having a lower surface 
density of PEG has been discussed previously in terms of a reduced aqueous stability 
and less effective masking from RES.  
 
The higher risk of aggregation with a lower surface density of PEG is especially 
prominent in small gold nanoshells where their surface energy is high. Therefore, 
even though the smaller gold nanoshells sizes may better escape recognition by 
macrophages, the higher tendency of aggregation of these particles may still exert a 
more dominant effect in increasing the macrophage uptake. As the size of the gold 
nanoshells increases beyond 186 nm, the particle surface curvature becomes more 
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conducive for PEG binding and so this size dependence effect on the PEG surface 
density and hence the macrophage uptake becomes less pronounced since the 
macrophage uptake remains relatively constant at the larger sizes. 
 
5.4 Conclusion 
Pegylation of gold nanoshells with mPEG-thiol provides an effective means to reduce 
macrophage phagocytosis. The three factors that are examined in this chapter which 
can affect the ability of macrophage to ingest gold nanoshells include the PEG surface 
density, PEG molecular weight and size of gold nanoshells. The results suggest that 
the effect of molecular weight of PEG and size of gold nanoshells can also influence 
the surface density of PEG, thus implying the surface density of PEG as a critical end 
parameter that determines their macrophage uptake. A saturated surface density 
would minimize any macrophage uptake and this could be obtained by experimental 
titration based on the Ellman’s reagent. The results have also shown that a suitable 
range of PEG molecular weight of around 2000 Da and a size range larger than 186 
nm would be appropriate for facilitating a high surface density. Sizes that are too 
small would render a less effective coating of PEG to overcome aggregation.  
 
Although the in vitro macrophage system provides a good model to accurately predict 
the RES response to different pegylation parameters, it would be of worth to note that 
the reduced phagocytosis in vitro may not necessary be translated to the same desired 
results in vivo since a whole host of other physiological factors may further 
complicate in vivo conditions. Nonetheless, the merits of this model allows results 
from this study to be used to synthesize long circulating gold nanoshells which can be 
injected intravenously into animal subjects for further in vivo studies.  
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Whilst the effective pegylation of gold nanoshells would be sufficient to prolong their 
circulation time for slow in vivo delivery to tumor site via the EPR effect, the delivery 
of these gold nanoshells to specific molecular markers in suspicious lesions would 
require specific targeting capability in the form of antibody conjugation. The 
conjugation of antibody to gold nanoshells and the application of the entire 
bioconjugate construct for specific molecular imaging are described in more detail in 
the following Chapter 6. 
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CELLULAR IMAGING WITH GOLD NANOSHELLS 
 
Abstract 
The use of gold nanoshells as a molecular contrast agent for performing molecular 
imaging under reflectance-based imaging systems requires appropriate antibody 
conjugation in addition to pegylation to facilitate the targeting and binding to these 
molecular targets. This chapter describes the antibody conjugation to gold nanoshells 
and the application of the entire gold bioconjugate construct for specific molecular 
imaging of the Epidermal Growth Factor Receptor (EGFR) in vitro under confocal 
reflectance microscopy. Gold nanoshells were synthesized and surface functionalized 
by conjugating them to anti-EGFR before introducing them to cells to examine for 
optical changes. The results show at least three areas where the imaging is improved 
upon with antibody functionalized gold nanoshells. Firstly, the optical response of 
gold nanoshells is able to provide a general contrast enhancement by increasing the 
reflectance signal. Secondly, this enhancement can be made specific to discriminate 
cancer from normal cells and lastly, molecular expression can be imaged when the 
gold nanoshells are conferred specificity to the molecular marker. These results 
suggest the potential of gold nanoshells in performing molecular contrast optical 
imaging under reflectance mode with appropriate surface functionalization. This work 
has been submitted for publication in Molecular Imaging and Biology and Technology 




Gold nanoparticles are bioinert optical plasmonic materials under development for 
clinical imaging and drug delivery [1-3]. The first demonstration of such an 
application by Sokolov et al. uses the gold nanoparticles to create an optical contrast 
to image precancer [4]. Since then, similar observations have also been published 
recently to corroborate such findings [5, 6]. While the use of gold nanoparticles as 
optical labelers in reflectance-based optical imaging is well appreciated, it is limited 
to a narrow optical excitation range that is appropriate for use with only certain 
optical systems having a suitable matching wavelength. This is due to its rather 
invariable optical plasmon resonance, typically at 520 nm (see Chapter 2.4.1). 
Although its plasmon resonance is known to vary with size of the nanoparticles, in 
practice, the plasmon resonance of gold nanoparticles hardly red-shifts by more than 
60 nm before their sizes become impractical for biological applications [7].  
 
Hence, for most optical imaging systems that operate in the near infrared (NIR) 
wavelengths, which is within the region of optimum physiological transmissivity of 
light best suited for optical bioimaging, such as the OCT, the use of gold 
nanoparticles is restrictive since their peak optical response (≈ 520 nm) is not matched 
to the 700-1300 nm wavelength commonly for NIR imaging, resulting in their sub-
optimum optical performance as contrast agents. 
 
In principle, the optical limitations associated with gold nanoparticles can be 
addressed by the use of gold nanoshells. Gold nanoshells have emerged as a 
promising class of optical contrast agent with the potential to deliver the needed red-
shifted plasmon resonance to NIR wavelength. These nanoparticles employ a core-
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shell construction with a spherical dielectric core is surrounded by a thin gold layer 
[8-16]. Unlike solid gold nanoparticles, the optical response of gold nanoshells can be 
tuned from the visible right up to the NIR wavelength range by changing the relative 
dimension of the gold shell thickness to the core radius to match the excitation 
wavelength of the light source of interest in different applications [17]. Hence, they 
are versatile for use with both the confocal reflectance microscope and OCT. 
 
Besides a strong scattering response from individual particles, gold nanoshells have 
the ability to undergo coupled SPR when closely-spaced to promote strong interaction 
with photons [18]. The scattering cross section per particle is known to increase when 
gold nanostructures aggregate and their surface plasmon interact to produce an even 
larger optical signal [4]. This mode of enhanced scattering from coupled SPR can be 
exploited to further enhance the optical scattering signal for better optical contrast 
when the gold nanoshells are brought close together under the influence of 
biochemical processes associated with disease pathology in cellular environment. 
 
Apart from their optical properties, gold nanoshells also present inert biological 
activities in living systems which make them appropriate for biological applications 
[19-21]. They can be surface functionalized readily with targeting moieties such as 
antibodies or peptides to probe for specific cellular biomarkers with high specificity 
and affinity. When coupled with appropriate biomarkers, these gold nanoshells 
bioconjugates may potentially provide useful optical signal for molecular specific 
information in the diagnosis of early pathologies such as pre-cancers before 
phenotypic changes occur [22]. 
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Since the optical resonance of the gold nanoshells can be easily tuned to the NIR, 
these gold nanostructures would therefore be preferred over solid gold nanoparticles 
as contrast agents for imaging applications involving longer optical wavelength. In 
this chapter, the antibody conjugation of gold nanoshells is described, together with 
their use as appropriate reflectance-based contrast agent for performing molecular 
specific contrast under confocal reflectance microscopy operating at 633 nm 
excitation. Their strong optical scattering response is exploited to improve the optical 
detectability of certain clinically relevant molecular markers which is subsequently 
used to discriminate abnormal from normal cells based on their differential expression 
in epithelial cell types in vitro. The EGFR is one such clinically relevant cell surface 
receptor biomarker used for imaging in this study that is overexpressed in vast 
majority of epithelial cancer but not in normal cells [23, 24]. Their ability to map the 
molecular expression of EGFR in these cells is also evaluated in comparison to 
conventional fluorescence staining. 
 
6.2 Materials and methods 
6.2.1 Synthesis and characterization of gold nanoshells 
Gold nanoshells were synthesized in a four-step process as described earlier in 
Chapter 4. (Figure 6.1) [25]. The process of shell growth on the silica core was 
imaged under transmission electron microscopy (TEM) (Jeol JEM-1010) operating at 
100 kV. The particle size was also characterized by TEM. Gold nanoshells with a 162 
nm diameter silica core surrounded with a gold shell of 23 nm thickness were 
synthesized in this process based on the dimension as determined earlier in Chapter 2 
for optimum backscattering response. Their extinction spectrum was characterized 
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using a UV-Vis spectrophotometer (Shimadzu UV-2401 PC) in the wavelength range 
from 400 nm to 900 nm. This experimentally measured spectrum was then compared 
to the theoretically predicted spectrum determined from a program written in 
MATLAB that calculates the theoretical optical spectra of core-shell structures based 
on Mie theory, which is described in more details in Chapter 2. The gold nanoshells 
were prepared to a final concentration of approximately 5 x 109 particles per ml as 
determined by correlating its measured extinction spectroscopy data to the theoretical 
extinction cross section data of the gold nanoshell based on Mie theory. The 
synthesized gold nanoshells were stored at 4C when not in use. 
 
 
Figure 6.1. Schematic representation of the four-step process in the synthesis of gold 
nanoshells. 
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6.2.2 Conjugation of gold nanoshells with anti-EGFR 
The monoclonal anti-EGFR (Santa Cruz Biotechnology Inc.) was conjugated to gold 
nanoshells using the heterobifunctional poly(ethylene)glycol SH-PEG-COOH (MW = 
3000 g/mol) (Celares GmbH) as the linker where the thiol end was attached to the 
gold surface of the nanoshells and the carboxylic end reacted with amine groups on 
the anti-EGFR via carbodiimide chemistry to form amide bond as shown in Figure 
6.2. In addition, another heterobifunctional methoxy-poly(ethylene glycol)-thiol 
MeO-PEG-SH (mPEG-thiol) (MW = 2000 g/mol) (Celares GmbH) was also attached 
to the gold surface that function as spacers in between the SH-PEG-COOH to “dilute” 
the functional groups on the gold surface to avoid too many conjugation sites while 
improving the stability of gold nanoshells in aqueous solution.  
 
 
Figure 6.2. A schematic illustration of the protocol used to conjugate antibodies to the 
surface of the gold nanoshells using pegylated linkers. The use of pegylated linkers 
allows simultaneous pegylation of the gold nanoshells for great surface hydrophilicity 
and stability. Additional PEGs were also added as spacers in between the antibodies. 
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Both PEGs i.e. SH-PEG-COOH and mPEG-thiol were dissolved in water to give a 
concentration of 10 mg/ml each, before mixing them together in the ratio of 9 mPEG-
thiol to 1 SH-PEG-COOH and adding the PEG mixture to the gold nanoshells. The 
mixture of both PEGs was attached to the gold nanoshells by incubating the gold 
nanoshells (5 x 109 particles per ml) with 1 ml of above mixture where the thiol group 
formed the Au-S bond at the gold surface within 30 minutes at room temperature.  
 
After at least five washes in water to remove excess PEGs from the pegylated gold 
nanoshells, the anti-EGFR was then attached to the other end of the SH-PEG-COOH 
linker via carbodiimide chemistry, with the aid of 400 mM 1-ethyl-3-(3-
dimethylaminopropyl)-carbo (EDC) (Sigma-Aldrich) and 100 mM of N-
hydroxysuccinimide (NHS) (Sigma-Aldrich) as activators that converted the 
carboxylic group to a reactive succinimide group which then reacted with the amine 
group on the antibody to form a stable amide bond. The schematic of the above 
reaction is shown in Figure 6.3 below. 
 
 




Both 200 µl of EDAC and NHS were added to 1 ml of the pegylated gold nanoshells 
and incubated for about 20 min at room temperature, before the addition of 20 µl (i.e. 
4 µg) of the anti-EGFR. The conjugation was completed within 1 h at room 
temperature. The anti-EGFR conjugated gold nanoshells were then washed for at least 
5 times in water before redispersing them in 2 ml of 1X PBS (pH 7.4) and stored in 4 
°C until further use. The successful pegylation as well as conjugation of the anti-
EGFR on pegylated gold nanoshells was determined using X-ray photoelectron 
spectroscopy (XPS) by examining the changes in the sulphur (2p) and nitrogen (1s) 
spectra due to the presence of thiol group and amide bond formed with the antibodies 
respectively on the surface of the gold nanoshells. 
 
6.2.3 Cell culture and EGFR expression analysis 
The poorly-differentiated nasopharyngeal epithelium carcinoma CNE2 cell line and 
the normal human bronchial epithelium (NHBE) cell line were used as the diseased 
and normal control cells respectively. The CNE2 cells were grown in RPMI 1640 
supplemented with 10% fetal bovine serum, 2 mM glutamine, sodium pyruvate, non-
essential amino acids and 100 unit/ml penicillin/streptomycin while the normal cells 
were grown in Bronchial Epithelium Growth Medium (BEGM) (Cambrex Bio 
Science Walkersville, Inc). Both cell lines were grown on a coverslip placed in petri 
dish and maintained at 37oC in humidified 5% CO2 and 95% air atmosphere.  
 
To validate the differential expression of EGFR between the normal and cancer cells, 
both the fluorescence activated cell sorting (FACS) and enzyme-linked 
immunosorbent assay (ELISA) analysis (Human EGFR ELISA Complete Kit, 
RayBiotech, Inc) were performed on the cell lines to ascertain a higher expression of 
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EGFR protein on the CNE2 cells compared to the NHBE cells. For FACS analysis, 
the primary mouse anti-EGFR conjugated to FITC (Santa Cruz Biotechnology, Inc) 
was used to stain the cells while the negative control staining was done with the 
normal mouse IgG2a conjugated to FITC (Santa Cruz Biotechnology, Inc). The cells 
were ran through a flow cytometer and sorted based on the fluorescence intensity of 
the FITC staining which corresponded to the EGFR expression on the cells. 
 
6.2.4 Cellular imaging in vitro 
Both the CNE2 and NHBE cells were incubated with anti-EGFR conjugated gold 
nanoshells for in vitro examination of the optical contrast of cancer cells over normal 
cells. Prior to imaging, both cell lines were washed in 1 X PBS and fixed in 4% 
paraformaldehyde, before incubating them with 100 μl of the anti-EGFR conjugated 
gold nanoshells in PBS i.e. 5 x 108 particles for 1 h at 37 °C. The CNE2 cells were 
also incubated with pegylated gold nanoshells in PBS without antibodies conjugated 
as a negative control to the antibody binding on cells. Following the incubation, the 
cells on the coverslip were then rinsed thrice with 1X PBS to wash away the excess 
and unbounded gold nanoshells. The coverslip with cells were then mounted on a 
microscope slide and sealed with nail varnish prior to imaging.  
 
The cells were imaged under a laser scanning confocal microscope (Carl Zeiss 
LSM510 Meta) under differential interference contrast (DIC) and confocal reflectance 
mode with an Olympus 63x oil immersion objective. The confocal reflectance 
microscopy was performed under 633 nm excitation with a helium neon laser. Both 
the DIC and confocal reflectance images were taken at the mid-focal plane of the 
cells. To compare the performance of EGFR labeling on cells between staining with 
 173
gold nanoshells versus conventional immunofluorescence dye, the CNE2 cells were 
also labeled with primary mouse anti-EGFR conjugated to FITC (Santa Cruz 
Biotechnology, Inc) for 1 h at 37 °C and examined for immunofluorescence staining 
under confocal fluorescence microscopy at 488 nm excitation with an argon laser. 
 
6.3 Results and discussion 
6.3.1 Synthesis and characterization of gold nanoshells 
Gold nanoshells with a silica core of radius 81 nm were synthesized. The gold 
hydroxide to seed solution volume ratio controls the amount of gold available for 
reduction onto the seed particles on the silica surface. Hence the growth of the gold 
shell depends on the amount of gold hydroxide solution used. With a volume ratio of 
200:1, the amount of gold ions is barely sufficient to form a complete layer of gold 
shell with a thickness of about 12 nm around the silica core. This amount is consistent 
with that obtained from mass calculation needed to achieve the observed dimension. 
At higher volume ratio of 300:1, the shell thickens to about 23 nm. 
 
The reduction of the gold hydroxide solution onto the silica results in a fast color 
change in the colloid: red, purple, blue or green corresponding to different degree of 
completeness of gold shell. Based on the results of the theoretically predicted 
backscattering cross section contour plot in Figure 2.9, gold nanoshells were 
synthesized with a silica core of radius 81 nm and a gold shell thickness of 23 nm 
such that this size configuration fit into the region having the largest backscattering 
cross section to provide an optimum backscattering response based on the theoretical 
prediction as described in Chapter 2.4.5 for subsequent experimental investigations. 
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The TEM image in Figure 6.4a shows the progressive growth of the gold shell around 
the silica core corresponding to the color change in the colloid as observed in Figure 
6.4b.  The gold nanoshells synthesized were spherical and generally monodispersed in 
size. The surface of the particles were also relatively smooth with an average surface 
roughness of 10 to 15 nm i.e. <10% of the particle radius from visual inspection. 
 
 
Figure 6.4. (a) TEM images of nanoshell growth on a 81 nm radius dielectric silica 
nanoparticle core showing the initial gold hydroxide nanoparticles deposited on the 
silica and gradual growth and coalescence of these nanoparticles on the silica surface 
until a complete growth of 23 nm thick gold shell is obtained. (b) Corresponding color 
changes in the colloid with the progressive growth of the gold shell demonstrating the 
changes in the optical properties as these gold nanoshells grow. 
 
The measured UV-Vis extinction spectrum of the synthesized gold nanoshells in 
Figure 6.5 shows a double peak in its surface plasmon resonance for this size 
configuration with one peak at 840 nm and another peak at 650 nm. The peak at 840 
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nm matches the excitation wavelength of most OCT systems. Both the peaks observed 
can be attributed to the plasmon interaction taking place at the dielectric silica-to-gold 
interface and the gold-to-dielectric medium interface respectively. 
 
 
Figure 6.5. Measured UV-Vis extinction spectrum of the synthesized gold nanoshells 
with a silica core of 81 nm radius and a complete gold shell of 23 nm (solid line). The 
theoretically calculated extinction spectrum of gold nanoshells of the same dimension 
is shown for comparison (dotted line), together with the contributions from the 
constituent scattering (dash-dot) and absorption (dash-dot-dot) of gold shells with a 
silica core as derived from the Mie theory. The theoretically predicted backscattering 
spectrum (dash line) is also shown that predicts a strong backscattering response at 
around 800 nm coinciding with the operating wavelength of the OCT system used in 
this study. 
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When compared to the theoretical extinction spectrum based on Mie theory for a 
single gold nanoshell of the same size, the experimentally measured spectrum 
generally agrees well with the theoretical spectrum as shown in Figure 6.5, with the 
same two extinction peaks observed. The relatively intensity between the two peaks is 
also rather consistent between the two spectra. However, small differences due mainly 
to slight shifts in peak wavelength as well as broadening of the measured spectrum are 
also observed. These differences may be attributed to the heterogeneity within the 
population of gold nanoshells formed. Such heterogeneity is inevitable because of the 
size variation in the silica core (typically about 4% in the synthesis process [25]) as 
well as the small differences in shape, surface roughness and thickness of the shell 
formed. There is also the possibility that some of the gold nanoshells may form 
aggregates during the synthesis process which may add to the spectral broadening. 
 
Using the same theoretical approach, the constituent scattering, absorption and 
backscattering spectrum as well as anisotropy factor of gold nanoshells can also be 
predicted (Figure 6.5). Since these optical spectra are usually difficult to determine 
experimentally, the agreement between the experimentally measured and theoretically 
predicted extinction spectrum based on Mie theory implies that the breakdown of the 
theoretical extinction spectrum into its constituent scattering and absorption spectrum 
can also predict the actual scattering and absorption spectrum of the synthesized gold 
nanoshells with good accuracy. 
 
A closer examination of the theoretically predicted extinction spectrum and its 
constituent scattering and absorption spectrum shows that the extinction peak at 
around 800 nm is largely attributed to light scattering with minimal contribution (< 
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10%) from absorption. The prediction thus suggests that the synthesized gold 
nanoshells are predominantly scattering at the 800 nm wavelength with a particularly 
high backscattering efficiency appropriate for OCT applications. Although the 
extinction peak at around 650 nm is also scattering dominant, the contribution from 
light absorption is higher, accounting for up to one-third of its total extinction. 
 
While the scattering-dominant peak at 800 nm renders the optical response of gold 
nanoshells favorable for OCT operating at around 800 nm, the other scattering-
dominant peak at 650 nm also renders their optical response favorable to elicit a good 
reflectance signal for cellular imaging under confocal reflectance microscopy at 633 
nm excitation. Since the light scattering in biological tissue within this NIR 
wavelength range is weak compared to the light scattering afforded by gold 
nanoshells [26], the presence of gold nanoshells in tissue may be discriminated from 
the surrounding tissue and made distinguishable based on their scattering intensity. 
 
6.3.2 Pegylation and antibody conjugation of gold nanoshells 
The optical characterization of the synthesized gold nanoshells encourages further 
evaluation of their actual optical response in vitro with the confocal reflectance 
microscope. Prior to these in vitro studies, surface functionalization was performed on 
the gold nanoshells in the form of pegylation and antibody conjugation to make them 
more stable in cell culture medium with high salt content and also more specific to the 
target to be imaged. Here, the anti-EGFR was used to confer the gold nanoshells 
specificity towards the EGFR target antigen located on the cell membrane. The results 
of the pegylation and conjugation were assessed by XPS as shown in Figure 6.6.  
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The XPS spectrum of both the pegylated and anti-EGFR conjugated gold nanoshells 
shows a peak at binding energy of ≈ 163 eV which correspond to the binding energy 
for sulphur (2p). This peak indicates the presence of thiol group on the surface of gold 
nanoshells arising from the successful pegylation of these two samples as such a peak 
is absent from the XPS spectrum of the naked gold nanoshells. 
 
 
Figure 6.6. X-ray photoelectron spectroscopy (XPS) of naked gold nanoshells (left), 
anti-EGFR conjugated gold nanoshells (middle) and pegylated gold nanoshells (right) 
to detect the presence of sulphur (2p) at binding energy of 163 eV (top) and nitrogen 
(1s) at binding energy of 400 eV (bottom). The peak observed indicates the successful 
thiol bonding on the surface of gold due to pegylation and the successful formation of 
amide bond in the conjugation with antibody respectively. 
 
The peak corresponding to nitrogen (1s) at ≈ 400 eV is observed in all three samples, 
including that of the naked gold nanoshells and pegylated gold nanoshells without 
antibodies conjugation. This may be due to the adsorption of ambient atmospheric 
nitrogen on the gold surface during the measurement. However, the nitrogen (1s) peak 
for anti-EGFR conjugated gold nanoshells is much stronger and distinct compared to 
the other two, thus indicating the presence of addition nitrogen found in the form of 
the amide bond that links the antibodies to the gold nanoshells. The successful 
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pegylation and conjugation of anti-EGFR onto the gold nanoshells based on the 
described scheme of reaction is thus ascertained from this XPS assessment. 
 
6.3.3 Binding of anti-EGFR conjugated gold nanoshells to cells 
The ability of anti-EGFR to retain their antigen binding affinity towards the cellular 
EGFR after conjugation was assessed by incubating the anti-EGFR conjugated gold 
nanoshells with CNE2 cells known to overexpress EGFR (see Figure 3.7). It is clear 
that the anti-EGFR conjugated gold nanoshells are able to bind to the cell surface just 
after 45 min of incubation to give the cells a greenish stain under the brightfield 
microscope due to the gold nanoshells as seen in Figure 6.7. 
 
 
Figure 6.7. Brightfield microscopy of CNE2 cells incubated with pegylated gold 
nanoshells and antibody conjugated gold nanoshells after two different time points of 
15 and 45 minutes. The images were taken prior to any washing of the cells after 
incubation and at a 20x magnification. 
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This implies that most of the anti-EGFR are linked to the gold surface via free amine 
groups located at their Fc region, leaving the Fab regions free for antigen binding. The 
pegylated gold nanoshells with no antibodies conjugated are unable to bind to the cell 
surface and thus settle down in the spaces between the cells. This shows that the anti-
EGFR are still able to retain their antigen binding sites and bind to the extracellular 
domain of EGFR on the cellular membrane even after conjugation to gold nanoshells. 
 
6.3.4 Increase in optical contrast in cells 
The promising optical response computed based on the size of the synthesized gold 
nanoshells encourages further study on their application in reflectance-based imaging. 
To demonstrate the ability of anti-EGFR conjugated gold nanoshells to increase the 
optical reflectance properties of cells, the labeling of CNE2 cells by anti-EGFR 
conjugated gold nanoshells was imaged under DIC and confocal reflectance 
microscopy as shown in Figure 6.8. The labeling of CNE2 cells by pegylated gold 
nanoshells are also shown as control. As the anti-EGFR conjugated gold nanoshells 
attach themselves to the cell surface, the presence of gold nanoshells on the cells 
results in changes to their optical properties.  
 
The confocal reflectance images show that the CNE2 cells by themselves are unable 
to produce any discernable signal against the background with their intrinsic 
reflectance. Although reflectance signal in biological cells is known to originate from 
refractive index variations in various cellular organelles and microstructures such as 
the nucleus or mitochondria [27], the microscope settings have been adjusted in this 
case such that the intrinsic reflectance of the cells is corrected for and any reflectance 
signal observed is due solely to an extrinsic optical contrast agent. 
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Figure 6.8. DIC (top) and confocal reflectance (bottom) images of CNE2 before 
labeling (left), after labeling with non-specific pegylated gold nanoshells (middle), 
and after labeling with anti-EGFR conjugated gold nanoshells (right). Images are 
cross-sectional slices of cells taken at the mid-focal plane at 63X magnification with 
an oil immersion lens. False-color reflectance images are obtained at excitation of 633 
nm. Scale bar in all images is 20 μm. 
 
Therefore, when the cells are incubated with anti-EGFR conjugated gold nanoshells, 
the presence of gold nanoshells on the cells give rise to strong reflectance signals that 
form a distinct bright reflective ring around the cells in the optically sectioned 
confocal image. The bright scattering ring around the cells can be attributed to the 
light scattering of the gold nanoshells. Furthermore, as the bright ring is continuous 
around the perimeter of the cells, this implies that the gold nanoshells may possibly be 
localized on the cell membrane where the EGFR antigens are located. Their 
localization on the cell membrane is ascertained and discussed in more detail below.  
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Such strong light scattering condition is known to be further enhanced when the gold 
nanoshells cluster close together on the cell membrane as they attach to their receptors 
and their surface plasmon interacts with each other [4, 18]. Hence, the mechanism of 
this optical contrast depends largely on the ability of anti-EGFR conjugated gold 
nanoshells to selectively bind to the extracellular domain of EGFR found 
overexpressed on cancer cells. 
 
The addition of non-specific pegylated gold nanoshells also results in their attachment 
on cells being observed albeit to a smaller extent. The attachment of gold nanoshells 
gives rise to some reflectance signal in this case, although the signal is weak and the 
bright reflective spots appear random in the image. Such labeling are non-specific in 
nature and could arise from a small fraction of the gold nanoshells that were not 
adequately pegylated with their surface exposed for non-specific binding to the milieu 
of proteins found on the cells surface.  
 
The quantification of this reflectance signal from the gold nanoshells is potentially 
possible with image analysis as with fluorescence dyes and such signal quantification 
could possibly provide a mean to correlate and hence quantify the protein or 
biomarker of interest being imaged. However, similar to non-specific labeling of 
conventional fluorescent dyes, the non-specific binding of the gold nanoshells can add 
to the noise level in the overall reflectance signal observed and may affect an accurate 
correlation between the reflectance signal observed and the protein of interest been 
measured in the case of signal quantification. 
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6.3.5 Discrimination of cancer from normal cells 
The anti-EGFR conjugated gold nanoshells are not just able to increase the light 
scattering of cells to “illuminate” them for better reflectance contrast, but are also able 
to discriminate cancer from normal cells on the basis of their selective binding to 
different levels of EGFR expression on the cells surface. The labeling of anti-EGFR 
conjugated gold nanoshells on cancerous CNE2 cells as compared to normal NHBE 
cells under DIC and confocal reflectance microscopy is shown in Figure 6.9. The 
NHBE cells were used as healthy control and were exposed to anti-EGFR conjugated 
gold nanoshells in the same manner as the CNE2 cells. The DIC images on the top 
row were taken at the mid-focal place with their corresponding confocal reflectance 
images excited at 633 nm shown on the bottom row. 
 
 
Figure 6.9. DIC (top) and confocal reflectance (bottom) images of both CNE2 and 
NHBE cells after labeling with anti-EGFR conjugated gold nanoshells. 
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The reflectance signal from the gold nanoshells on NHBE cells is significantly lower 
and can barely be resolved against the dark background. An analysis of the image 
histogram reveals that the reflectance intensity from the NHBE cells is about 30 times 
lower than that of the CNE2 cells. Such a difference in the reflectance intensity may 
be attributed to the different level of EGFR expression on both cell lines which directs 
the amount of anti-EGFR conjugated gold nanoshells bound to the cell surface.  
 
The results of the FACS analysis for each cell line in Figure 6.10 below indeed show 
a 6-fold increase in the EGFR expression of CNE2 cells over NHBE cells. This is 
further confirmed by another independent observation based on ELISA analysis 
where the CNE2 cells contain 242 pg of EGFR per µg of cell lysate compared to 42 
pg in NHBE cells. 
 
Figure 6.10. The reflectance signal observed from the gold nanoshells on the cells 
shown in Figure 6.9 provides an indication of their EGFR expression level which is 
assessed by FACS analysis (top) and ELISA (bottom) to show a six fold increase in 
EGFR expression in CNE2 cells over NHBE cells. 
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Since EGFR is differentially expressed in the two cell lines, this allows us to make 
use of their differential expression to regulate the amount of gold nanoshells being 
attached to the cells. As the NHBE cells are shown to have a lower expression of 
EGFR than CNE2 cells, they may give rise to fewer binding and localization of the 
anti-EGFR conjugated gold nanoshells on them, thus giving rise to a weaker 
reflectance signal. Such result thus shows that the anti-EGFR conjugated gold 
nanoshells are able to discriminate cancer cells from normal cells on the basis of their 
selective binding to different levels of EGFR expression on cells surface. 
 
In practice, the EGFR expression in cells is detected at all stages of carcinogenesis, 
from normal-early hyperplasia, dysplasia to invasive carcinoma [28] and it is elevated 
during the progression from hyperplasia to dysplasia and increases during progression 
from dysplasia to invasive carcinoma [23], thus giving a spectrum of expression 
levels with disease progression. As the reflectance signal depends on the level of 
EGFR expression, its intensity may further provide indications to the progression of 
diseases at the molecular level in addition to simply discriminating diseased cells. 
 
6.3.6 Molecular mapping of EGFR expression 
The dependence of the reflectance intensity from gold labeling on EGFR expression 
provides an avenue where the anti-EGFR conjugated gold nanoshells can potentially 
be used as a probe for molecular imaging and quantification of cellular proteins. This 
can be investigated by first identifying the regions of high EGFR expression using 
conventional techniques with fluorescent dyes and subsequently mapping the 
corresponding reflectance signal from the gold nanoshells to the fluorescence signal 
to determine any correlation between these regions. The staining of EGFR by gold 
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nanoshells is compared to conventional immunofluorescence staining using FITC as 
shown in Figure 6.11 below.  
 
 
Figure 6.11. Comparison between the labeling of EGFR expression by gold 
nanoshells (right) and conventional immunofluorescence labeling using FITC (left) 
under the confocal reflectance microscopy at 633 nm excitation and confocal 
fluorescence microscopy at 488 nm excitation respectively. The reconstructed z-
stacks of a series of confocal optical sectioning of CNE2 cells shown on the top and 
right side of the en face image show the staining on the cross section side profile of 
the cells. The top and right cross sectional image corresponds to the position of the 
horizontal (green) and vertical (red) line on the en face image respectively. The 
regions of strong reflectance signal that arises from the cell membrane are due to the 
presence of anti-EGFR gold nanoshells labeling the EGFR on the cell membrane. 
 
As the anti-EGFR conjugated gold nanoshells are localized on the cell membrane to 
probe for EGFR, the transverse cross section labeling pattern of EGFR arising from 
the reflectance signal of gold nanoshells compares well with the fluorescence signal 
of FITC dye, thus indicating that the gold nanoshells are able to provide an accurate 
molecular mapping of EGFR expression under confocal reflectance microscopy. After 
acquiring a series of confocal optical sections, the reconstructed z-stacks showing the 
side profile of the CNE2 cells on the top and right side of the main image in Figure 
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6.11 also shows comparable staining pattern on the cell membrane by both methods of 
staining. The staining by gold nanoshells forms a distinct outline of the cells in the 
longitudinal cross sectional images and thus corroborates the postulation regarding the 
origin and localization of the bright reflective ring due to the gold nanoshells on the 
cell membrane. 
 
Therefore, apart from simply increasing the reflectance signal and discriminating 
diseased from normal cells, the study has also shown the possibility of exploiting the 
light scattering properties of gold nanoshells to image the expression of EGFR in 
cells, similar to how the fluorescent properties of dyes are used to image such 
expression in conventional immunofluorescence imaging. The dependence of the 
reflectance signal on EGFR expression clearly demonstrates that the anti-EGFR 
conjugated gold nanoshells do not merely function as a generic non-specific contrast 
agent, but can also serve as a specific molecular probe for cancer biomarkers on 
cancer cells. The map of EGFR expression under reflectance-based images potentially 
holds several implications for cancer diagnosis particularly those of early detection 
based on molecular specific information. 
 
6.4 Conclusion 
Optical imaging in the non-fluorescent regime offers alternative perspectives in 
diagnosing diseased conditions despite being plague by poor contrast inherent to such 
techniques. Combining advances in these techniques with appropriate contrast agents 
may potentially offer even greater diagnostic value especially in the area of detecting 
early molecular changes. In this study, gold nanoshells are designed with a dimension 
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that would provide the optimum backscattering response appropriate for the two 
reflectance-based imaging modalities discussed in this thesis.  
 
The cellular imaging results with gold nanoshells under the confocal reflectance 
microscopy suggest at least three areas where the imaging can be improved upon with 
the use of gold nanoshells: 1. The optical response of gold nanoshells are able to 
provide a general contrast enhancement. 2. This contrast enhancement can be made 
specific to discriminate disease from normal cells and 3. Molecular expression can be 
imaged and mapped when the gold nanoshells are conferred biomarker specificity 
with appropriate surface functionalization to provide a form of optical labeling based 
on light reflectance.  
 
Although antibodies of murine origin are used in this study, potential clinical 
applications can involve the use of humanized antibodies currently in clinical trials 
which are much less immunogenic in humans. As molecular changes occurs before 
phenotypic changes of a disease becomes apparent, such a general trend of interest 
towards earlier cancer diagnosis of suspicious lesions at a stage before debilitating 
symptoms appear promises improved patient care in the near future.  
 
The promising in vitro cellular microscopy results discussed in this chapter encourage 
further investigations on the optical properties of gold nanoshells in phantom models 
to optimize their optical contrast for subsequent imaging applications in OCT. Such a 
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PHANTOM STUDIES OF OPTICAL CONTRAST 
 
Abstract 
The study of different parameters of gold nanoshells in tissue phantom provides a 
realistic model to their contrast enhancement in tissue under OCT imaging. One such 
parameter is its concentration which is key to obtaining a good signal enhancement. 
The effective use of gold nanoshells as a contrast agent for OCT may be hampered by 
the delivery of a wrong dose to tissue that result in unwanted signal attenuation. In 
this chapter, gold nanoshells with a 81 nm radius silica core and 23 nm shell thickness 
are synthesized and their optical response is evaluated against phantom models under 
OCT. The effect of changes in scattering coefficient, µs due to concentration 
variations of gold nanoshells on the OCT image is also examined with the aim of 
defining a dosing range that would result in appropriate µs to maintain an acceptable 
signal attenuation level. The results show that gold nanoshells are able to elicit an 
increase in OCT signal near the imaging surface over 1% Intralipid commonly used to 
model intrinsic tissue scattering. Furthermore, an increase in sample µs not only 
enhances the OCT signal near the imaging surface but also attenuates the signal 
deeper into the sample. A gold nanoshells concentration range of 5.6 x 109 < c < 2.3 x 
1010 particles/ml was found to provide an adequate signal enhancement near the 
surface without severely compromising the imaging depth due to signal attenuation. 
This concentration range was subsequently verified in in vivo studies with animal 
models. This work has been published in Applied Optics 2009; 48: D96–D108. 
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7.1 Introduction 
The effectiveness of optical imaging is often improved with the aid of exogenous 
contrast agents such as bioluminescent and fluorescent dye that enhance the tissue 
contrast and highlight specific molecular events within the subject. Despite being 
widely used with incoherent light imaging systems such as confocal and multiphoton 
microscopy, these contrast agents rely on fluorescent process and are therefore not 
appropriate for use with coherent light imaging systems such as the Optical 
Coherence Tomography (OCT). 
 
The previous chapter describes the use of gold nanoshells as a contrast agent to 
improve the optical signal in confocal reflectance microscopy. In this chapter, the in 
vitro confocal reflectance imaging results are extended to OCT which is another type 
of reflectance-based imaging modality that also form images based on incident light 
that are backscattered back from tissue sample. While the confocal reflectance 
microscope forms an image using mostly single backscattered light from a single 
optical plane of the sample, OCT forms its image based on both single and multiple 
backscattered coherent light from a continuous series of optical planes in the sample 
to give a depth profile. 
 
OCT provides both real time and in situ imaging of tissue and is capable of producing 
<10 µm resolution cross-sectional images by detecting the optical echoes of coherent 
light backscattered from tissue [1]. The ability to obtain high resolution images has 
led to several promising applications in the diagnosis of cancers in real time without 
the need for tissue removal and sectioning [2-4]. Whilst the intrinsic optical contrast 
in OCT may arise from subcellular changes that alter light scattering such as increase 
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in nuclear size during carcinogenesis, the contrast between cancer and normal tissue, 
especially early stage lesions are often too modest to be of any significant value in 
clinical imaging. Furthermore, many other valuable molecular indicators of tissue 
abnormalities may not generate obvious intrinsic optical contrast. In these cases, the 
use of OCT would thus require a separate class of contrast agents that rely on elastic 
coherent light scattering. 
 
The traditional way of improving the contrast in OCT images employs the use of 
osmotically active immersion liquids such as glycerol, propylene glycol, dextranes 
and concentrated glucose solution to cause a change in the tissue refractive index [5, 
6]. This is improved with a new generation of contrast agents based on particle 
technologies due to their improved optical properties and ease of performing surface 
modifications. Several types of particulate contrast agents such as air-filled 
microbubbles, engineered microspheres and gold nanostructures have been developed 
to improve the OCT image by enhancing the intensity of backscattered light from the 
tissue [7, 8].  
 
Amongst these, gold nanostructures of different types e.g. gold nanorods [9], gold 
nanocages [10] and gold nanoshells [11] have been the most widely studied. The 
choice of gold nanostructures as OCT contrast agents for is motivated by several 
factors: 1. the known biocompatibility of gold, 2. the small size of the nanoparticles 
that increases their portability in tissue, 3. the easy tunability of their optical 
properties, and 4. their high scattering efficiencies (>1) arising from the surface 
plasmon resonance of gold at the nanoscale compared to dielectrics such as 
polystyrene which must be micron-sized to achieve efficiencies near unity. 
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Amongst the different types of gold nanostructures, the optical efficiency of gold 
nanoshells as an exogenous contrast agent for optical imaging of cells and tissue 
phantoms is well documented [12, 13]. The optical and physico-chemical properties 
of gold nanoshells as well as an in vitro demonstration of their optical contrast under 
confocal reflectance microscopy have been described extensively in the preceding 
chapters. OCT imaging enhancement with gold nanoshells has been documented in 
literature although the results presented are mostly qualitative in nature [11, 13, 14]. 
The first effort to quantify the performance of nanoshells by Agrawal et al. [15] uses 
tissue phantom to examine the effect of different size configurations of gold 
nanoshells as well as the concentration dependence of gold nanoshells on the OCT 
signal intensity gain. However, a holistic characterization of the changes in OCT 
image due to addition of gold nanoshells to tissue demands more than just an 
understanding of the influence of size parameters and gold nanoshells concentration 
on the intensity gain. 
 
In general, optical characterization of OCT has been studied by several groups and a 
few theoretical models have been established to relate the optical parameters of the 
sample being imaged to its corresponding depth-dependent A-scan signal profile [16-
18]. It is known that the depth-dependent scattering in OCT has been modeled as a 
function of the scattering coefficient, µs of the medium [17, 19] and µs affects not 
only the intensity gain of the OCT signal, but also its attenuation with imaging depth. 
The available experimental data in literatures lack a detailed treatment of the 
influence of gold nanoshells concentration on the changes in the overall A-scan 
profile which is also significant in affecting the overall quality of the gold nanoshells-
enhanced OCT images.  
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In this chapter, the optical enhancement by gold nanoshells under a benchtop OCT 
system is evaluated against tissue phantom models as well as other types of particle 
scatterers in a preliminary demonstration of their ability to improve the OCT signal 
when added to tissue. The influence of changes in tissue µs as modeled by varying 
concentration of Intralipid as well as the effect of changes in µs due to different 
concentrations of gold nanoshells added to tissue phantom on the OCT contrast 
enhancement is also examined on a commercial OCT system. An analysis algorithm 
is developed to extract the sample µs from the average OCT depth-dependent 
backscattering profiles i.e. A-scans.  
 
The relationship between the gold nanoshells concentration and extracted µs implies 
that the extracted µs may be used to determine the unknown particle concentration in 
tissue from the OCT signal profile for concentration mapping. Since a tissue phantom 
with different concentrations of gold nanoshells is able to model the localization of 
gold nanoshells after various mode of nanoshells delivery in tissue, the results in this 
study could provide further insights on the changes in OCT image contrast for 
different delivery mode of nanoshells into tumor tissue of animal models. 
 
7.2 Materials and methods 
7.2.1 Synthesis and characterization of gold nanoshells 
Gold nanoshells were synthesized and pegylated as described in preceding chapters. 
The pegylation provides steric stabilization to improve their stability in aqueous 
medium without adversely affecting their optical properties. The particle size was 
determined by transmission electron microscopy (TEM) (Jeol JEM-1010) operating at 
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100 kV. Their extinction spectrum was measured using a UV-Vis spectrophotometer 
(Shimadzu UV-2401 PC) in the wavelength range from 400 to 900 nm and compared 
to the theoretically predicted spectrum from Mie theory for a single nanoshell of the 
same size configuration.  
 
The gold nanoshells were synthesized with a silica core diameter of 162 nm 
surrounded by a gold shell of 23 nm thick. The TEM image of synthesized gold 
nanoshells and its measured UV-Vis extinction spectrum is shown in Figure 7.1. This 
size configuration was selected based on an optimized backscattering cross section at 
800 nm predicted from Mie theory as described in Chapter 2.4.5. Here, the 800 nm 
surface plasmon resonance peak of the synthesized gold nanoshells matches the 800 
nm excitation wavelength of the OCT systems used in this study to generate a large 
optical extinction in the gold nanoshells when they are excited by the light source.  
 
 
Figure 7.1. TEM image of the synthesized gold nanoshells with a 162 nm silica core 
surrounded by a 23 nm thick gold shell. (b) Comparison between the measured 
extinction spectrum (solid line) and theoretically predicted spectrum based on Mie 
theory for concentric spheres (dotted line). 
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The pegylated gold nanoshells were dispersed in phosphate buffer solution, pH 7.4 to 
a final concentration of 2.0 x 1013 particles/ml as determined by correlating its 
measured extinction spectroscopy data to the theoretical extinction cross-section data 
based on Mie theory for gold nanoshells having the same size configuration. In this 
case, the concentration can be obtained by dividing the extinction coefficient by the 
extinction cross section. The synthesized gold nanoshells were stored at 4 °C until 
further use. 
 
7.2.2 Benchtop OCT system setup 
Two OCT systems were employed in this phantom study: a benchtop setup used to 
compare the OCT signal of suspended gold nanoshells with tissue phantoms and other 
particle scatterers and a commercial system used to examine the concentration 
parameter of gold nanoshells. The benchtop setup was developed by Chow et al. from 
Nanyang Technological University. For the benchtop setup, a single-mode fiber based 
bench top Fourier-domain OCT system with operating wavelength centered at 800 nm 
was used with the schematic of system setup as shown in Figure 7.2. The light source 
used is a Ti:Sapphire laser (Integral OCT, Femtolaser Inc) operating at a centre 
wavelength of 800 nm with a bandwidth of 120 nm to give a power output of 
approximately 7 mW at the sample and a measured in-focus axial resolution of 4 μm. 
A low 0.3 NA, 10x microscope objective was used to provide a lateral resolution of 9 
μm. Instead of having a reference arm in a typical time-domain OCT setup, a cover 




Figure 7.2. Schematic of the bench top Fourier-domain OCT system setup used for 
the phantom studies with a Ti:Sapphire laser source operating at 800 nm to give an 
axial resolution of 4 μm and lateral resolution of 9 µm. The scanning arrangement is 
shown as an insert in the figure. 
 
Backscattered light from the samples was collected via the microscope objective and 
directed to a spectrometer (Ocean Optics HR4000) that was used as a detector to 
detect the interference fringes. The Fourier spectrum was then output to a computer 
for digital processing using a routine written in Labview 8.0 to obtain the OCT M-
scan images. 
 
7.2.3 Commercial OCT system setup 
The commercial OCT system from Bioptigen, Inc. (Durham, NC) was used and the 
system schematic is shown in Figure 7.3. This portable system employs the Optical 
Spectral Domain Reflectometers (OSDR)TM engine based on the Spectral Domain 
OCT (SDOCT) technology. The light source used is a superluminescence diode 
operating at a centre wavelength of 840 nm with a bandwidth of about 60 nm, giving 
an optical power output of 750 µW at the sample and an output SNR of 110 dB. This 
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broadband single-mode illumination gives a measured in-focus axial resolution of ≤ 6 
μm in tissue and the lateral resolution is around 20 µm. The system is able to achieve 
an imaging speed of 20,000 lines (or A-scans) per second and an imaging depth of 1.5 
to 2 mm. The OCT imaging scanner consists of a 0.6” x 5” 2-axes hand-held 
borescope probe with telecentric scanning optics that performs non-contact telecentric 
scan with a lateral scan range of 6 mm. Backscattered light from the samples was 
collected and directed to a spectrometer that was used as a detector to detect the 
interference fringes that provided the scattering profile of the samples. 
 
 
Figure 7.3. The schematic of the Spectral domain OCT imaging system used in this 
study. In the figure, the various components of the system are annotated as such: 
Polarization Controller (PC) which controls the polarization of light; Faraday Isolator 
(FI) that prevents back-reflection into the SLED; Beam Splitter (BS) which splits the 
beam into the reference and sample path; and mirror (M) which serves as the 
reference plane. The water (H2O) is used for dispersion compensation. Image 
courtesy of Bioptigen Inc. The phantom and small animal imaging setup are shown as 
insert in the figure. 
 
The Fourier spectrum was then output to a computer for digital processing using the 
proprietary InVivoVue OCT software suite (Bioptigen Inc, Durham NC) to obtain the 
OCT individual A-scan and B-scan images. The two-dimensional B-scan images of 
784 x 468 pixels were obtained by scanning the single-mode optical beam laterally 
over the sample. A custom routine was written in MATLAB to further process the 
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OCT image file offline to obtain the average A-scans for subsequent analysis and 
extraction of the µs of the imaged sample described in more details below. 
 
7.2.4 OCT imaging for comparative studies of liquid phantoms 
The OCT image of a colloidal solution of gold nanoshells (2 x 1011 particles/ml) was 
acquired together with that of a colloidal solution of naked silica core nanoparticles of 
the same size and concentration but without the gold shell as well as 1% Intralipid 
(Sigma-Aldrich) which is commonly used as a tissue phantom to mimic intrinsic 
tissue scattering over a wide range of wavelengths [20, 21]. At 1% Intralipid 
concentration, it has a known µs of 1.6 to 2.4 mm-1 (depending on the manufacturing 
batch) [22, 23] and an anisotropy factor, g of 0.68 in the 800 nm NIR region [22, 24]. 
OCT imaging was also performed on saline as a negative control, which is not known 
to give any signal with OCT as well as a sample of gold nanoshells added to 1% 
Intralipid to model the addition of gold nanoshells into tissue. The OCT images from 
all these five samples were compared in terms of image signal intensity. 
 
These homogenous liquid samples were prepared in 7 mm circular wells of an 
immuno module (Nunc Maxisorp Immuno Module), filled to the brim with about 400 
µl for imaging. Since the information of interest was the OCT signal as a function of 
depth, the surface of the liquid samples was placed at the same height with no tilt to 
reduce any error due to focusing. This was done by covering the top of the well with a 
coverslip to remove the meniscus of the liquid samples so that the transverse imaging 
location will not be affected by it (Figure 7.2 and 7.3). The coverslip also helps to 
reduce specular reflection at the air-liquid interface arising from the meniscus. 
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The samples were scanned using the benchtop OCT under M-mode imaging with 400 
M-scans (scanning at a fixed spatial location with time) per image frame. Each 
colloidal suspension was agitated by micropipetting just prior to OCT imaging to 
ensure a homogeneous distribution of particles during scan. Due to the limited 
bandwidth of the spectrometer and limited dynamic range of the benchtop system, the 
imaging depth was limited to only 200 μm corresponding to 2000 axial points. The 
OCT images were analyzed using the ImageJ software (National Institutes of Health, 
USA) to determine the average histogram value of the M-scan images for comparison 
between their OCT signal. 
 
7.2.5 OCT imaging for parametric studies of different sample µs 
OCT B-mode imaging and its corresponding average A-scans were performed on two 
types of samples in the parametric studies using the commercial OCT system as 
described earlier. In the first sample imaging, the changes in OCT signal with varying 
µs were examined by using different concentrations of Intralipid. The 20% Intralipid 
stock solution were diluted with water to give 1, 2, 3, 4, 10 and 20% Intralipid tissue 
phantoms and OCT images of the individual concentration were acquired. In the 
second sample imaging, different concentrations of gold nanoshells in 1% Intralipid 
were imaged. The gold nanoshells stock solution was serially diluted in half to give a 
range of seven different concentrations: 1.4, 2.8, 5.6, 11.3, 22.5, 45.0 and 90.0 x 109 
particles/ml.  OCT B- and A-scans were also performed on water which is not known 




The samples were prepared in the same manner as described above in 7 mm circular 
wells of an immuno module with the top covered by a coverslip. The samples were 
positioned and imaged with the top surface of the coverslip at 200 µm from the top of 
the OCT image screen for standardization. The scanning was done under B-mode 
with 1,000 axial A-scans to give an overall lateral scan range of 6 mm per B-scan 
image frame and the imaging depth was about 1.5 mm. All the 1,000 columns of axial 
A-scans from each B-scan were averaged to reduce random speckle fluctuations and 
obtain a reliable average A-scan profile for further analysis. All parameters including 
focus position and software constants remained the same throughout the entire study. 
 
7.2.6 OCT theoretical curve fitting and µs extraction 
In the analysis of OCT signal, the multiple scattering theoretical OCT model based on 
the extended Huygens-Fresnel (EHF) theory was used to fit the measured average A-
scan profile to extract the µs of the sample under measurement [16]. This model 
accounts for both single and multiple scatterings in the sample and is thus able to fit 
well into the average A-scan profile for a wide range of µs including those used in this 
study. The detected signal intensity as a function of the optical axial depth, z in the 
theoretical OCT equation is given by: 
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where A is a proportionality constant. wH and ws are the 1/e irradiance radii in the 
absence and presence of scattering. ρ0 is the lateral coherence length and θrms is the 
root mean square scattering angle. The square root in Equation 7.1 accounts for the 
fact that OCT detects the electric field rather than the intensity of the sample. The 
curve fitting process utilized a non-linear least square fit of the data to Equation 7.1. 
For fitting of different concentrations of Intralipid and different concentrations of gold 
nanoshells in Intralipid, θrms was set to 0.8 for all cases. This is the θrms value for 
Intralipid [24] which is the dominant scatterer used in the study. The θrms value for 
gold nanoshells were not considered in the fitting as the volume fraction of gold 
nanoshells used in our study i.e. ranging from 0.00066 % to 0.0424 % is negligible to 
cause a substantial change in the overall scattering angle when added into tissue. 
 
Since the system parameters such as the focal length, beam waist, source wavelength 
and sample refractive index of the sample are known a priori, the fitting process only 
involved μs, A and an additive factor i0 representing the noise level. It is also known 
that the total sample extinction coefficient is the sum of the absorption and scattering 
coefficient i.e. µt = µa + µs. For most samples being imaged in this study, the 
absorption is often assumed to be negligible i.e. µt ≈ µs since the absorption of 
Intralipid and gold nanoshells is known to be very small around the source 
wavelength. Hence, the OCT depth-dependent scattering has been modeled as a 
function of the scattering coefficient, µs of the medium instead of µt. 
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7.3 Results and discussion 
7.3.1 Comparison of OCT signal with tissue phantom 
The use of gold nanoshells to improve the OCT signal in simple tissue phantom is 
investigated by comparing the OCT M-scan images of gold nanoshells with other 
colloidal samples and the results are shown in Figure 7.4 below. 
 
 
Figure 7.4. OCT M-scans of (a) saline as a negative control, (b) colloidal suspension 
of naked silica nanoparticles (162 nm, 2 x 1011 particles / ml) used as the core in the 
gold nanoshells, (c) colloidal suspension of synthesized gold nanoshells (2 x 1011 
particles / ml) with a 162 nm silica core and 23 nm thick gold shell, (d) 1% Intralipid 
used to mimic intrinsic tissue scattering and (e) a mixture of gold nanoshells added to 
1% Intralipid. These M-mode images were generated by performing repeated scans at 
a fixed spatial location in the phantom over an interval of time with the lateral axis 
represented by time. The range of scanning depth shown is 200 µm and the bright 
signal from the top reflective layer attributed to the reflective glass slide. 
 
The mean histogram values and standard deviation of the 8-bit OCT M-scan images 
of the five samples are also shown in Table 7.1 for comparison. Apart from the saline 
used as a negative control, all of the samples that are evaluated for their OCT signal in 
this study are colloidal solution having different particulate nature. The results show 
that whilst the bare silica core nanoparticles of the same size and concentration as the 
gold nanoshells are able to elicit an observable OCT signal compared to the negative 
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saline control due to their inherent Mie scattering, the signal remains much weaker 
compared to signal from intrinsic tissue scattering as modeled by the 1% Intralipid. 
The mean histogram value of silica is slightly less than half that of the Intralipid. 
 
The 1% Intralipid that is used in this study as a phantom model to mimic the intrinsic 
light scattering in tissue consisted of spherical shaped fat emulsion particles having a 
broad size distribution with a mean particle diameter of 1.01 µm and an anisotropy 
factor of around 0.8 in the NIR region [22, 25]. This makes the Intralipid particles 
forward light scatterers. In contrast, the silica core nanoparticles without the gold shell 
were smaller at 162 nm that their light scattering tends to be isotropic with an 
anisotropy factor of around 0.12 (based on theoretical Mie calculation). Although 
these silica core nanoparticles were able to generate an observable OCT signal, their 
smaller scattering cross section and more isotropic light scattering nature account for 
a weaker OCT signal with greater attenuation with depth compared to 1% Intralipid. 
 
Table 7.1. The mean histogram value and standard deviation of the 8-bit OCT M-scan 
images of different samples examined in the phantom study. 
Sample for OCT M-scan Mean histogram 
value (0 to 255) 
Standard 
Deviation
Saline 6.6 15.7 
Naked core silica nanoparticles (2 x 1011 particles/ml) 18.4 23.9 
Synthesized gold nanoshells (2 x 1011 particles/ml) 58.0 27.4 
1% Intralipid 41.4 25.6 
1% Intralipid with gold nanoshells                             





As the layer of gold shell is grown over the silica core, the geometric cross section of 
the particle is not only increased (diameter increased from 162 to 208 nm), the layer 
of gold shell also brought about an additional surface plasmon effect that increased 
the backscattering efficiency of the entire particle from 0.0029 to 6.1, based on 
theoretical Mie calculation. Such combination of an increase in backscattering 
efficiency coupled with an increase in geometric cross section resulted in a much 
larger backscattering cross section of the gold nanoshells to give a large positive 
offset in the OCT signal as discussed in Chapter 2.  
 
The end result is that the surface plasmon resonance from the gold shell is able to 
increase the OCT signal to produce a correspondingly brighter OCT image compared 
to naked silica core nanoparticles of the same concentration as observed in Figure 7.4. 
This increase in the mean histogram value from 18.4 to 58.0 i.e. ≈ 3.2 times increase, 
is so distinct that the OCT signal from gold nanoshells alone is even stronger 
compared to the signal from 1% Intralipid tissue phantom within the 200 µm depth of 
imaging. In fact, the mean histogram value of the gold nanoshells scan is nearly 1.5 
times that of the 1% Intralipid tissue phantom (58.0 vs. 41.4) despite having a 
geometric cross section about 23 times smaller compared to the Intralipid particles. 
 
When the gold nanoshells are added to the 1% Intralipid to model the addition of the 
gold nanoshells into tissue, the final OCT image is brighter than any of its 
constituents and the mean histogram value of the 1% Intralipid increases from 41.4 to 
89.9, which is slightly more than a twofold increase. This twofold increase in the 
mean histogram value shows that by adding appropriate amount of gold nanoshells 
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into tissue, the OCT image signal can potentially be increased by at least two orders 
since the visual observation from the image histogram value is in the log scale.  
 
It is also interesting to note that the mean histogram value of the 1% Intralipid 
mixture with gold nanoshells is an approximate linear summation of the mean 
histogram values of its constituent 1% Intralipid and gold nanoshells i.e. 89.9 ≈ 41.4 + 
58.0. Such observation assumes that the backscattering increase linearly with the 
concentration of the particles which is true only in the case of single scattering 
approximation at small depth of imaging. With the shallow scanning depth of 200 µm, 
the predominance of single scattering in sample validates such linear summation. 
 
In the present discussion, it should also be noted that the depth of OCT imaging 
shown here using the benchtop setup is at most up to 200 µm. Such shallow depth of 
imaging does not permit any depth-dependent attenuation of the OCT signal deeper 
into the sample to be observed. Such depth-dependent attenuation affects the overall 
quality of the OCT images and can be examined with greater depth of imaging using 
the commercial OCT system. The effect of this depth-dependent attenuation is shown 
and discussed in the following section. 
 
7.3.2 Changes in OCT signal with different µs 
Intralipid of different concentrations were used to examine how changes in the tissue 
µs affect the OCT image and its corresponding average A-scan profile. The results in 
Figure 7.5 show at least two observable changes in the OCT images as the 
concentration of Intralipid increases. Firstly, the OCT signal attenuation with depth 
becomes more pronounce to result in a reduction in image brightness deeper into the 
 209
sample. This is accompanied by a corresponding increase in the OCT signal nearer to 
the sample surface, especially in the first 200 µm. The overall visual effect is a 
gradual “compression” of the OCT signal i.e. image brightness increases towards the 
superficial direction as µs increases to give two distinct regions: a bright but narrow 
band of about 200 µm from the sample surface atop a dark region arising from the 
attenuated OCT signal. 
 
 
Figure 7.5. OCT imaging of tissue phantom samples based on Intralipid showing the 
changes observed in OCT image with increasing µs as given by an increasing 
Intralipid concentration. 
 
The average A-scan profile shown in Figure 7.6 corresponding to each of the OCT 
image in Figure 7.5 characterizes the above mentioned changes with a gradual 
increase in the slope of the depth-dependent signal and the signal intensity at the 
sample surface as the µs increases. These observations imply that whilst the signal 
near the sample surface is strong, the effective imaging depth is compromised for 




Figure 7.6. Changes in the average A-scan profile for different concentration of 
Intralipid corresponding to each of the OCT image in Figure 7.5. The fitted curve 
based on the theoretical multiple scattering OCT model is shown as an overlay onto 
the measured signal to extract the sample µs which is indicated in the figure. The 
noise floor is shown in dotted line. 
 
Previous studies have shown that the negative gradient of the average A-scan profile 
is a function of µt [26, 27]. As µt increases, the slope of the depth attenuation profile 
also increases. Since Intralipid is known to be scattering dominant with negligible 
absorption i.e. µa ≈ 0, the extracted µt ≈ µs. Therefore the slope of the average A-scan 
profile is determined by the µs of Intralipid. As µs increases with higher Intralipid 
concentration, the incident light source entering the sample experiences higher level 
of scattering near the surface which reduces its mean free paths.  
 
This scattering is attributed to the presence of spherically shaped fat emulsion 
particles in Intralipid as described earlier. The amount of single backscattered light 
that collectively contribute to the overall backscattered light is also higher due to 
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higher concentration of the particles, thus presenting a strong OCT signal 
enhancement near the sample surface as observed in the results. With a significant 
amount of light backscattered out of the sample, the amount of light that reaches 
deeper into the sample is reduced, which explains the significant signal attenuation 
with depth as µs increases. 
 
The plot of the µs extracted from the fitted model (see Figure 7.6) against different 
concentration of Intralipid is shown in Figure 7.7. The extracted µs of Intralipid based 
on the multiple scattering OCT model increases proportionately with lower 
concentrations of Intralipid. For higher concentrations of Intralipid, the µs does not 
scale linearly with concentration in the same way as for low concentration, but begins 
to deviate from linearity at 4% concentration. This nonlinear relationship between µs 
and Intralipid concentration was similarly observed by others [22, 24, 28] and occurs 
when the mean Intralipid particle spacing is small (typically less than 3-5 particle 
diameters [22]) at high concentrations to result in the shadowing effect of particles 
that effectively reduces the apparent Intralipid particle concentration and hence its µs. 
 
As the Intralipid µs increases from 1.53 ± 0.16 mm-1 (1% Intralipid) to 8.49 ± 0.26 
mm-1 (20% Intralipid), the depth at which the OCT signal attenuates to the noise floor 
decreases from >1.2 mm to about 500 µm. As the Intralipid is able to model the 
scattering behavior of tissue well, the same observation concerning the reduction in 




Figure 7.7. Plot of the extracted µs against different concentration of Intralipid. The 
predicted linear relationship between µs and concentration is shown in dotted line as a 
reference to show the nonlinearity occurring at high concentration of Intralipid. 
 
This reduction in the depth of imaging suggests the importance of appropriate sample 
µs that would allow an acceptable imaging depth particularly for diseases such as 
cancer where the pathological changes may not be sufficiently superficial. Since most 
of the early phenotypic changes in tissue associated with diseases such as pre-cancers 
of the epithelium originates at about 300 - 600 µm beneath the tissue surface at the 
basal layer within the mucosa, the OCT signal level at 600 µm should be above the 
noise floor to be effective for cancer imaging. 
 
The results in Figure 7.6 show that any sample µs less than 5.85 mm-1 would maintain 
the OCT signal above the noise floor at 600 µm to image any critical changes 
occurring at the mucosa. This criterion allows a wide range of human soft tissue to be 
imaged [29, 30]. It is noteworthy that the results obtained are specific to the 
commercial OCT system used in this study. Other OCT systems would give different 
outcomes depending on their SNR and dynamic range. 
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7.3.3 Change in OCT signal with different concentration of gold nanoshells 
The effect of having different gold nanoshells concentration in Intralipid on the OCT 
image holds several implications on the delivery of these nanoparticle contrast agent 
into living systems as an imaging contrast agent since different delivery routes would 
result in different level of gold nanoshells localization at the targeted site of imaging. 
Different concentrations of gold nanoshells in 1% Intralipid were imaged to model the 
localization of their different amount in tissue and hence understand the effects on the 
image enhancement. The OCT image of a range of gold nanoshells concentration (1.4 
x 109 to 9.0 x 1010 particles/ml) in 1% Intralipid is shown in Figure 7.8. 
 
 
Figure 7.8. OCT imaging of phantom samples showing the changes observed in OCT 
image with increasing concentration of gold nanoshells in Intralipid. 
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At a low concentration of < 5.6 x 109 particles/ml, the change in OCT image is barely 
observable. The corresponding average A-scan profile of these concentrations in 
Figure 7.9 also remains largely unchanged except for slight increase in the slope of 
the signal attenuation with depth. The change in the image only becomes more 
apparent at 5.6 x 109 particles/ml where the signal intensity near the surface increases 
slightly and the OCT signal attenuation with depth becomes observable. 
 
 
Figure 7.9. Changes in average A-scan profile for different concentration of gold 
nanoshells corresponding to each of the OCT image in Figure 7.8. The fitted curve 
based on the theoretical multiple scattering OCT model is shown as an overlay onto 
the measured signal to extract the sample µs which is indicated in the figure. The 
noise floor is shown in dotted line. 
 
As the gold nanoshells concentration increases to 1.1 x 1010 particles/ml and beyond, 
the characteristic gradual “compression” of OCT image brightness towards the 
superficial direction as previously observed in Intralipid becomes increasingly 
pronounced. The average A-scan profile also show the gradual sharpening of the 
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signal attenuation with depth accompanied by an increasing signal intensity near the 
sample surface (< 200 µm) as observed previously. 
 
The overall µs of different gold nanoshells concentration in 1% Intralipid (GNS in 
ILP) was extracted from their average A-scans in Figure 7.9. The µs contributed by 
gold nanoshells alone can be derived simply by subtracting the µs of Intralipid (i.e. 
1.53 ± 0.16 mm-1 from the result the previous section 7.3.2) from µs,GNS in ILP [31] i.e.  
 µs,GNS = µs,GNS in ILP - µs,ILP (7.3) 
The extracted µs,GNS in ILP and derived µs,GNS is plotted against different concentration 
of gold nanoshells as shown in Figure 7.10. The theoretical µs,theoretical based on Mie 
calculations for different gold nanoshells concentration is also shown as comparison. 
 
 
Figure 7.10. Plot of the calculated µs of gold nanoshells in Intralipid (solid line) 
derived from subtraction of µs, ILP from the extracted µs, GNS in ILP (dash-dot-dot) against 
different concentration of gold nanoshells in Intralipid.  The theoretical linear 
relationship between µs and gold nanoshells concentration is shown in dotted line. 
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The µs of gold nanoshells derived from the measured OCT signal exhibit a positive 
linear relationship with concentration and agree well with that determined from 
theoretical calculation except for slight deviation towards higher concentration where 
the derived µs is lower than expected. To understand the link between the gold 
nanoshells concentration and extent of OCT signal enhancement or attenuation when 
different amount of gold nanoshells are delivered to tissue, the relationship between 
the µs and gold nanoshells concentration is examined by the following equation: 
 µs = ρ A Qsca (7.4) 
where ρ is the concentration in number of particles per unit volume, A is the 
geometric cross section and Qsca is the scattering efficiency. With a constant gold 
nanoshells size configuration (81 nm core radius and 23 nm shell thickness) used 
throughout this study i.e. A = 3.40 x 10-14 m2 and Qsca at 840 nm = 4.58, µs scales 
linearly with concentration theoretically and can be further simplified to 
 µs = 1.556 ρ x 10-10 mm-1 (7.5) 
where ρ is the concentration of the synthesized gold nanoshells in particles/ml. This 
linear relationship is seen in Figure 7.10, which is also observed at low Intralipid 
concentrations (Figure 7.7). Therefore, the changes observed in the OCT image for 
increasing gold nanoshells concentration is similar to that of increasing Intralipid 
concentration and can be explained in terms of the changes in µs as discussed earlier. 
 
However, the nonlinearity observed at higher Intralipid concentrations is less apparent 
at higher gold nanoshells concentration where the measured µs of gold nanoshells 
appear to deviate only slightly from the theoretical linearity at high concentrations. 
The same argument used to account for the nonlinearity in Intralipid in terms of 
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interparticle effects also holds true in the case of gold nanoshells. However, this effect 
is less prominent in gold nanoshells probably due to their smaller sizes. This region of 
linearity allows for a good estimation of any unknown concentration of gold 
nanoshells in tissue given its extracted µs and a wide linearity region allows an 
accurate concentration to be mapped over a wide range. 
 
By incorporating the extraction results into the average A-scan profiles in Figure 7.9, 
it is shown that a µs,GNS in ILP of 2.43 mm-1 (as given by 5.6 x 109 particles/ml) is just 
sufficient to elicit an increase in the signal intensity over that of 1% Intralipid within 
the first 200 µm. Although the signal intensity at the top 200 µm layer continues to 
increase with larger µs,GNS in ILP to give an even brighter image, the signal deeper into 
the sample gets rapidly attenuated. As the µs,GNS in ILP increases to 4.85 mm-1 (2.3 x 
1010 particles/ml), the OCT signal is just above the noise floor at 600 µm depth, 
beyond which any higher concentration would render the contrast agent ineffective in 
maintaining an acceptable imaging depth. The results thus suggest an appropriate 
working range of 2.43 mm-1 < µs,GNS in ILP < 4.85 mm-1. This working range falls 
within the earlier suggested range of µs < 5.85 mm-1 in section 7.3.2 needed to 
maintain the OCT signal above the noise floor at 600 µm.  
 
Using Equation 7.5, the above working range of µs translates to a gold nanoshells 
concentration window of 5.6 x 109 < c < 2.3 x 1010 particles/ml that would be useful 
to provide signal enhancement and yet maintain an acceptable imaging depth of at 
least 600 µm for imaging tissue under the OCT. This concentration window lies 
within the linearity region in Figure 7.10 to suggest that the concentration can be 
accurately mapped from the extracted µs using the theoretical Equation 7.4. 
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The results above have demonstrated that an appropriate range of gold nanoshells 
concentration to be optimized for imaging exists. Although this concentration range is 
specific to the size of gold nanoshells and optical specifications of the OCT system 
used in this study, the approach to determine this range holds applicable for other 
OCT-gold nanoshells matching systems. The concentration window implies the need 
for an appropriate delivery protocol of gold nanoshells to achieve the desired amount 
in tissue. This is because different delivery protocol such as intratumoral or 
intravenous injection would deliver different amount of gold nanoshells to the target 
tissue and hence produce varying effect on the contrast enhancement as demonstrated 
in this phantom study. 
 
7.4 Conclusion 
The performance of OCT in achieving an acceptable imaging depth depends as much 
on the µs of the sample as its source power, dynamic range or SNR. This chapter has 
shown that an increase in the sample µs not only increase the OCT signal near the 
sample surface but also concurrently attenuates the signal further in depth. Such 
results hold several implications to the use of gold nanoshells as a contrast agent for 
OCT imaging since their addition into tissue affects the overall µs. For the gold 
nanoshells enhanced OCT investigated in this study, a concentration range of 5.6 x 
109 < c < 2.3 x 1010 particles/ml in 1% Intralipid would achieve a good compromise 
between increasing the OCT signal near the sample surface while maintaining 
acceptable signal attenuation at the deeper region. This implies the need for an 
appropriate delivery protocol for subsequent in vivo studies that would result in this 
concentration to effectively enhance the tissue being imaged.  
 219
The phantom results have hitherto shown that the gold nanoshells have the optical 
response sufficient to function as a generic OCT contrast agent over intrinsic tissue 
scattering. With appropriate antibody functionalization as demonstrated in previous 
Chapter 6, these gold nanoshells can potentially be targeted to early lesions in vivo 
where only molecular changes occur. This will elicit an early molecular-based 
contrast under the OCT that facilitates earlier cancer diagnosis of suspicious lesions in 
vivo before phenotypic changes occur, while leaving surrounding normal tissue 
untouched, thus further adding value to its clinical significance. Such in vivo studies 
on the targeting, accumulation and image contrast of gold nanoshells in tumor tissue 
of mouse model will be described in more details in the following Chapter 8. 
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SMALL ANIMAL TUMOR IMAGING IN VIVO 
 
Abstract 
The results of the phantom study described in Chapter 7 implies that contrast 
enhancement can be controlled by the dosage administered to the tissue of interest, 
which is essential towards optimizing a contrast enhancement procedure in OCT. In 
this chapter, the in vivo control of optical contrast in a mouse tumor model is 
examined. Gold nanoshells were administered into mice via intratumoral or 
intravenous (i.v.) delivery. In the case of i.v., the injected dosage and particle surface 
parameters were further varied and the level of gold nanoshells localization in tumor 
under these variations were determined using the noninvasive theoretical OCT 
modeling technique described in Chapter 7. Compared to intratumoral delivery, i.v. 
delivery of pegylated gold nanoshells allows a moderate amount of gold nanoshells in 
tumor to achieve a good enhancement to OCT signal with minimal signal attenuation 
deeper into the tissue. Further increases in the i.v. dosage of gold nanoshells reveal a 
corresponding nonlinear increase in their tumor localization as well as a nonlinear 
reduction in the percentage of injected gold nanoshells that localizes in the tumor. 
Furthermore, this percentage is improved with the use of appropriate anti-EGFR 
surface functionalization, which not only facilitates a more specific active targeting to 
the cancer marker of interest, but also simultaneously reduces the time required for 
effective tumor delivery from 6 h to 2h. The work presented in this chapter has been 
accepted for publication in Journal of Biomedical Optics 2009. 
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8.1 Introduction 
In biomedical imaging of tissue, it is often desirable to enhance the signal measured 
from specific structures. For most imaging modalities, the effectiveness of medical 
images has been enhanced with the aid of contrast agents. Contrast agents are often 
used to increase the diagnostic and analytical capabilities of imaging modalities by 
site-specific labeling of tissues of interest. They have been successfully utilized in 
almost every medical imaging techniques.  
 
These agents selectively localize at specific organ sites or tissues of interest to 
produce specific image signatures. By targeting contrast agents to a specific tissue of 
interest, the imaging contrast between different cells and tissues can be increased over 
their inherent optical properties to provide a clear demarcation between normal and 
pathological tissues. Therefore, a selective optical agent would be useful to detect 
subtle changes in tissue morphology, better differentiate tissue types with similar 
scattering properties, and identify early cancerous changes in human tissues that are 
morphologically similar to surrounding normal tissues. 
 
This above true for OCT, where the use of contrast agents offers the promise of 
enhanced diagnostic power to overcome the limitation of relying on inherent optical 
properties to discriminate pathology. Inasmuch as OCT detects scattering changes, 
this image contrast enhancement can be achieved by delivery of highly scattering 
contrast agents such as gold nanoshells into the tissue and allowing the agents to 
attach to specific regions of interest. Thus, the tissues with injected contrast agents 
scatter more light back from regions of interest and produce a stronger OCT signal, 
which is detected to form a contrast-enhanced OCT image. The efficiency of using 
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gold nanoshells in enhanced OCT imaging has been demonstrated in previous 
published studies [1-3]. 
 
O’Neal et al. reported on the use of polyethylene glycol coated gold nanoshells (≈ 130 
nm in diameter) that localized in the tumor passively after i.v. injection [4] due to the 
enhanced permeability and retention (EPR) effect, by which nanoscale materials are 
preferentially deposited in tumors (as opposed to normal tissue) as they passively 
extravasate through the leaky and aberrant tumor vasculature [5, 6]. This nanoparticle 
localization within the tumor can be detected by its optical contrast under OCT.  
 
However, gold nanoshells may also be tailored to adhere to specific molecules, cells, 
or tissue types, and thus provide additional selectivity that can further enhance in vivo 
delivery of gold nanoshells quantities that are suitable for imaging. This form of 
active targeting is effected through appropriate surface functionalization, for example 
by conjugation with antibody or proteins to facilitate extravasation from tumor blood 
vessels as well as extravascular transport through the interaction between tumor cell 
surface receptors and receptor ligands attached to gold nanoshells.  
 
Despite the successful demonstration of gold nanoshells as an OCT contrast agent, 
there are at least three identified issues that should be addressed for a more effective 
imaging in vivo. Firstly, the available in vivo experimental data are insufficient for 
developing an appropriate contrasting procedure since detailed parametric studies 
such as dosage of gold nanoshells administered have not been performed to 
demonstrate control of optical contrast in vivo. 
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Secondly, while passive targeting of macromolecular anticancer drugs has been 
studied in detail, less is known about the dynamics of EPR for metal nanoparticles in 
vivo primarily due to the lack of techniques to monitor them in a tissue noninvasively. 
For example, the current standard method to measure gold nanoshells concentrations 
in tissue is neutron activation analysis (NAA) [7] which requires tissue excision, 
dehydration, and irradiation within a nuclear reactor. While extremely sensitive, this 
method is invasive, and thus, does not allow for longitudinal monitoring of metal 
nanoparticles distribution in living systems. 
 
Thirdly, although improvement in optical contrast of tumor cells has been 
demonstrated in vitro using various shapes of immuno-gold nanoparticles, including 
spherical gold nanoshells [1], gold nanocages targeted to HER-2/neu receptors [8] and 
gold nanorods targeted to EGFR [9], active targeting of gold nanoshells capable of 
mediating a more specific improvement in optical contrast in vivo has not yet been 
reported to date. 
 
In this chapter, the promising use of gold nanoshells as a contrast agent in OCT 
imaging is further examined in an in vivo model with the aim to address the issues 
described above. The control of optical contrast in tumors grown in a murine in vivo 
model is demonstrated through three approaches: 1. The use of different modes of 
gold nanoshells delivery into tumor tissue, 2. Variations in concentration of injected 
gold nanoshells via i.v. and 3. The use of active targeting with appropriate antibody 
surface functionalization compared to passive targeting. A noninvasive technique to 
determine the gold nanoshells concentration in tumor tissue of live mice based on the 
theoretical modeling of OCT backscattering signal profile is also developed and 
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described. Using this technique, the concentration of gold nanoshells in the tumor 
tissue for each of the delivery condition is estimated and cross-examined with the 
optical contrast in imaging to allow a better understanding of the dynamics of tumor 
delivery under different circumstances. 
 
The studies described in this chapter builds on the results of the phantom model 
discussed in the previous chapter. The Intralipid tissue phantom with different 
concentrations of gold nanoshells added provides insights on the possible changes in 
OCT image contrast that may occur in vivo with different delivery modes and 
concentration variations of nanoshells since it accurately models the different levels 
of gold nanoshells localization. Two modes of gold nanoshells delivery into the tumor 
model in vivo are examined in this chapter, namely intratumoral and i.v. injection 
which delivers contrasting amounts of gold nanoshells to the tumor. 
 
A covalent conjugation method was previously developed [10] to enable the synthesis 
of monoclonal antibody conjugated gold nanoshells with excellent colloidal stability. 
The selective targeting of epidermal growth factor receptor (EGFR) positive cancer 
cells in vitro using anti-EGFR monoclonal antibody has also been demonstrated in 
chapter 6 [11, 12]. EGFR is a transmembrane glycoprotein that is frequently 
overexpressed in a variety of solid tumors including cancers of the brain, breast, 
colon, head and neck, lung, ovary, and pancreas [13-15], and is used as a selected 
cancer marker for imaging in this study. The results showing a successful 
demonstration of the control of optical contrast and estimation of gold nanoshells 
concentration in tumors in vivo is briefly discussed. 
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8.2 Materials and methods 
8.2.1 Preparation of anti-EGFR conjugated gold nanoshells 
Gold nanoshells were synthesized and pegylated for passive targeting as described in 
preceding chapters and the antibody conjugation was performed on the synthesized 
gold nanoshells as described in Chapter 6.2.2. Both the pegylated and antibody 
conjugated gold nanoshells were then rinsed before being redispersed in 2 ml of 
phosphate buffer solution (1X PBS, pH 7.4) to a final concentration of 2.0 x 1013 
particles/ml as determined by correlating its extinction spectroscopy data to the 
theoretical extinction cross section data of the gold nanoshells based on Mie theory. 
The synthesized gold nanoshells were stored at 4C until further use. 
 
Gold nanoshells with a 162 nm diameter silica core surrounded by a gold shell of 23 
nm thickness were synthesized and used for subsequent study. The TEM image which 
shows the particle size in Figure 8.1a was obtained using a transmission electron 
microscopy (TEM) (Jeol JEM-1010) operating at 100 kV. This size configuration was 
selected based on an optimized backscattering cross-section at 840 nm as predicted 
from Mie theory described in Chapter 2. Their extinction spectrum in Figure 8.1b was 
measured using a UV-Vis spectrophotometer (Shimadzu UV-2401 PC) in the 
wavelength range from 400 nm to 900 nm. The measured spectrum shows a peak 
surface plasmon resonance at 765 nm which compares well to the theoretically 
predicted spectrum determined from a program written in MATLAB that calculates 
the theoretical optical spectra of core-shell structures based on Mie theory for a single 
gold nanoshell of the same size configuration [16]. This peak wavelength is also close 
to the operating wavelength of the OCT system to generate a large optical extinction 
in the gold nanoshells when excited by the light source. 
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Figure 8.1. (a) Electron micrograph of synthesized gold nanoshells with an 81 nm 
radius dielectric silica nanoparticle core and 23 nm thick gold shell. (b) Measured 
UV-Vis extinction spectrum of the synthesized gold nanoshells (solid line). The 
theoretically calculated extinction spectrum of gold nanoshells of the same dimension 
as derived from Mie theory is shown for comparison (dotted line). 
 
8.2.2 Mouse xenograft tumor model 
The mouse xenograft tumor model used in this study was developed on male Balb/c 
nude mice obtained from the Animal Resource Centre (ARC, Western Australia). The 
mice were 6-8 weeks of age and weighed an average of 24-25 g. Approximately 5.0 × 
106 human epidermoid carcinoma cell line, A-431 (ATCC) suspended in 150 μl of 
Hanks’ balanced salt solution (HBSS) (Gibco, USA) were injected subcutaneously 
into the lower flanks of the mice to establish the xenograft tumor model. A-431 cells 
are widely known to overexpress EGFR, which is the selected cancer marker used in 
this study. The expression of EGFR in A-431 cells compared to other cancer cell 
types as well as normal cells is shown in Figure 1.4. The tumors were allowed to grow 
to 5–6 mm in diameter as measured using a vernier caliper approximately after 14 
days of inoculation before OCT imaging was carried out. All handling procedures for 
mice were approved by the Institutional Animal Care and Use Committee (IACUC) at 
SingHealth, Singapore, in accordance with international standards. 
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8.2.3 Gold nanoshells delivery into mice 
Prior to imaging, the pegylated gold nanoshells were suspended in HBSS to various 
concentrations and administered into the mice via intratumoral or i.v. injection. For 
the intratumoral injection, the mouse was first anaesthetized before 150 µl of the gold 
nanoshells (9.0 x 1010 particles/ml) was directly injected with care about 2 to 3 mm 
into the tumor. The injection was performed in at most two injection sites within the 
tumor to minimize leakage. For the i.v. delivery, 150 µl of the pegylated gold 
nanoshells of four different concentrations: 1.1 x 1010, 2.3 x 1010, 4.5 x 1010 and 9.0 x 
1010 particles/ml were injected into the tail vein and allowed to circulate for 6 h for 
passive targeting to tumor before the mouse was anaesthetized for imaging. As a 
comparison between passive and active antibody targeting, 150 µl of anti-EGFR 
conjugated gold nanoshells with a concentration of 9.0 x 1010 particles/ml were also 
injected into the tail vein and allowed to circulate for 2 and 6 h prior to imaging to 
investigate and compare their longitudinal accumulation in tissue. For each of the test 
condition, the OCT measurements were performed in triplicates i.e. n = 3. 
 
8.2.4 Mouse tumor imaging 
The mouse tumor imaging was done with a commercial OCT system from Bioptigen, 
Inc. (Durham, NC) which is described in detail in Chapter 7.2.3. During the imaging 
procedure, the skin covering the tumor was removed to create an open tumor window 
as shown in Figure 8.1 that allowed the underlying tumor and the tumor-skin interface 
to be imaged. The normal skin adjacent to the tumor was also imaged as a reference. 
A coverslip was positioned on top of the exposed tumor to remove the uneven contour 
for imaging. The space in between was immerse with glycerol to provide index 
 230
matching to reduce specular reflective artifact at the tissue-glass interface. The OCT 
probe was placed directly on top of the coverslip and the tumors were vertically 
positioned and imaged with the top surface of the coverslip at 200 µm from the top of 
the OCT image screen for standardization. 
 
 
Figure 8.2. OCT imaging of the tumor with the skin covering the tumor being 
removed to create an open tumor window that allows the underlying tumor and the 
tumor-skin interface to be imaged. 
 
The scanning was done under B-mode imaging with 1,000 axial A-scans to give an 
overall lateral scan range of 6 mm per B-scan frame and the imaging depth was about 
1.5 mm. All the 1,000 columns of axial A-scans from each B-scan were also averaged 
to obtain an average A-scan profile for further analysis. As each test condition were 
performed in triplicates i.e. n = 3, the A-scan profile for each of the mouse 
measurement was further averaged to obtain the mean A-scan profile of the triplicates 
for further analysis. All parameters including focus position and software constants 
remained the same throughout the entire study. 
 
8.2.5 Tumor tissue examination for gold nanoshells 
The imaged tumor tissues were examined for gold nanoshells using Hematoxylin and 
Eosin staining and confocal reflectance microscopy. Cryosections of 10 µm thickness 
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at the site of imaging were obtained using a microtome cryostat (Cryo-Star HM 
560MV, Germany) and the tissue sections were mounted onto slides. Sections were 
then counterstained with a combination of Harris’ hematoxylin and eosin, dehydrated 
in ascending grades of alcohol, mounted onto a coverslip with DePex as the mounting 
medium, and sealed with nail varnish prior to imaging.  
 
Images from the slides were obtained using the Olympus CK40 microscope with a 
20X objective and were captured in brightfield mode using the image processing 
software (Kontron KS400, version 3.0, Hallbergmoos, Germany). For confocal 
reflectance microscopy, the sectioned tissues were imaged using a laser scanning 
confocal microscope (Carl Zeiss LSM510 Meta) under confocal reflectance mode 
with an Olympus 20X objective. The confocal reflectance microscopy was performed 
under 633 nm excitation with a helium neon laser. 
 
8.2.6 OCT theoretical curve fitting and analysis 
In the analysis of OCT signal, the multiple scattering theoretical OCT model based on 
the extended Huygens-Fresnel (EHF) theory was used to fit the measured average A-
scan profile to extract the µs of the sample under measurement [17]. This model 
accounts for both single and multiple scatterings in the sample and is thus able to fit 
well into the average A-scan profile for a wide range of µs including those used in this 
study. The detected signal intensity as a function of the optical axial depth in the 
theoretical OCT equation is given by Equation 7.1. 
 
The curve fitting process utilized a non-linear least square fit of the data to Equation 
7.1. For fitting of tumor tissue, the anisotropy factor of tumor tissue was set to 0.7 to 
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give a θrms of 0.77. The θrms value for gold nanoshells were not considered in the 
fitting as the volume fraction of gold nanoshells in the tumor is assumed to be 
negligible to cause any change in the overall scattering angle when added into tissue. 
 
Since the system parameters such as the focal length, beam waist, source wavelength 
and refractive index of the sample are known a priori, the fitting process only 
involved μt. It is also known that the total tissue extinction coefficient is the sum of 
the absorption and scattering coefficient i.e. µt = µa + µs. For most tissues, the 
absorption is often assumed to be negligible i.e. µt ≈ µs since the intrinsic tissue 
absorption is known to be very small around the source wavelength. Hence, the OCT 
depth-dependent scattering has been modeled as a function of the scattering 
coefficient, µs of the medium instead of µt. 
 
8.3 Results and discussion 
8.3.1 Changes in optical contrast with different delivery modes 
The gold nanoshells concentration window deduced from the phantom model in 
Chapter 7 suggests a relatively tight range of concentration that would require an 
appropriate delivery mode to deliver the right amount of gold nanoshells for effective 
tumor contrast enhancement in vivo. The significance of such an appropriate delivery 
is demonstrated by delivering gold nanoshells via two different modes into the tumor: 
intratumoral and i.v. These two delivery modes deliver different amount of gold 
nanoshells to the target tumor, resulting in different levels of gold nanoshells 
localization in tumors.  
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The OCT images in Figure 8.3 were acquired at the interface between the tumor and 
surrounding normal skin tissue. Compared to tumor tissue without the presence of 
gold nanoshells, a large amount of gold nanoshells delivered to the tumor via 
intratumoral injection shows at least two distinct changes in the OCT images. Firstly, 
the OCT signal attenuates rapidly with depth to result in a loss of image brightness 
deeper into the tissue. This is accompanied by a signal intensity enhancement at the 
tissue surface. The overall visual effect is a bright but narrow signal band at the 
sample surface atop a dark region arising from the highly attenuated OCT signal. This 
characteristic bright surface enhancement on top of a highly attenuated signal region 
is similar to that observed in the earlier phantom study with a high gold nanoshells 
concentration of 9.0 x 1010 particles/ml in Intralipid (Figure 7.8). 
 
 
Figure 8.3. OCT images of the interface between normal peripheral skin and tumor 
tissue of mouse model prior to and after i.v. and intratumoral gold nanoshells 
delivery. The horizontal reflective surface shown on top of the tissue arises from the 
coverslip used to remove the uneven tissue contour for imaging. The top row of 
images show the skin on the left of the interface while the bottom row of images show 
the skin on the right of the interface. 
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With a large amount of gold nanoshells delivered to the tumor via intratumoral 
injection, the incident light entering the tumor experiences a high level of scattering 
near the surface due to the presence of gold nanoshells scatterers, which reduces its 
mean free path. The amount of single backscattered light that collectively contribute 
to the overall backscattered light is also higher due to a higher concentration of 
particle scatterers, thus accounting for the strong OCT signal enhancement near the 
tissue surface as observed in Figure 8.3. With a significant amount of light 
backscattered out of the tissue, the amount of light that reaches deeper into the tissue 
is reduced, which explains the significant signal attenuation with depth. 
 
However, for a moderately small amount of gold nanoshells localized in the tumor 
after i.v. delivery, the OCT signal intensity from the tumor is generally increased 
more uniformly with depth with slower signal attenuation with depth into the tissue. 
This change is similar to that observed in the phantom model with a moderate 5.6 x 
109 particles/ml of gold nanoshells in Intralipid (Figure 7.8). In this case, the incident 
light entering the tumor experiences a longer mean free path that allows them to reach 
deeper into the tissue, thus reducing the signal attenuation with depth. Consequently, 
the amount of single backscattered light near the tissue surface is reduced, thus giving 
a weaker signal enhancement there compared to intratumoral delivery. 
 
The differences in OCT images between i.v. and intratumoral delivery of gold 
nanoshells implies the need for an appropriate delivery mode to deliver the desired 
amount in tissue. This is because different delivery modes would deliver different 
amount of gold nanoshells to the target tissue and hence produce varying effect on the 
contrast enhancement as demonstrated in the two cases earlier. Both of the delivery 
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modes used in this study are commonly used to deliver therapeutic compounds to the 
target site of interest, which is the tumor in this case. 
 
In intratumoral delivery, the bolus injection of a 9.0 x 1010 particles/ml dosage of gold 
nanoshells directly into the tumor causes a high concentration to localize there. On the 
other hand, the delivery of the same dose by i.v. results in a much lower amount of 
gold nanoshells passively reaching the tumor site via the Enhanced Permeation and 
Retention (EPR) effect. The exact concentration of gold nanoshells in the tumor for 
both cases is determined and discussed further in Section 8.3.4.  
 
The reason for a much lower tumor localization after i.v. delivery is because a 
significant amount of injected gold nanoshells is either lost from the bloodstream 
during the circulation due to renal excretion or removal by the reticulo-endothelial 
system (RES) such as the liver. In this case, the liver of the mice before and after 6 h 
of gold nanoshells circulation is shown in Figure 8.4 below. 
 
 
Figure 8.4. Liver of male balb/c nude mice before (left) and after (right) i.v. delivery 




The RES removal of gold nanoshells by the liver causes the gold nanoshells to 
accumulate and result in a dull brown coloration in the liver. The removal of gold 
nanoshells by RES is inevitable despite their pegylation since pegylation only serves 
to minimize the RES uptake as discussed in Chapter 5. The instability of the gold-
monothiol interaction between the gold surface and mPEG-thiol tether after prolonged 
circulation in the biological environment such that the PEGs are easily detached from 
the gold nanoshells may have contributed significantly towards the RES uptake. 
 
In terms of its efficacy in improving the tumor contrast with the surrounding normal 
tissue, Figure 8.3 shows that i.v. delivery of gold nanoshells seems to improve the 
visibility of tumor compared to intratumoral delivery. In addition to improvement in 
tumor visibility, the OCT images also show that the tumor margin between the tumor 
and adjacent normal skin tissue is also more clearly demarcated.  
 
In both delivery modes, the amount of gold nanoshells that localizes in the 
surrounding normal skin tissue is insignificant to warrant any observable change in 
the OCT signal intensity compared to the tumor. This is because the gold nanoshells 
injected directly into the tumor via intratumoral delivery are unable to diffuse out of 
the tumor to the surrounding skin tissue sufficiently via the interstitial space or the 
capillary circulation within the 6 h of circulation. Furthermore, the blood vessels 
supplying gold nanoshells to the non-cancerous normal tissue are also not sufficiently 
porous to facilitate the migration of gold nanoshells out of the bloodstream and into 
the skin tissue after i.v. delivery. Because of their preferential localization in the 
tumor, the gold nanoshells are therefore able to elicit an optical contrast to 
discriminate the tumor from surrounding normal tissue. 
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8.3.2 Changes in average A-scan profile 
The changes in the OCT images with different modes of gold nanoshells delivery 
described above can be characterized by changes to the scattering coefficient, µs of 
the tumor tissue, which in turn, can be extracted from the average OCT A-scans of the 
tissue. This will be discussed in more detail in the following section 8.3.3. The 
average A-scan profile of the tumors prior to and after i.v. and intratumoral delivery 
of gold nanoshells is shown in Figure 8.5.  
 
 
Figure 8.5. Average A-scan profiles of the mouse tumor tissue (i) prior to gold 
nanoshells delivery i.e. tumor without gold nanoshells and after (ii) i.v. and (iii) 
intratumoral delivery of 150 µl pegylated gold nanoshells (9.0 x 1010 particles/ml) 
colloid. The measured OCT signal is shown in dotted line while the non-linear least 
square fit of the data based on the multiple scattering EHF theory is shown in solid 
line superimposed, giving an extracted µs of the composite gold nanoshells in tumor 
tissue of (i) 1.65 mm-1, (ii) 2.62 mm-1 and (iii) 14.95 mm-1. In all three fittings, the 
coefficient of determination, r2 > 0.90. 
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Compared to the average A-scan profile of tumor tissue without gold nanoshells, the 
inclusion of gold nanoshells in tumor after i.v. delivery causes an increase in the OCT 
signal intensity mainly at the top 200 µm of tissue while the signal attenuation with 
depth as given by the slope of the depth-dependent OCT signal becomes slightly more 
pronounced. This depth related attenuation is relatively small compared to that by 
intratumoral delivery where the large amount of gold nanoshells delivered to the 
tumor causes the signal in the average A-scan to attenuate rapidly with depth. 
 
The OCT images and histological tissue sections corresponding to the A-scan profiles 
acquired from the same scanned site are shown in Figure 8.6 below. The OCT images 
of adjacent normal skin tissue are also shown as a reference. The changes in the 
average A-scan profile with different modes of gold nanoshells delivery are well 
reflected in the corresponding OCT images (Figure 8.6a) and have been described 
earlier. The corresponding histological tissue sections after H & E staining in Figure 
8.6b show the localization of the gold nanoshells in the tumor tissue. Despite their 
nanoscale sizes smaller than the resolution limit of conventional light microscope, the 
sudden intratumoral bolus injection of gold nanoshells forces them to be highly 
concentrated in the tumor tissue to the point of aggregation where these nanoparticle 
aggregates become observable under the light microscope. 
 
With a slower delivery of gold nanoshells to the tumor via i.v., the quantity of gold 
nanoshells that localizes in the tissue is smaller and the gold nanoshells are more 
uniformly scattered with a much reduced aggregation within the tumor tissue. In fact, 
their presence in tumor can hardly be discerned visually from the tissue section since 
the sizes of these nanoparticles are beyond the resolution limit of the light microscope 
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used, except in isolated instances of aggregation. In both cases, the gold nanoshells 
seem to be distributed evenly throughout the tumor tissue with no preferential 
localization in any part of the tissue. 
 
 
Figure 8.6. (a) OCT images of normal skin (top row) and tumor tissue (bottom row) 
of mouse model prior to gold nanoshells delivery i.e. tumor without gold nanoshells 
and after i.v. and intratumoral gold nanoshells delivery. The horizontal reflective 
surface shown on top of the tissue arises from the coverslip used to remove the 
uneven tissue contour for imaging. (b) Histological tissue sections of the tumor after 
H & E staining for tumor without gold nanoshells (left) and tumor post i.v. (middle) 
and intratumoral (right) gold nanoshells delivery. The H & E stained tissue sections 
show the localization of the gold nanoshells in the tumor tissue.  Images were 






8.3.3 Determination of tissue µs 
The average A-scan profiles allow the extraction of overall µs,GNS in tumor of the tumor 
with embedded gold nanoshells (GNS in tumor) by means of a non-linear least square 
curve fitting of the theoretical OCT model [17]. In general, the theoretical optical 
characterization of OCT has been studied by several groups and a few theoretical 
models have been established to relate the sample optical parameters to its 
corresponding A-scan profile [17-19] with the aim to extract out the parameters for 
diagnostic purposes such as diabetic glucose sensing [20].  
 
Previous studies have shown that the negative gradient of the average A-scan profile 
is a function of sample µt [21, 22]. In this case, the µt refers to µt,GNS in tumor. As µt 
increases, the slope of the depth attenuation profile also increases. Since biological 
tissues as well as gold nanoshells are known to be scattering dominant with negligible 
absorption i.e. µa,GNS in tumor ≈ 0, the extracted µt,GNS in tumor ≈ µs,GNS in tumor of tissue. 
Therefore, the slope of the average A-scan profile determines the µs,GNS of tumor of the 
tissue being examined. 
 
The µs,GNS contributed by gold nanoshells alone in the tumor can then be derived 
simply by subtracting the µs,tumor of tumor tissue from µs,GNS in tumor [23] according to 
the following equation:  
 µs,GNS = µs,GNS in tumor - µs,tumor (8.1) 
The results of the curve fitting on the average A-scan profiles in Figure 8.5 shows that 
the extracted µs,tumor of mouse tumor tissue without gold nanoshells is 1.65 ± 0.73 
mm-1, while the extracted overall µs of tumor after i.v. and intratumoral delivery of 
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gold nanoshells i.e. µs,GNS in tumor are 2.62 ± 0.23 mm-1 and 14.95 ± 0.65 mm-1 
respectively. The post-subtraction µs,GNS contributed by gold nanoshells alone in 
tumor after i.v. and intratumoral delivery is then calculated to be 0.97 and 13.30 mm-1 
respectively. It would be of worth to note here that the 1% Intralipid (extracted µs = 
1.53 ± 0.16 mm-1) used as a phantom model in Chapter 7 indeed models the mouse 
tumor tissue well, hence verifying that the phantoms can be used to model the actual 
small animal tissue accurately. 
 
In the extraction of µs from the average A-scan profile, the importance of tissue 
homogeneity should not be understated. This is because the theoretical OCT model 
used to fit the A-scan profile was developed based on an optically homogenous 
sample whose entire signal profile can be fitted by a single equation. Heterogeneous 
samples with multiple layers or regions of different µs would require multiple 
equations to fit different layers individually thus rendering the single equation fitting 
inappropriate. For this reason, the average A-scan profile of normal skin with multiple 
stromal layers of different µs was not fitted to extract the “mean” µs of skin.  
 
The tumor tissue, on the other hand, is often assumed to have homogenous optical 
properties [24]. Therefore, the µs of the tumor tissue can be extracted with a good 
degree of fit, having a coefficient of determination, r2 = 0.94. In fact, the rest of the 
average A-scans in the small animal imaging were also well fitted with r2 > 0.97 to 
provide an accurate extraction of µs. To enable the current technique to be more 
robust for multilayer tissue, further studies are needed to develop an analysis 
algorithm that would accurately extract out the µs of individual layers. 
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8.3.4 Determination of gold nanoshells concentration 
The extracted µs contributed by gold nanoshells alone in tumor tissue allows its 
concentration in the tumor to be deduced through the following theoretical 
relationship: 
 µs = ρ A Qsca (8.2) 
where ρ is the concentration of the synthesized gold nanoshells in particles/ml, A is its 
geometric cross section and Qsca is the scattering efficiency.  
 
With a constant gold nanoshells size configuration (81 nm core radius and 23 nm shell 
thickness) of A = 3.40 x 10-14 m2 used in this study and a Qsca of 4.58 at 840 nm based 
on theoretical calculations, µs scales linearly with concentration and the relationship 
can be further simplified to: 
 µs = 1.556 ρ x 10-10 mm-1 (8.3) 
This linear relationship allows for a good estimation of any unknown concentration of 
gold nanoshells in tissue given its extracted µs. In both cases described above, the 
gold nanoshells concentration in the tumor after i.v. and intratumoral delivery is 
approximately 6.2 x 109 and 8.5 x 1010 particles/ml respectively. This estimated 
concentration suggests that 94.4 % of the intratumoral dose administered reaches the 
tumor while only about 6.9 % of the injected gold nanoshells eventually reached the 




Here, it is of worth to note that accuracy of the estimated concentration using this 
technique assumes that the absorption in gold nanoshells is small such that the 
extracted µt of gold nanoshells approximates its µs as in the case of the biological 
tissue. This is true given that the gold nanoshells of this size configuration are 
predominantly scattering as determined from Mie theory in Chapter 2. 
 
In the subtraction of µs,GNS in tumor to obtain the µs,GNS in tissue, the scattering 
coefficient of tumor, µs,tumor is assumed to be 1.65 mm-1 (Figure 8.5) and this is used 
in all the analysis across different mice in this study. This value concurs with those 
reported in literature [25, 26] and is used although there may be some small variations 
in the scattering coefficients of tumor tissue which may affect the computation of the 
gold nanoshells concentration. 
 
The use of Equations 8.2 and 8.3 also assumes the monodispersity of gold nanoshells 
in the tissue to give a narrow size profile centered around the experimental size 
configuration. In practice, the gold nanoshells do not remain in a monodisperse state 
in tissue since there is a tendency for them to aggregate to different degree as 
observed in the histological tissue sections in Figure 8.6. This aggregation occurs 
despite prior successful pegylation [27] in vitro and could possibly be attributed to the 
instability of the gold-monothiol interaction between the gold surface and mPEG-thiol 
tether in the tissue interstitial environment such that the PEGs are easily detached 
from the gold nanoshells. The aggregation of gold nanoshells results in changes to 
their optical properties. Such hypothesis is also discussed earlier to account for the 
high RES uptake of gold nanoshells. 
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Furthermore, the linear relationship between µs and particle concentration is limited; 
as studies with other particle scatterers such as Intralipid have shown that the 
relationship turns nonlinear at high particle concentrations due to the interparticle 
shadowing effects [28]. Nonetheless, the previous studies on Intralipid phantom 
models in Chapter 7 have shown that the measured µs of gold nanoshells appear to 
deviate only slightly from the theoretical linearity even at high concentrations. This 
linear region is thus sufficiently wide to allow an accurate gold nanoshell 
concentration to be determined over a wide range which includes that used in this 
study. Therefore, the deduced concentration from the µs is only an approximation that 
is highly subjected to the various physical properties of gold nanoshells e.g. size 
configuration, state of aggregation and concentration in tissue as discussed. 
 
Despite the approximation, such a technique in determining the concentration of gold 
nanoshells in tissue from the OCT average A-scan profile holds possible applications 
in biodistribution studies and may allow concentration mapping of gold nanoshells for 
quantitative molecular imaging of certain crucial biomarkers associated with cancer, 
especially if the gold nanoshells are functionalized for specific antibody targeting to 
that identified biomarker as shown in this study. 
 
8.3.5 Changes in optical contrast with concentration variations 
The previous results suggest that i.v. delivery of gold nanoshells is effective for tumor 
contrast enhancement, having minimal signal attenuation with tissue depth compared 
to intratumoral delivery. The study on i.v. delivery is extended further to demonstrate 
that intravenous control of optical contrast in tumors is possible by varying the 
concentration of gold nanoshells injected. The mice were injected with a range of gold 
 245
nanoshells concentrations via i.v. (1.1 x 1010 to 9.0 x 1010 particles/ml) for passive 
targeting to tumor and the OCT images of the tumor after 6 h of vascular circulation is 
acquired. 
 
The OCT images in Figure 8.7 show a gradual increase in the signal intensity 
especially from the top 300 µm region as the concentration of gold nanoshells injected 
increases. The signal attenuation with depth also becomes more slightly pronounced 
with increasing concentration. 
 
Figure 8.7. Changes in the OCT image after 6 h of vascular circulation for a range of 





These changes are similarly observed in the corresponding average A-scan profiles 
after 6 h of vascular circulation as shown in Figure 8.8 where the negative slope of the 
depth-dependent A-scan curve increases together with an increase in the OCT signal 




Figure 8.8. Changes in the average A-scan profile of mouse tumor tissue after 6 h of 
vascular circulation for a range of gold nanoshells concentration (1.1 x 1010 to 9.0 x 
1010 particles/ml) injected intravenously. The measured OCT signal is shown in 
dotted line while the non-linear least square fit of the data is shown in solid line 





The corresponding confocal reflectance images of the tissue sections acquired at the 
same imaging site as shown in Figure 8.9 further verify the increasing localization of 
gold nanoshells in the tumor tissue with an increasing dosage administered. Here, the 
reflectance signal arising from the gold nanoshells are pseudo-colored red. The 
confocal images show that the gold nanoshells localize in the tumor tissue to form 
random bright specks that are scattered with increasing amount in the tissue as the 
injected concentration increases. These visible bright specks are possibly due to the 
aggregation of the gold nanoshells in the tissue environment although the presence of 
noise from the tissue reflectance cannot be ruled out. 
 
Figure 8.9. Changes in the confocal reflectance image of mouse tumor tissue taken 
from the OCT imaging site after 6 h of vascular circulation for a range of gold 
nanoshells concentration (1.1 x 1010 to 9.0 x 1010 particles/ml) injected intravenously.  
The confocal images were acquired under a 20X objective and the confocal 
reflectance microscopy was performed under 633 nm excitation. 
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The extracted µs of gold nanoshells laden tumor as determined from the theoretical 
curve fitting of the average A-scan profile for different gold nanoshells concentrations 
i.e. µs,GNS in tumor is indicated in Figure 8.8 and summarized in Table 8.1 below. The 
post-subtraction µs,GNS contributed by gold nanoshells alone in tumor shows that the 
scattering coefficient attributed to gold nanoshells and its estimated tumor 
concentration exhibit a positive correlation with the injected concentration although 
the relationship does not scale linearly with the amount of gold nanoshells injected as 
shown in Figure 8.10. 
 
Table 8.1. Summary of extracted µs,GNS in tumor of gold nanoshells laden tumor as 
determined from the theoretical curve fit of average A-scan profile as well as the 
estimated gold nanoshells concentration in tumor for different concentration of gold 
nanoshells injected intravenously. In all cases, the tumor tissue µs of 1.65 mm-1 is 

















localize in tumor 
1.1 x 1010 2.07 ± 0.30 0.42 ± 0.30 2.7 ± 1.9 x 109 24.0 % 
2.3 x 1010 2.21 ± 0.31 0.56 ± 0.31 3.6 ± 2.0 x 109 16.0 % 
4.5 x 1010 2.51 ± 0.25 0.86 ± 0.25 5.5 ± 1.6 x 109 12.3 % 
9.0 x 1010 2.62 ± 0.34 0.97 ± 0.34 6.2 ± 2.2 x 109 6.9 % 
 
However, when the estimated gold nanoshells concentration in the tumor is expressed 
as a fraction of the injected concentration, we observe that this fractional 
concentration actually decreases with increasing injected concentration to show a 
negative correlation. Likewise, this negative correlation does not scale linearly to the 
injected concentration. As the injected concentration increases eight-fold from 1.1 x 
1010 to 9.0 x 1010 particles/ml, the fractional concentration of injected gold nanoshells 
that localizes in the tumor merely decreases about four-fold from 24.0 % to 6.9 %. 
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Figure 8.10. Nonlinear relationship between the concentration of gold nanoshells 
localized in tumor and the injected gold nanoshells concentration (-■-). The tumor 
concentration of gold nanoshells expressed as a fractional concentration of the 
injected gold nanoshells concentration (-▲-) is also plotted. 
 
One clear observation that emerges from the trend observed above is a less responsive 
tumor localization at higher gold nanoshells dosage. The data could suggest a limiting 
concentration of gold nanoshells in the tumor at the 6 h time point based on a limiting 
rate of passive localization. This result shows that a higher dosing may not necessarily 
be more efficient in delivering the gold nanoshells to the tumor site despite being able 
to deliver a larger amount. An even larger percentage of gold nanoshells are wasted at 
higher injection dose. 
 
The changes in OCT images and average A-scan profiles for increasing gold 
nanoshells content in the tumor agree well with the phantom model shown in Figure 
7.8. The effect of different concentration of gold nanoshells in tumor on the OCT 
image holds several implications on the dosing of these nanoparticulate contrast agent 
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in living systems to control the OCT image enhancement. Therefore, it is imperative 
that the gold nanoshells dosage administered to the mouse can be controlled to 
establish an appropriate dosing regime so as to achieve a good compromise between 
OCT signal enhancement at the surface region and minimal signal attenuation deeper 
into the tissue. This control can be achieved based on the nonlinear relationship 
between the injected and localized amount arising from passive targeting as described 
earlier, which has not been reported to date and may be useful to further understand 
the dynamics of gold nanoshells passive localization in tumors. 
 
8.3.6 Comparison between passive and active targeting 
The percentage of injected gold nanoshells delivered to the tumor can be increased 
with appropriate antibody surface functionalization on the gold nanoshells to allow 
specific targeting to cancer markers of interest. By altering the dynamics of gold 
nanoshells tumor localization this way, active antibody targeting facilitates the control 
of optical contrast in tumors. The anti-EGFR conjugated gold nanoshells were 
injected i.v. into the mice at a concentration of 9.0 x 1010 particles/ml and allowed to 
circulate in the blood before OCT images of tumor were acquired after 2 and 6 h. The 
pegylated gold nanoshells without antibody functionalization were also injected with 
the same dosage in separate mice and monitored as a control for comparison.  
 
The OCT images in Figure 8.11 show that the signal intensity at both 2 and 6 h for 
tumor targeted with anti-EGFR gold nanoshells is generally higher especially at 
regions nearer to the tissue surface compared to tumor targeted with pegylated gold 
nanoshells and the difference is more significant at 2 h time point. The signal 
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attenuation with depth is also slightly more pronounced with the anti-EGFR gold 
nanoshells compared to their non-antibody counterparts at both time points.  
 
 
Figure 8.11. Comparison of the gold nanoshells localization in tumor tissue between 
passive targeting using pegylated gold nanoshells (left column) and active targeting 
using anti-EGFR conjugated gold nanoshells (right column) showing the changes in 
OCT images after 2 h (top) and 6 h (bottom) of gold nanoshells (9.0 x 1010 
particles/ml) i.v. delivery. 
 
 
Furthermore, the change in optical contrast of tumor from 2 to 6 h due to gold 
nanoshells localization is observable for both types of gold nanoshells, although the 
longitudinal signal change seems more apparent for the passively targeted pegylated 
gold nanoshells compared to the anti-EGFR targeted gold nanoshells. In the case of 
pegylated gold nanoshells, the increase in optical contrast over the tumor baseline i.e. 
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tumor without gold nanoshells is hardly observable at 2 h and would require another 4 
h of circulation before the optical effect of gold nanoshells can be observed clearly. 
This is unlike the case of anti-EGFR gold nanoshells where the increase in optical 
contrast is already observable after 2 h and it continues to increase, albeit more 
slowly, during the next 4 h. 
 
The average A-scans shown in Figure 8.12 below correspond to the OCT images in 
Figure 8.11. It shows the non-linear least square fit of the theoretical curve over the 
tumor data and the extracted µs,GNS in tumor for all the four instances in Figure 8.11. 
From the post-subtraction µs,GNS, the gold nanoshells concentration in tumor is 
derived as shown in Table 8.2. The results show that the concentration of pegylated 
gold nanoshells is estimated to increase from 2.6 x 108 particles/ml at 2 h to 6.2 x 109 
particles/ml at 6 h. This represents a 24-fold increase from 0.29 % to 6.9 % of injected 
gold nanoshells that reaches the tumor over the two time points. 
 
In comparison, the estimated concentration of anti-EGFR conjugated gold nanoshells 
in tumor is higher at both time points and it increases from 4.9 x 109 particles/ml at 2 
h to 7.4 x 109 particles/ml at 6 h. Despite having a higher concentration of gold 
nanoshells in tumor at both time points, the percentage of injected anti-EGFR gold 
nanoshells that reaches the tumor over the 4 h interval increases by only 1.5 times 




Figure 8.12. Comparison of the gold nanoshells localization in tumor tissue between 
passive targeting using pegylated gold nanoshells (left column) and active targeting 
using anti-EGFR conjugated gold nanoshells (right column) showing the changes in 
the average A-scan profile after 2 h (top) and 6 h (bottom) of gold nanoshells (9.0 x 
1010 particles/ml) i.v. delivery. The measured OCT signal is shown in dotted line 
while the non-linear least square fit of the data is shown in solid line superimposed 
with the extracted µs shown in the figure. 
 
The results from this study have also shown that antibody targeting with the use of 
appropriate antibody surface functionalization is one strategy that can improve the 
speed and efficiency of gold nanoshells tumor localization. In this study, the 
overexpression of EGFR is used as an appropriate cancer marker and the anti-EGFR 
antibody is used to guide the gold nanoshells to the mouse tumor based on this 
marker. This form of antibody guidance is specific to the tumor due to the 
overexpression of the EGFR receptor on the surface of tumor forming cancer cells. 
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Table 8.2. Summary of extracted µs,GNS in tumor of tumor with gold nanoshells as 
determined from the theoretical curve fit of average A-scan profile as well as the 
estimated gold nanoshells concentration in tumor after 2 h and 6 h of vascular 
circulation with non-specific pegylated and anti-EGFR conjugated gold nanoshells. 
The µs,GNS of gold nanoshells alone in tumor is obtained from the subtraction of µs of 



























2 h 1.69 ± 0.27 0.04 ± 0.27 2.6 ± 1.7 x 108 0.29 % 






2 h 2.42 ± 0.23 0.77 ± 0.23 4.9 ± 1.5 x 109 5.5 % 
6 h 2.80 ± 0.25 1.15 ± 0.25 7.4 ± 1.6 x 109 8.2 % 
 
 
The A-431 cells that were inoculated to form the xenograft tumor in mice are known 
to have a high expression of EGFR, several times higher than normal cells. This high 
expression of EGFR, together with a relatively porous tumor vasculature, facilitates a 
greater amount of receptor-ligand interaction that results in larger quantity of gold 
nanoshells targeting and binding to the cancer cells. On the other hand, the nominal 
EGFR expression found in normal cells coupled with the non-porosity of the normal 
vasculature does not encourage much receptor -anti-EGFR interaction and thereby 
resulting in minimal tumor localization. 
While passive targeting using pegylated gold nanoshells relies solely on vascular 
porosity to confer a moderate level of tumor specificity, antibody targeting offers a 
higher level of tumor specificity that is based on differences in cancer marker 
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expression in addition to vascular porosity. For this reason, active targeting with anti-
EGFR gold nanoshells offers greater control of gold nanoshells delivery to the tumor 
site to enable a larger amount of gold nanoshells to be delivered to the tumor within a 
shorter period of time. This explains the increase in absolute amount as well as 
percentage increase of injected gold nanoshells that localizes in the tumor at both time 
points compared to passive targeting. 
 
Apart from a greater amount of tumor localization, active targeting using anti-EGFR 
also tends to accelerate the rate gold nanoshells tumor localization, which explains the 
significant difference in the OCT image intensity between active and passive targeting 
at 2 h. This comes about because the EPR effect of passive targeting is an inefficient 
biological process of transporting gold nanoshells out of the blood circulation into the 
tumor and would thus require prolong period of vascular circulation i.e. 6 h before a 
sufficient amount of gold nanoshells are localized to cause an observable change in 
the OCT image.  
 
The antibody receptor binding in active targeting eliminates this problem through 
promoting a strong interaction between the nanoparticles and the biological 
environment, thus allowing sufficient amount of gold nanoshells to localize within a 
shorter time of 2 h. However, given more time for the pegylated gold nanoshells to 
localize passively in the tumor, the difference in the OCT image intensity between 
passive and active targeting at 6 h is reduced. This occurs as the pegylated gold 
nanoshells continue to accumulate consistently in the tumor while the rate of anti-
EGFR gold nanoshells delivery to tumor becomes slower when the EGFR receptors 
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available for binding is reduced as increasingly more and more receptors are being 
bounded to the anti-EGFR gold nanoshells. 
 
For the same reason as discussed above, the longitudinal change in the OCT image 
and average A-scan profile between 2 and 6 h is more apparent with passively 
targeted gold nanoshells compared to antibody targeted gold nanoshells since the 
pegylated gold nanoshells would require a longer period of 6 h before they localizes 
to produce an observable contrast while the anti-EGFR conjugated gold nanoshells 
localizes sufficiently fast within 2 h to produce the same observable contrast. Such 
delivery dynamics hold considerable implications towards developing a contrasting 
regime where time is crucial to the subject being studied. 
 
8.4 Conclusion 
In this chapter, the in vivo control of optical contrast in a mouse xenograft tumor 
model using gold nanoshells as a contrast agent in OCT is demonstrated. This is 
achieved via three approaches: 1. Employing different gold nanoshells delivery modes 
such as intratumoral or i.v., 2. Varying the concentration of injected dosing and 3. 
Enabling active targeting with appropriate antibody surface functionalization on gold 
nanoshells. The estimation of gold nanoshells concentration in tumor tissue of live 
mice derived from the extraction of µs presents a novel technique that could be used 
to noninvasively determine gold nanoshells concentration in tissue in real time. When 
used to examine the dynamics of gold nanoshells localization in tumor with variations 
in i.v. dosage and presence of surface functionalization and the results reveal a non-
linear response of gold nanoshells tumor localization with increasing dosage.  
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Furthermore, the use of antibody active targeting serves not just to improve the tumor 
localization of gold nanoshells but also hasten their delivery over passive targeting. 
Such insights aid in better understanding of the dynamics of gold nanoshells tumor 
delivery and thereby hold several implications towards developing an optimized 
contrast protocol to add further value to the clinical significance of OCT. Being able 
to target the tumor cells overexpressing EGFR, the findings also highlight the 
versatility of gold nanoshells not just as a generic contrast agent but one which can 
potentially be associated with disease markers to further elucidate the molecular 
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PHOTOTHERMAL CANCER THERAPY 
 
Abstract 
Besides imaging applications, the optical properties of gold nanoshells can also be 
exploited for cancer therapy as in the case of photothermal cancer therapy (PTT). 
Similar to photodynamic therapy (PDT), both treatments have proven to be effective 
treatment strategies for cancer, but the approach of combining them into a single 
treatment modality may offer better treatment efficacy. In this chapter, the 
combinational treatment of PTT using gold nanoshells with conventional PDT to 
improve treatment efficacy is described in an in vitro study. The treatment efficacy of 
such combined treatment is compared with that of the individual treatment. The 
individual PDT, PTT and combined treatment were performed under selected in vitro 
condition with a low light dose of 1.44 J/cm2 and their cell viability were compared 
using crystal fast violet assay. Compared to PDT and PTT alone which can reduce 
cell viability to 30.9% and 44.0% respectively, the combined treatment under a single 
irradiation can further reduce the cell viability to 17.5%. A combined PDT and PTT 
treatment appears to be a more effective treatment strategy compared to conventional 
PDT or emerging PTT treatment. The work presented in this chapter has been 




Photodynamic therapy (PDT) has emerged as a promising treatment modality in 
cancer. It involves a combined effect of a photosensitizer administered either topically 
or intravenously and a non-thermal light dose with appropriate fluence and 
wavelength that matches the excitation of photosensitizer to initiate an irreversible 
photochemical destruction to cells. Whilst PDT has achieved much success in the 
clinical settings [1-3], it is without its own limitations. Apart from its known side 
effects of phototoxicity, most of the photosensitizers require the activation by light of 
wavelengths that limits its penetration into tissue, thus confining the treatment area to 
superficial regions. These photosensitizers also suffer from modest specificity and 
thus have a tendency to also localize in non-pathological region of tissue [4]. 
 
The destruction of tumors using hyperthermia has been under investigation for some 
time but photothermal therapy (PTT) only emerge as a promising treatment modality 
after the advent of exogenous absorption agents such as indocyanine green [5, 6]. This 
is because these agents can interact with deep penetrating near infrared (NIR) lasers 
and allow the lethal dose of heat formed to be localized deep in target site with little 
damage to the intervening and surrounding healthy tissue as the activating NIR light 
propagates through the tissue with minimum absorption and maximum transmission 
to reach the underlying tumor.  
 
Gold nanoshells have also recently shown efficacy in PTT both in vitro [7, 8] and in 
vivo [9, 10] due to their tunable surface plasmon resonance coupled with a large 
absorption cross section (exceeding indocyanine green by several orders of 
magnitude) which allows them to strongly absorb light in the NIR wavelength with 
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maximum tissue penetration. The mechanism of cell kill that has been reported by 
others [11] is shown in Figure 9.1 below. Gold nanoshells are also photostable, 
biocompatible [12, 13] and can be easily conjugated to targeting moieties such as 
antibodies and oncoproteins to confer greater specificity for targeted PTT [14]. These 
benefits associated with nanoshell-mediated photothermal therapy seem to have the 
potential to address the limitations of PDT. 
 
 
Figure 9.1. The principle of selective nanophotothermolysis with self-assembling gold 
nanoclusters. Based on the study by Zharov et al. [11], the human breast 
adenocarcinoma cell (MDA-MB-231) targeted with primary antibody IgG (F19), 
which is selectively attached to surface proteins (seprase), and secondary goat anti-
mouse IgG conjugated with 40 nm gold nanoparticles, which is selectively attached to 
the primary antibodies. The schematics of laser-induced overlapping heated zones and 
bubbles from closely located nanoparticles. 
 
The present study described in this chapter aim to determine if the combination of 
PDT and PTT administered with a single irradiation will result in a better treatment 
efficacy compared to their individual treatment in terms of lower cell viability. The 
approach of combining both treatment modalities has not been reported and may 
potentially offer greater therapeutic efficacy. The PDT performed in this study is 
based a previously published in vitro treatment regime using a low light dose with 
hypericin as the photosensitizer [15] while the in vitro PTT involves the same light 
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dose with gold nanoshells that are conjugated to anti-epidermal growth factor receptor 
(EGFR) as the photothermal agent.  
 
As there are currently no report on PTT using a low light dose to date, two factors will 
first be examined, namely the irradiation time and concentration of gold nanoshells 
and quantified for their photothermal treatment efficacy in order to select a suitable 
treatment condition to yield maximum cell kill based on the low light dose prior to 
evaluating the combination treatment. The results demonstrate that upon combining 
both PDT and PTT together under a single irradiation, a synergistic effect that leads to 
a further reduction in cell viability is observed and this will be discussed briefly. 
 
9.2 Materials and methods 
9.2.1 Preparation of antibody conjugated gold nanoshells 
Gold nanoshells with a silica core radius of 81 nm and gold shell thickness of 23 nm 
were synthesized in a four-step process which is described in more detail in Chapter 
4. The gold nanoshells were imaged under the TEM (Jeol JEM-1010) and their 
extinction spectrum was characterized using a UV-Vis spectrophotometer (Shimadzu 
UV-2401 PC) The monoclonal anti-EGFR (Santa Cruz Biotechnology Inc.) was 
conjugated to gold nanoshells using the heterobifunctional poly(ethylene)glycol 
(PEG) SH-PEG-COOH (MW = 3000 g/mol, Celares GmbH) as the linker where the 
thiol end was attached to the gold surface of the nanoshells and the carboxylic end 
reacted with amine groups on the anti-EGFR via carbodiimide chemistry to form an 
amide bond. The details of the antibody conjugation are documented in Chapter 6. 
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9.2.2 Light source for treatment 
The irradiation were performed using a 100 x 50 cm light diffusing surface 
illuminated by a bank of 14 fluorescent tubes (Philips type OSRAM L30W11-860, 
30W), filtered with red acetate filters (No. 17; Roscolux, Rosco, CA, USA) to give to 
a wide band illumination above 585 nm. The energy fluence rate was 4 mW/cm2 at 
800 nm as measured using a power meter (Laser check; Coherent, USA). The cells 
were irradiated for a range of time to give light fluence of 0.48 to 2.88 J/cm2. 
 
9.2.3 Photodynamic therapy in vitro 
The photosensitizer hypericin with a peak absorbance at 595 nm was obtained from 
Molecular Probes. For PDT treatment, the poorly differentiated CNE2 cells were 
plated in 96-well plates at 2 x 104 cells per well and allowed to attach overnight. 
Medium was then removed and replaced with 200 µl of fresh medium containing 1.25 
µM of Hypericin for 6 h. After 6 h of hypericin incubation, the hypericin-containing 
medium was then replaced with fresh growth medium, and the cells were irradiated 
for 6 minutes and incubated again in the dark for 18 h. After 18 h of incubation, the 
irradiated cells were evaluated for cell kill using the crystal fast violet assay. The use 
of crystal fast violet assay to quantify cell viability in in vitro assays is well 
documented [15]. It detects cell viability by binding to DNA of viable cells. 
Incubation of live cells in a mixture of crystal violet causes cells to lyse and the 
released nuclei to be stained purple. Cells exposed to the light alone without any drug 
and cells receiving drug alone without any light were used as controls. 
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9.2.4 Photothermal therapy in vitro 
For the PTT study, the following factors were investigated to select a suitable 
treatment condition: irradiation exposure and concentration of gold nanoshells. The 
protocol used for PTT is the same as that for PDT, except that instead of hypericin, 
the cells were incubated with medium containing a range of concentration of anti-
EGFR conjugated gold nanoshells (3.0 x 109 to 6.0 x 1011 particles/ml) for 45 minutes. 
The 45 minutes of incubation period is the typical time known to be sufficient for 
antibodies binding to their antigens. The cells were then irradiated for a range of 
exposure time. The controls were the same as that of PDT. The study was performed 
in triplicates and the unpaired 2-sided Student’s t-test was performed to determine any 
statistical difference in the treatment efficacy between each condition and its 
respective controls. The temperature rise in the culture medium after irradiation was 
measured by a thermocouple (type K) that is able to exhibit instantaneous response to 
real-time temperature changes with an accuracy range of ±[0.05% + 0.3°C] (Fluke 52 
II Thermometers, USA). 
 
9.2.5 Combinational treatment of PDT and PTT 
The protocol is the same as above. The CNE2 cells were incubated with fresh medium 
containing 1.25 µM of hypericin for 6 h and anti-EGFR conjugated gold nanoshells 
(6.0 x 1010 particles/ml) were added to the hypericin-containing medium 45 minutes 
before the 6 h incubation lapsed so as to allow 45 minutes of incubation of cells with 
gold nanoshells. After incubation, the medium was replaced with fresh medium and 
cells were irradiated for 6 minutes. The controls were the same as that of PDT and the 
study was performed in triplicates. The one-way ANOVA test with one-way analysis 
 266
of variance was performed to determine any statistical difference in the treatment 
efficacy between the combined treatment and the individual PDT or PTT treatment as 
well as their respective controls with either drug or light alone. 
 
9.3 Results and discussion 
9.3.1 Synthesis and characterization of gold nanoshells 
The TEM image of the gold nanoshells and its UV-Vis absorption spectrum is shown 
in Figure 9.2. The emission spectrum of the light source used for the irradiation is also 
shown as a comparison. The gold nanoshells synthesized were generally spherical and 
monodispersed. Their absorption spectrum shows a rather broad extinction band of 
wavelength > 580 nm with two discernable peaks at around 650 nm and 800 nm. This 
absorption spectrum matches the emission spectrum of the light source well and thus 
allows an efficient transfer of optical energy from the light source to the gold 
nanoshells for photothermal conversion. 
 
 
Figure 9.2. (a) TEM image of the synthesized gold nanoshells with a 162 nm silica 
core and a 23 nm gold shell, and (b) their absorption spectrum (solid curve) compared 
to the emission spectrum (dotted curve) of the light source used in this study. 
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9.3.2 Optimization of irradiation dose for PTT 
The CNE2 cell lines were incubated with these gold nanoshells conjugated to anti-
EGFR (6.0 x 109 particles/ml) and irradiated under various exposure times to 
investigate the effect of different irradiation dose on cell viability. The cell viability 
and temperature in cell medium after exposing them to light from 2 to 12 minutes is 
shown in Figure 9.3. As the cells were irradiated, the temperature of the medium 
increased rapidly from 33.0 °C after 2 minutes of irradiation to 40.1 °C after 6 
minutes of irradiation. Thereafter, the temperature rise in the medium becomes more 
gradual beyond 6 minutes of irradiation, eventually reaching a plateau of around 43 
°C. This temperature rise is the result of the light absorption of gold nanoshells 
attached to the surface of cells via the EGFR receptors and their subsequent 
photothermal conversion to heat up the cells, thereby causing the temperature rise. 
 
 
Figure 9.3. Cell viability and temperature of cell medium after incubating the CNE2 
cells with gold nanoshells (6.0 x 109 particles/ml) for 45 minutes and subsequently 
exposing them to light for a range of irradiation exposure to give a PTT light dose of 
0.48 to 2.88 J/cm2. 
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This thermal effect on the cells also resulted in their destruction as the corresponding 
cell viability decreased from 94.0% after 2 minutes of irradiation to just 53.6% after 6 
minutes of irradiation. The cell viability remained relatively constant at around 52% 
beyond 6 minutes of irradiation. The results for each irradiation exposure time were 
significantly different when compared to their respective control of irradiation without 
gold nanoshells using an unpaired Student’s t-test with a p-value of <0.05. Therefore, 
there seems to be a negative correlation between the cell viability and the temperature 
of the medium as controlled by the irradiation exposure.  
 
An exposure time of 6 minutes would be sufficient to optimize the cell kill with a low 
light dose of 1.44 J/cm2 as any further irradiation have little or no impact on the cell 
viability. The published data on PTT in vitro have so far demonstrated cell kill 
qualitatively with cell viability staining immediately after irradiation under a high 
light dose with a fluence rate of >10W/cm2 [16, 17]. While a high light dose is known 
to induce immediate necrotic cell death with severe heating, PTT with a low light 
dose may induce cell death via a slower mechanism with its gentler thermal effect.  
 
As the temperature in the medium rise beyond 40 °C due to the photothermal 
conversion between the matching source spectrum and the absorption spectrum of the 
gold nanoshells, the cell viability drops by nearly half. Although this temperature is 
only slightly higher than normal physiological temperature, it would be worth noting 
that the actual temperature experienced by the cells with the presence of gold 
nanoshells heating on their surface will be higher than the measured temperature in 
the medium. Whilst the actual difference could not be determined experimentally with 
the current setup, it could be significant enough to induce cell mortality. This is 
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especially true for cancer cells which are known to be more sensitive to increase in 
temperature in terms of their biochemical changes compared to normal cells [18, 19]. 
Previous studies have shown that these cells are susceptible to destruction at 
temperature of 43 °C as effects due to DNA damage, glucose deprivation etc. during 
hyperthermia prove to be strongly accelerated to result in a lethal lack of cellular 
energy and subsequent cell death [20-22].  
 
As the irradiation exposure increases, the gold nanoshells continue to absorb more 
photons and convert them to thermal energy to heat its surroundings until a point 
where the temperature in the medium reaches a steady state of around 43 °C after 6 
minutes of irradiation and any further temperature rise is limited by the fluence rate of 
the light source. Such a steady state in the temperature thus results in a corresponding 
plateau in the cell mortality where no further lowering of cell viability is observed 
upon further irradiation. 
 
9.3.3 Optimization of gold nanoshells concentration for PTT 
The same correlation between the cell viability and temperature of medium was 
observed when the concentration of gold nanoshells added to the cells was varied as 
shown in Figure 9.4. The temperature of the medium increased gradually from 38.0 
°C with 3.0 x 109 particles/ml to 45.4 °C with 6.0 x 1010 particles/ml and remained 
rather constant thereafter at temperature of around 46 °C even with further addition of 
gold nanoshells to the cells. With an increasing temperature heating the cells, the 
corresponding cell viability decreased from 63.0% with 3.0 x 109 particles/ml to 
44.0% with 6.0 x 1010 particles/ml and likewise remained constant with a cell viability 
of around 43%, independent of any further addition of gold nanoshells. 
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The results for each concentration were significantly different when compared to their 
respective control without irradiation using an unpaired Student’s t-test with a p-value 
of < 0.05. This result suggests that a concentration of 6.0 x 1010 particles/ml would be 
sufficiently suitable to maximize cell kill with the low light dose treatment condition 
without the addition of more than necessary amount of gold nanoshells to the cells. 
 
 
Figure 9.4. Cell viability and temperature of cell medium after incubating the CNE2 
cells with a range of gold nanoshells concentration from 3.0 x 109 to 6.0 x 1011 
particles/ml for 45 minutes and subsequently exposing them to light for 6 minutes to 
give a PTT light dose of 1.44 J/cm2. 
 
The temperature in the medium and hence the cell viability is therefore affected by the 
concentration of the gold nanoshells added to the cells. This concentration determines 
the amount of anti-EGFR conjugated gold nanoshells available to bind to the EGFR 
receptors on the CNE2 cells. As the cells were incubated with an increasing 
concentration of gold nanoshells from 3.0 x 109 to 6.0 x 1011 particles/ml, more of the 
nanoshells were bound to the cells which resulted in a higher temperature rise with 
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more photothermal centre and consequently lower cell viability when the cells were 
subsequently irradiated for 6 minutes. 
 
The EGFR signaling pathway is one of the most important pathways that regulate 
proliferation in mammalian cells and an abnormal expression of EGFR is often 
associated with increased cell proliferation and decreased apoptosis leading to 
carcinogenesis. The EGFR is highly expressed in a variety of human cancer of 
epithelial origin. Based on a separate ELISA analysis as described in Chapter 6, the 
CNE2 cells express about 180.9 pg of EGFR per 1000 cells which is about 6 x 105 
EGFR receptors on each cell. This represents an approximate 6 times higher 
expression compared to normal cells with typical expression level of 9 x 104 EGFR 
per cell. This difference in expression level allows the PTT treatment with anti-EGFR 
gold nanoshells to be targeted more specifically to cancer cells.  
 
As the concentration of gold nanoshells added to the cells increases, more of the 
EGFR receptors on the cells will be bound to the anti-EGFR gold nanoshells and 
subsequent irradiation raises the temperature due to a larger amount of gold 
nanoshells present to heat the cells. This ligand-receptor binding continues until all 
the EGFR binding sites on cells are saturated. This saturation concentration roughly 
corresponds to 6.0 x 1010 particles/ml where about 1.2 x 1010 anti-EGFR gold 
nanoshells were added to fully bind to all the receptors on the 2 x 104 CNE2 cells in 
each well. Any further addition of gold nanoshells that exceeds this saturation 
concentration will form unbound excesses in medium which will be removed by 
washing and will have no impact on further increasing the photothermal effect and 
reducing the cell viability. 
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9.3.4 Combinational treatment of PDT and PTT 
A quantitative analysis of the cell viability under low light dose has not been reported 
to date and the results from previous section show that a light dose of 1.44 J/cm2 from 
6 minutes of irradiation on CNE2 cells incubated with 6.0 x 1010 particles/ml of gold 
nanoshells is sufficient to reduce the cell viability to 44.0% and any further increase 
in the light dose or concentration of gold nanoshells does not affect the cell viability 
much. Once the suitable treatment condition to maximize cell kill for PTT was 
established based on this condition, the treatment efficacy when both PDT and PTT 
were combined under a single irradiation of 6 minutes was evaluated.  
 
The results in Figure 9.5 show that both PDT and PTT alone resulted in a cell 
viability of 30.9% and 44.0% respectively. For the in vitro PDT treatment, the cell 
viability of 30.9% achieved is consistent with previously published results using the 
same PDT treatment regime [23]. When the treatment was combined under a single 
irradiation, the cell viability was reduced to just 17.5%, which is lower than either of 
the individual treatment. These three treatment results were significantly different (p < 
0.05) compared to their respective controls with either the drug or light alone which 
maintained a high cell viability of > 94.5% for all control cases (Figure 9.5). 
Furthermore, the improvement from combined treatment in terms of lowering the cell 
viability was also statistically significant compared to the respective individual PDT 




Figure 9.5. Cell viability after the individual PDT and PTT as well as the combined 
treatment. The conditions for in vitro PDT follows a previously published treatment 
protocol [15] while the condition for in vitro PTT follows that which is established in 
this study i.e. incubation of cells with 6 x 1010 particles/ml of gold nanoshells for 45 
minutes followed by light irradiation of 6 minutes to give a light dose of 1.44 J/cm2. 
The cell viability of their respective controls with either the drug or light alone is also 
shown for comparison. 
 
Although both PDT and PTT have the same basic treatment principle that involves a 
synergistic interaction between a light source and a drug of interest, their mechanism 
for eliciting cell kill is different. While the cell kill for PTT is attributed to the 
photothermal heating of the cancer cells due to the light absorption of gold nanoshells, 
the cell death induced by PDT is due to the generation of toxic singlet oxygen species 
by the activation of photosensitizer in the presence of light and ambient oxygen. As in 
the case of PDT, PTT may also induce cell death via necrosis or apoptosis depending 
on the light dose administered.  
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Previous results with PDT have shown that necrotic cell death tends to occur with 
high light dose from a high fluence rate coupled with a long exposure time while a 
low light dose PDT tends to trigger a slower apoptotic cell death that promotes 
subsequent tissue healing with lesser inflammatory response [24]. The low light dose 
used in the PTT treatment in this study may induce cell death via apoptosis since the 
temperature rise is gentler and may not be sufficient to “cook” the cells but yet 
sufficient to raise their temperature to the apoptotic window to trigger the slower 
programmed cell death [25]. With this in mind, the irradiated cells were evaluated for 
cell kill only after 18 h of further incubation in fresh medium instead of immediate 
staining with tryphan blue after irradiation. 
 
It is also clear from the cell viability results of the individual treatment that a full 
eradication of the cancer cells was not achieved with the treatment protocol based on 
the low light dose. However, when both treatments are combined under a single 6 
minutes irradiation, the combined treatment is able to achieve about 15 to 30% more 
cell kill compared to the individual treatment to further reduce the cell viability to 
17.5%. Full eradication of the cancer cells may be possible with the combined 
treatment under a low light dose if the combined drug conditions are further 
optimized. Such improvements with a combined treatment have also been observed in 
other forms of treatment when combined with hyperthermia such as chemotherapy 
[26, 27] and radiotherapy [27-29].  
 
The improvement in treatment efficacy observed in this study may be due to a variety 
of possible synergistic effect. One such possibility is when either treatment alone may 
damage the cells but not sufficient to induce cell death. In this case, the presence of 
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another treatment may further augment the damage and trigger the actual cell death. 
The thermal energy generated by the gold nanoshells may also accelerate the 
generation of the singlet oxygen species. It would also be of worth to note that the 
results observed could also be specific to the particular response assay used, which is 
the crystal fast violet assay in this case. A different assay such as a clonogenic assay 
may produce a qualitatively different result. An elucidation of the actual mechanism 




This study presents a preliminary in vitro evaluation on the treatment efficacy of a 
combined PDT and PTT treatment regime under low light dose condition compared to 
their individual treatment response. Compared to PDT and PTT alone which can 
reduce cell viability to 30.9% and 44.0% respectively, a combined treatment regime 
under a single irradiation can further reduce the cell viability to 17.5%. In essence, the 
current finding shows the versatility of gold nanoshells not just as an optical contrast 
agent for reflectance-based imaging, but also its potential is improving current cancer 
therapeutics. The combined PDT and PTT treatment modality as demonstrated in this 
chapter promises to be a more effective treatment strategy compared to conventional 
PDT or emerging PTT treatment method. Such combined treatment may impact 
current clinical practice by potentially yielding better treatment efficacy in terms of 
higher cell kill and greater tumor specificity conferred by the antibody targeting to 
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CHAPTER TEN  
FINAL CONCLUSION 
 
This thesis discusses the use of gold nanostructures, in particular, gold nanoshells as 
an optical contrast agent in reflectance-based imaging with the potential of 
performing molecular contrast of relevant cancer markers. Two of such imaging 
technique is described in this work, namely, the confocal reflectance microscope and 
the OCT. Preliminary studies were done using simple spherical gold nanoparticles 
where they have shown to provide an optical contrast to discriminate cancer from 
normal cells as well as to map the expression of EGFR cancer marker under a suitably 
matching wavelength to their surface plasmon resonance at 520 nm. However, most 
of the clinical optical imaging system that operates in NIR would require 
nanoparticles with matching optical response in the NIR and the tunability of gold 
nanoshells facilitates further study which forms the main focus of this thesis. 
 
The use of gold nanoshells would require their size configuration to provide an 
optimized backscattering response which can be predicted by Mie theory based on a 
concentric shell configuration. The synthesis of gold nanoshells using the DP process 
of seeding has shown to be a time and cost efficient technique compared to 
conventional synthesis techniques. Pegylation of gold nanoshells with mPEG-thiol 
provides an effective means to increase their stability in solution and reduce 
macrophageal clearance and the PEG surface density is a critical end parameter that 
determines such clearance. This surface density is not just affected by the amount of 
PEG added, but also on its molecular weight and the size of gold nanoshells.  
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The optical response of gold nanoshells is able to provide a contrast enhancement 
under in vitro confocal reflectance in NIR and antibody conjugation to gold 
nanoshells confers specificity to this contrast enhancement to discriminate cancer 
from normal cells based on differential molecular expression, which can coincidently 
be imaged and mapped with gold nanoshells. Further phantom studies have confirmed 
the improvement in OCT signal with gold nanoshells and have shown a concentration 
window of gold nanoshells in tissue that achieves a good compromise between signal 
enhancement near sample surface and signal attenuation deeper into sample. 
 
The results from the phantoms model the actual optical response in an in vivo mouse 
xenograft tumor model well. The contrast enhancement in tumor tissue can be 
controlled by varying the dosage administered to the tissue of interest and the gold 
nanoshells concentration in tumor can be reliably estimated from the OCT signal 
profile. The use of antibody conjugated gold nanoshells results in stronger signal 
enhancement in tumor within a shorter circulation time in mice. Besides promising in 
vivo imaging results, gold nanoshells also show potential as a cancer therapeutic in 
vitro when combined with conventional PDT to further improve treatment efficacy, 
thus showing promise of an integrated cancer imaging and therapeutic agent. 
 
10.1 Future directions 
The final conclusion would not be complete without the mention of possible future 
directions that would bring the use of gold nanoshells closer to the clinic. The present 
in vivo study discussed in this thesis can be further developed in at least three 
different aspects. The first aspect addresses the limitations of the current analytical 
technique to deduce the concentration of gold nanoshells in multilayer tissue. The 
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present OCT theoretical models used to extract the µs of the sample is only applicable 
for homogenous sample whereas most tissues are present with multiple stromal layers. 
To enable the current technique to be more robust for multilayer tissue, the analysis 
algorithm has to be further develop to accurately extract out the µs of the individual 
layers. An evaluation of the accuracy of this technique in determining the gold 
nanoshells concentration in tissue is also necessary and would warrant further study to 
compare against the concentration obtained from another independent technique such 
as inductively coupled plasma mass spectroscopy (ICP-MS). 
 
The second aspect addresses the experimentation needed to further understand the 
dynamics of gold nanoshells passive localization in tumor in vivo. The current 
nonlinear logarithmic relationship between the injected and localized gold nanoshells 
amount arising from passive targeting is deduced from a single 6 h time point based 
on a narrow concentration range. The results can be made more conclusive following 
further studies involving a wider dosing range over more time points to facilitate a 
proper interpretation of the results. The same can be applied to antibody 
functionalized gold nanoshells to further understand the dynamic of gold nanoshells 
active targeting to tumors. 
 
The third aspect lies with possible improvements to the in vivo tumor model to more 
accurately represent the disease progression in cancer. Whilst the current in vivo 
results demonstrate the control of contrast enhancement by varying the gold 
nanoshells delivery, the use of xenograft tumor models with a gradient expression of 
EGFR arising from well calibrated cell lines will serve well to correlate the contrast 
enhancement with EGFR expression for quantitative molecular imaging. The use of 
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orthotropic tumor model such as the hamster’s cheek pouch model with well defined 
tumor progression parameters can also serve to evaluate the effectiveness of optical 
contrast from targeted gold nanoshells to monitor cancer progression.  
 
In addition, the promising integrated imaging and therapeutic feature of gold 
nanoshells can also be further evaluated on its efficacy in performing simultaneous 
imaging and photothermal therapy. Besides their performance evaluation, the 
biodistribution and long term clearance of gold nanoshells would also deserve further 
studies to ascertain minimal health risk prior to potential clinical applications. 
 
The successful implementation of anti-EGFR conjugated gold nanoshells as a 
molecular specific contrast agent in OCT have the potential to significantly impact 
current clinical practice in the following ways. Firstly, it will provide a noninvasive 
alternative to tissue biopsy and allows clinicians to have an accurate real time 
diagnosis that minimizes waiting time. Secondly, the combination of phenotypic 
markers and molecular expression profiling will allow earlier detection and improved 
diagnosis of suspicious premalignant lesion, thus enhancing its diagnostic capability 
which is currently limited to detecting phenotypic abnormalities. Thirdly, expression 
profiling will also provide critical information for rational selection of therapy.  
 
The combination of detailed anatomical resolution given by OCT together with 
molecular information generated by optical contrast from the antibody conjugated 
gold nanoshells will enhance the sensitivity and specificity of early epithelial cancer 
diagnosis in vivo. Early detection of curable precancers can dramatically reduce the 
incidence and mortality of cancer in high-risk individuals. 
